{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:40:28Z","timestamp":1792604428345,"version":"4.5.0"},"reference-count":739,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":672,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["pharmrev.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reviews"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1124\/pharmrev.122.000684","type":"journal-article","created":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T14:40:17Z","timestamp":1676472017000},"page":"328-379","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":123,"title":["Pharmacology of Heparin and Related Drugs: An Update"],"prefix":"10.1016","volume":"75","author":[{"given":"John","family":"Hogwood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Mulloy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebeca","family":"Lever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clive P.","family":"Page","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/pharmrev.122.000684_bib1","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1055\/s-0032-1301410","article-title":"Tissue factor pathway inhibitor: new insights into an old inhibitor","volume":"38","author":"Adams","year":"2012","journal-title":"Semin Thromb Hemost"},{"key":"10.1124\/pharmrev.122.000684_bib2","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/978-3-030-34521-1_32","article-title":"Heparanase, heparan sulfate and viral infection","volume":"1221","author":"Agelidis","year":"2020","journal-title":"Adv Exp Med Biol"},{"key":"10.1124\/pharmrev.122.000684_bib3","doi-asserted-by":"crossref","first-page":"15579","DOI":"10.1038\/s41598-021-95050-2","article-title":"Characterization of the structural forces governing the reversibility of the thermal unfolding of the human acidic fibroblast growth factor","volume":"11","author":"Agrawal","year":"2021","journal-title":"Sci Rep"},{"key":"10.1124\/pharmrev.122.000684_bib4","doi-asserted-by":"crossref","first-page":"111851","DOI":"10.1016\/j.msec.2020.111851","article-title":"Enema based therapy using liposomal formulation of low molecular weight heparin for treatment of active ulcerative colitis: new adjunct therapeutic opportunity","volume":"121","author":"Ahmad","year":"2021","journal-title":"Mater Sci Eng C"},{"key":"10.1124\/pharmrev.122.000684_bib5","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1164\/ajrccm\/145.3.566","article-title":"Effects of inhaled heparin on immunologic and nonimmunologic bronchoconstrictor responses in sheep","volume":"145","author":"Ahmed","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"10.1124\/pharmrev.122.000684_bib6","doi-asserted-by":"crossref","first-page":"gaab004","DOI":"10.1093\/molehr\/gaab004","article-title":"Heparin fragments induce cervical inflammation by recruiting immune cells through Toll-like receptor 4 in nonpregnant mice","volume":"27","author":"\u00c5kerud","year":"2021","journal-title":"Mol Hum Reprod"},{"key":"10.1124\/pharmrev.122.000684_bib7","doi-asserted-by":"crossref","DOI":"10.1177\/10760296211052293","article-title":"General considerations for diversifying heparin drug products by improving the current heparin manufacturing process and reintroducing bovine sourced heparin to the US market","volume":"27","author":"Al-Hakim","year":"2021","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1124\/pharmrev.122.000684_bib8","doi-asserted-by":"crossref","first-page":"12699","DOI":"10.1021\/acsomega.1c00935","article-title":"Sulfonated nonsaccharide heparin mimetics are potent and noncompetitive inhibitors of human neutrophil elastase","volume":"6","author":"Al-Horani","year":"2021","journal-title":"ACS Omega"},{"key":"10.1124\/pharmrev.122.000684_bib9","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3389\/fcell.2018.00163","article-title":"Heparan sulfate as a therapeutic target in tauopathies: insights from zebrafish","volume":"6","author":"Alavi Naini","year":"2018","journal-title":"Front Cell Dev Biol"},{"key":"10.1124\/pharmrev.122.000684_bib10","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/978-3-642-23056-1_10","article-title":"Adverse effects of heparin","volume":"207","author":"Alban","year":"2012","journal-title":"Handb Exp Pharmacol"},{"key":"10.1124\/pharmrev.122.000684_bib11","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.carbpol.2016.09.032","article-title":"Structural features of heparanase-inhibiting non-anticoagulant heparin derivative Roneparstat","volume":"156","author":"Alekseeva","year":"2017","journal-title":"Carbohydr Polym"},{"key":"10.1124\/pharmrev.122.000684_bib12","doi-asserted-by":"crossref","first-page":"115913","DOI":"10.1016\/j.carbpol.2020.115913","article-title":"In-depth structural characterization of pentosan polysulfate sodium complex drug using orthogonal analytical tools","volume":"234","author":"Alekseeva","year":"2020","journal-title":"Carbohydr Polym"},{"key":"10.1124\/pharmrev.122.000684_bib13","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.tcm.2020.12.004","article-title":"COVID-19 and thrombosis: from bench to bedside","volume":"31","author":"Ali","year":"2021","journal-title":"Trends Cardiovasc Med"},{"key":"10.1124\/pharmrev.122.000684_bib14","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/jbm.a.36885","article-title":"Study on the potential mechanism of anti-inflammatory activity of covalently immobilized hyaluronan and heparin","volume":"108","author":"AlKhoury","year":"2020","journal-title":"J Biomed Mater Res A"},{"key":"10.1124\/pharmrev.122.000684_bib15","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s11239-019-01900-2","article-title":"The use of direct oral anticoagulants for extended duration thromboprophylaxis in medically ill patients: a systematic review and meta-analysis","volume":"48","author":"Alshouimi","year":"2019","journal-title":"J Thromb Thrombolysis"},{"key":"10.1124\/pharmrev.122.000684_bib16","doi-asserted-by":"crossref","first-page":"700","DOI":"10.3390\/biomedicines9060700","article-title":"Optimization of heparin monitoring with anti-FXA assays and the impact of dextran sulfate for measuring all drug activity","volume":"9","author":"Amiral","year":"2021","journal-title":"Biomedicines"},{"key":"10.1124\/pharmrev.122.000684_bib17","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ejphar.2018.03.014","article-title":"Diverse signalling of the platelet P2Y1 receptor leads to a dichotomy in platelet function","volume":"827","author":"Amison","year":"2018","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pharmrev.122.000684_bib18","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1124\/jpet.115.229823","article-title":"Histones differentially modulate the anticoagulant and profibrinolytic activities of heparin, heparin derivatives, and dabigatran","volume":"356","author":"Ammollo","year":"2016","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pharmrev.122.000684_bib19","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1515\/hsz-2021-0176","article-title":"Collagen\/glycosaminoglycan-based matrices for controlling skin cell responses","volume":"402","author":"Anderegg","year":"2021","journal-title":"Biol Chem"},{"key":"10.1124\/pharmrev.122.000684_bib20","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1182\/bloodadvances.2019000975","article-title":"American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients","volume":"3","author":"Anderson","year":"2019","journal-title":"Blood Adv"},{"key":"10.1124\/pharmrev.122.000684_bib21","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.biologicals.2020.06.004","article-title":"Processing bovine intestinal mucosa to active heparin removes spiked BSE agent","volume":"67","author":"Andrews","year":"2020","journal-title":"Biologicals"},{"key":"10.1124\/pharmrev.122.000684_bib22","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.3390\/polym12112619","article-title":"Ibuprofen-loaded heparin modified thermosensitive hydrogel for inhibiting excessive inflammation and promoting wound healing","volume":"12","author":"Andrgie","year":"2020","journal-title":"Polymers (Basel)"},{"key":"10.1124\/pharmrev.122.000684_bib23","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1002\/pro.3423","article-title":"Investigating the dynamics and polyanion binding sites of fibroblast growth factor-1 using hydrogen-deuterium exchange mass spectrometry","volume":"27","author":"Angalakurthi","year":"2018","journal-title":"Protein Sci"},{"key":"10.1124\/pharmrev.122.000684_bib24","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3389\/fmed.2018.00346","article-title":"Oligosaccharide chromatographic techniques for quantitation of structural process-related impurities in heparin resulting from 2-O desulfation","volume":"5","author":"Anger","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"10.1124\/pharmrev.122.000684_bib25","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1093\/eurheartj\/ehab637","article-title":"Ciraparantag reverses the anticoagulant activity of apixaban and rivaroxaban in healthy elderly subjects","volume":"43","author":"Ansell","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1124\/pharmrev.122.000684_bib26","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1182\/blood.2020007116","article-title":"Ciraparantag, an anticoagulant reversal drug: mechanism of action, pharmacokinetics, and reversal of anticoagulants","volume":"137","author":"Ansell","year":"2021","journal-title":"Blood"},{"key":"10.1124\/pharmrev.122.000684_bib27","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1056\/NEJMc1411800","article-title":"Use of PER977 to reverse the anticoagulant effect of edoxaban","volume":"371","author":"Ansell","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1124\/pharmrev.122.000684_bib28","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.thromres.2016.07.008","article-title":"Ciraparantag safely and completely reverses the anticoagulant effects of low molecular weight heparin","volume":"146","author":"Ansell","year":"2016","journal-title":"Thromb Res"},{"key":"10.1124\/pharmrev.122.000684_bib29","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1039\/C8AN01703D","article-title":"Reversible fluorescence modulation of BSA stabilised copper nanoclusters for the selective detection of protamine and heparin","volume":"144","author":"Aparna","year":"2019","journal-title":"Analyst (Lond)"},{"key":"10.1124\/pharmrev.122.000684_bib30","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1053\/j.jvca.2020.10.042","article-title":"Successful antithrombin administration in andexanet alfa-associated heparin resistance","volume":"35","author":"Apostel","year":"2021","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1124\/pharmrev.122.000684_bib31","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.trsl.2020.04.014","article-title":"Pathogenesis of heparin-induced thrombocytopenia","volume":"225","author":"Arepally","year":"2020","journal-title":"Transl Res"},{"key":"10.1124\/pharmrev.122.000684_bib32","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1161\/ATVBAHA.120.315445","article-title":"Heparin-induced thrombocytopenia: a focus on thrombosis","volume":"41","author":"Arepally","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1124\/pharmrev.122.000684_bib33","doi-asserted-by":"crossref","first-page":"778","DOI":"10.3390\/molecules22050778","article-title":"Sulfated alginates as heparin analogues: a review of chemical and functional properties","volume":"22","author":"Arlov","year":"2017","journal-title":"Molecules"},{"key":"10.1124\/pharmrev.122.000684_bib34","doi-asserted-by":"crossref","first-page":"509","DOI":"10.4097\/kja.19418","article-title":"Nebulized heparin and salbutamol versus salbutamol alone in acute exacerbations of chronic obstructive pulmonary disease requiring mechanical ventilation: a double-blind randomized controlled trial","volume":"73","author":"Ashoor","year":"2020","journal-title":"Korean J Anesthesiol"},{"key":"10.1124\/pharmrev.122.000684_bib35","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/bs.vh.2019.01.008","article-title":"The role of heparin, heparanase and heparan sulfates in hepcidin regulation","volume":"110","author":"Asperti","year":"2019","journal-title":"Vitam Horm"},{"key":"10.1124\/pharmrev.122.000684_bib36","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.ijbiomac.2018.03.001","article-title":"The smaller heparin fragments bind non-specifically through the IAPP sequence: an in silico study","volume":"113","author":"Asthana","year":"2018","journal-title":"Int J Biol Macromol"},{"key":"10.1124\/pharmrev.122.000684_bib37","doi-asserted-by":"crossref","first-page":"100192","DOI":"10.1016\/j.ctarc.2020.100192","article-title":"The use of heparin and heparin-like molecules in cancer treatment: a review","volume":"24","author":"Atallah","year":"2020","journal-title":"Cancer Treat Res Commun"},{"key":"10.1124\/pharmrev.122.000684_bib38","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00216-012-6085-5","article-title":"Validation of quantitative polymerase chain reaction methodology for monitoring DNA as a surrogate marker for species material contamination in porcine heparin","volume":"404","author":"Auguste","year":"2012","journal-title":"Anal Bioanal Chem"},{"key":"10.1124\/pharmrev.122.000684_bib39","doi-asserted-by":"crossref","first-page":"095620","DOI":"10.1101\/pdb.prot095620","article-title":"Purification of recombinant adeno-associated virus 2 (rAAV2) by heparin column affinity chromatography","volume":"2020","author":"Auricchio","year":"2020","journal-title":"Cold Spring Harb Protoc"},{"key":"10.1124\/pharmrev.122.000684_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0159739","article-title":"Synthetic site-selectively mono-6-O-sulfated heparan sulfate dodecasaccharide shows anti-angiogenic properties in vitro and sensitizes tumors to cisplatin in vivo","volume":"11","author":"Avizienyte","year":"2016","journal-title":"PLoS One"},{"key":"10.1124\/pharmrev.122.000684_bib41","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jpba.2012.01.002","article-title":"Application of quality by design elements for the development and optimization of an analytical method for protamine sulfate","volume":"62","author":"Awotwe-Otoo","year":"2012","journal-title":"J Pharm Biomed Anal"},{"key":"10.1124\/pharmrev.122.000684_bib42","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s12033-021-00403-x","article-title":"BMP-4 extraction from extracellular matrix and analysis of heparin-binding properties","volume":"64","author":"Aykul","year":"2022","journal-title":"Mol Biotech"},{"key":"10.1124\/pharmrev.122.000684_bib43","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1055\/s-0038-1650696","article-title":"Heparin stimulation of the inhibition of activated protein C and other enzymes by human protein C inhibitor\u2014influence of the molecular weight of heparin and ionic strength","volume":"76","author":"Aznar","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1124\/pharmrev.122.000684_bib44","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jconrel.2014.09.011","article-title":"Self-assembling lipid modified glycol-split heparin nanoparticles suppress lipopolysaccharide-induced inflammation through TLR4-NF-kappaB signaling","volume":"194","author":"Babazada","year":"2014","journal-title":"J Control Release"},{"key":"10.1124\/pharmrev.122.000684_bib45","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s10719-016-9745-4","article-title":"Computational drill down on FGF1-heparin interactions through methodological evaluation","volume":"34","author":"Babik","year":"2017","journal-title":"Glycoconj J"},{"key":"10.1124\/pharmrev.122.000684_bib46","first-page":"261","article-title":"Laboratory monitoring of low-molecular-weight heparin and fondaparinux","volume":"43","author":"Babin","year":"2017","journal-title":"Semin Thromb Hemost"},{"key":"10.1124\/pharmrev.122.000684_bib47","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1038\/s41467-019-11256-z","article-title":"Bypassing pan-enterovirus host factor PLA2G16","volume":"10","author":"Baggen","year":"2019","journal-title":"Nat Commun"},{"key":"10.1124\/pharmrev.122.000684_bib48","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1365-2141.2005.05953.x","article-title":"Guidelines on the use and monitoring of heparin","volume":"133","author":"Baglin","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1124\/pharmrev.122.000684_bib49","doi-asserted-by":"crossref","first-page":"11079","DOI":"10.1073\/pnas.162232399","article-title":"Crystal structures of native and thrombin-complexed heparin cofactor II reveal a multistep allosteric mechanism","volume":"99","author":"Baglin","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pharmrev.122.000684_bib50","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1089\/jamp.2009.0745","article-title":"Inhalable lactose-based dry powder formulations of low molecular weight heparin","volume":"23","author":"Bai","year":"2010","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"10.1124\/pharmrev.122.000684_bib51","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1111\/jth.13405","article-title":"Protamine (heparin)-induced thrombocytopenia: a review of the serological and clinical features associated with anti-protamine\/heparin antibodies","volume":"14","author":"Bakchoul","year":"2016","journal-title":"J Thromb Haemost"},{"key":"10.1124\/pharmrev.122.000684_bib52","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1080\/17474086.2017.1345306","article-title":"Therapeutic monitoring of unfractionated heparin - trials and tribulations","volume":"10","author":"Baluwala","year":"2017","journal-title":"Expert Rev Hematol"},{"key":"10.1124\/pharmrev.122.000684_bib53","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jcrc.2016.04.005","article-title":"Is inhaled prophylactic heparin useful for prevention and management of pneumonia in ventilated ICU patients? The IPHIVAP investigators of the Australian and New Zealand Intensive Care Society Clinical Trials Group","volume":"34","author":"Bandeshe","year":"2016","journal-title":"J Crit Care"},{"key":"10.1124\/pharmrev.122.000684_bib54","doi-asserted-by":"crossref","first-page":"10524","DOI":"10.3390\/ijms221910524","article-title":"Heparin and its derivatives: challenges and advances in therapeutic biomolecules","volume":"22","author":"Banik","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1124\/pharmrev.122.000684_bib55","article-title":"Mannose 2, 3, 4, 5, 6-O-pentasulfate (MPS): a partial activator of human heparin cofactor II with anticoagulation potential","author":"Bano","year":"2022","journal-title":"J Biomol Struct Dyn"},{"key":"10.1124\/pharmrev.122.000684_bib56","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1055\/s-0038-1661103","article-title":"Inhibition by heparin of platelet accumulation in vivo","volume":"51","author":"Barrett","year":"1984","journal-title":"Thromb Haemost"},{"key":"10.1124\/pharmrev.122.000684_bib57","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10719-016-9744-5","article-title":"RGTA\u00ae or ReGeneraTing Agents mimic heparan sulfate in regenerative medicine: from concept to curing patients","volume":"34","author":"Barritault","year":"2017","journal-title":"Glycoconj J"},{"key":"10.1124\/pharmrev.122.000684_bib58","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-642-23056-1_1","article-title":"History of heparin","volume":"207","author":"Barrowcliffe","year":"2012","journal-title":"Handb Exp Pharmacol"},{"key":"10.1124\/pharmrev.122.000684_bib59","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1055\/s-0038-1651034","article-title":"The effect of calcium chloride on anti-Xa activity of heparin and its molecular weight fractions","volume":"62","author":"Barrowcliffe","year":"1989","journal-title":"Thromb Haemost"},{"key":"10.1124\/pharmrev.122.000684_bib60","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0049-3848(84)90069-0","article-title":"Low-affinity heparin potentiates the action of high-affinity heparin oligosaccharides","volume":"34","author":"Barrowcliffe","year":"1984","journal-title":"Thromb Res"},{"key":"10.1124\/pharmrev.122.000684_bib61","doi-asserted-by":"crossref","first-page":"e691S","DOI":"10.1378\/chest.11-2300","article-title":"VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Bates","year":"2012","journal-title":"Chest"},{"key":"10.1124\/pharmrev.122.000684_bib62","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1182\/bloodadvances.2018024802","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy","volume":"2","author":"Bates","year":"2018","journal-title":"Blood Adv"},{"key":"10.1124\/pharmrev.122.000684_bib63","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1161\/01.CIR.98.16.1610","article-title":"Oral delivery of anticoagulant doses of heparin. A randomized, double-blind, controlled study in humans","volume":"98","author":"Baughman","year":"1998","journal-title":"Circulation"},{"key":"10.1124\/pharmrev.122.000684_bib64","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/j.jcrs.2004.07.003","article-title":"Heparin in the intraocular irrigating solution in pediatric cataract surgery","volume":"30","author":"Bayramlar","year":"2004","journal-title":"J Cataract Refract Surg"},{"key":"10.1124\/pharmrev.122.000684_bib65","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/j.drudis.2020.09.011","article-title":"Advances in the preparation and synthesis of heparin and related products","volume":"25","author":"Baytas","year":"2020","journal-title":"Drug Discov Today"},{"key":"10.1124\/pharmrev.122.000684_bib66","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1021\/acs.jmedchem.0c02019","article-title":"Preparation of low molecular weight heparin from a remodeled bovine intestinal heparin","volume":"64","author":"Baytas","year":"2021","journal-title":"J Med Chem"},{"key":"10.1124\/pharmrev.122.000684_bib67","first-page":"268","article-title":"Effect of heparin, dermatan sulfate, and related oligo-derivatives on human polymorphonuclear leukocyte functions","volume":"121","author":"Bazzoni","year":"1993","journal-title":"J Lab Clin Med"},{"key":"10.1124\/pharmrev.122.000684_bib68","doi-asserted-by":"crossref","first-page":"21100","DOI":"10.1074\/jbc.M700841200","article-title":"C1 inhibitor serpin domain structure reveals the likely mechanism of heparin potentiation and conformational disease","volume":"282","author":"Beinrohr","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1124\/pharmrev.122.000684_bib69","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1080\/14767058.2020.1760834","article-title":"Low-dose low-molecular-weight heparin prophylaxis against obstetrical complications in pregnancies with metabolic and immunological disorder-associated placental inflammation","volume":"35","author":"Beksac","year":"2022","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1124\/pharmrev.122.000684_bib70","doi-asserted-by":"crossref","first-page":"11267","DOI":"10.1074\/jbc.M807211200","article-title":"Unfractionated heparin and new heparin analogues from ascidians (chordate-tunicate) ameliorate colitis in rats","volume":"284","author":"Belmiro","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1124\/pharmrev.122.000684_bib71","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/978-3-030-34521-1_11","article-title":"Heparanase in cancer metastasis\u2014heparin as a potential inhibitor of cell adhesion molecules","volume":"1221","author":"Bendas","year":"2020","journal-title":"Adv Exp Med Biol"},{"key":"10.1124\/pharmrev.122.000684_bib72","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.3389\/fimmu.2017.01115","article-title":"Factor XII-driven inflammatory reactions with implications for anaphylaxis","volume":"8","author":"Bender","year":"2017","journal-title":"Front Immunol"},{"key":"10.1124\/pharmrev.122.000684_bib73","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1177\/1076029616685430","article-title":"Characterization of PF4-heparin complexes by photon correlation spectroscopy and zeta potential","volume":"23","author":"Bertini","year":"2017","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1124\/pharmrev.122.000684_bib74","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1177\/1076029616685430","article-title":"Characterization of PF4-heparin complexes by photon correlation spectroscopy and zeta potential","volume":"23","author":"Bertini","year":"2017","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1124\/pharmrev.122.000684_bib75","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.3390\/molecules22071214","article-title":"Molecular weights of bovine and porcine heparin samples: comparison of chromatographic methods and results of a collaborative survey","volume":"22","author":"Bertini","year":"2017","journal-title":"Molecules"},{"key":"10.1124\/pharmrev.122.000684_bib76","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.3201\/eid2610.200142","article-title":"Eliminating spiked bovine spongiform encephalopathy agent activity from heparin","volume":"26","author":"Bett","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"10.1124\/pharmrev.122.000684_bib77","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1055\/s-0040-1715460","article-title":"The anticoagulant and nonanticoagulant properties of heparin","volume":"120","author":"Beurskens","year":"2020","journal-title":"Thromb Haemost"},{"key":"10.1124\/pharmrev.122.000684_bib78","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.carbpol.2014.10.054","article-title":"Combinatorial one-pot chemoenzymatic synthesis of heparin","volume":"122","author":"Bhaskar","year":"2015","journal-title":"Carbohydr Polym"},{"key":"10.1124\/pharmrev.122.000684_bib79","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/bjh.15091","article-title":"Inactivated antithombin as anticoagulant reversal in a rat model of cardiopulmonary bypass: a potent and potentially safer alternative to protamine","volume":"180","author":"Bianchini","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1124\/pharmrev.122.000684_bib80","doi-asserted-by":"crossref","first-page":"14371","DOI":"10.1074\/jbc.RA118.003191","article-title":"Domains with highest heparan sulfate-binding affinity reside at opposite ends in BMP2\/4 versus BMP5\/6\/7: implications for function","volume":"293","author":"Billings","year":"2018","journal-title":"J Biol Chem"},{"key":"10.1124\/pharmrev.122.000684_bib81","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.addr.2016.12.002","article-title":"Heparin coatings for improving blood compatibility of medical devices","volume":"112","author":"Biran","year":"2017","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1124\/pharmrev.122.000684_bib82","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13433","article-title":"High rates of pulmonary artery occlusions in COVID-19: a meta-analysis","volume":"51","author":"Birocchi","year":"2021","journal-title":"Eur J Clin Invest"},{"key":"10.1124\/pharmrev.122.000684_bib83","doi-asserted-by":"crossref","first-page":"605","DOI":"10.33594\/000000438","article-title":"Extracellular histones bind vascular glycosaminoglycans and inhibit the anti-inflammatory function of antithrombin","volume":"55","author":"Biswas","year":"2021","journal-title":"Cell Physiol Biochem"},{"key":"10.1124\/pharmrev.122.000684_bib84","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/BF00421226","article-title":"Mechanism of the anticoagulant action of heparin","volume":"48","author":"Bj\u00f6rk","year":"1982","journal-title":"Mol Cell Biochem"},{"key":"10.1124\/pharmrev.122.000684_bib85","doi-asserted-by":"crossref","DOI":"10.1002\/bip.23252","article-title":"Molecular dynamics insights into protein-glycosaminoglycan systems from microsecond-scale simulations","volume":"110","author":"Bojarski","year":"2019","journal-title":"Biopolymers"},{"key":"10.1124\/pharmrev.122.000684_bib86","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/s41577-021-00536-9","article-title":"Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19","volume":"21","author":"Bonaventura","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"10.1124\/pharmrev.122.000684_bib87","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/S0161-6420(92)31816-0","article-title":"Effect of heparin surface modification of polymethylmethacrylate intraocular lenses on signs of postoperative inflammation after extracapsular cataract extraction. One-year results of a double-masked multicenter study","volume":"99","author":"Borgioli","year":"1992","journal-title":"Ophthalmology"},{"key":"10.1124\/pharmrev.122.000684_bib88","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1128\/JVI.00200-16","article-title":"Impact of heparan sulfate binding on transduction of retina by recombinant adeno-associated virus vectors","volume":"90","author":"Boye","year":"2016","journal-title":"J Virol"},{"issue":"Suppl 1","key":"10.1124\/pharmrev.122.000684_bib89","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/00325481.2021.1955542","article-title":"A comprehensive review of DOACs for cancer associated VTE prophylaxis or treatment","volume":"133","author":"Brea","year":"2021","journal-title":"Postgrad Med"},{"key":"10.1124\/pharmrev.122.000684_bib90","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1055\/s-0041-1736188","article-title":"Approach to the evaluation and treatment of venous thromboembolism in pregnancy","volume":"39","author":"Brenner","year":"2021","journal-title":"Semin Reprod Med"},{"key":"10.1124\/pharmrev.122.000684_bib91","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1126\/science.1092385","article-title":"Neutrophil extracellular traps kill bacteria","volume":"303","author":"Brinkmann","year":"2004","journal-title":"Science"},{"key":"10.1124\/pharmrev.122.000684_bib92","doi-asserted-by":"crossref","first-page":"L1240","DOI":"10.1152\/ajplung.00206.2007","article-title":"Unfractionated heparin reduces the elasticity of sputum from patients with cystic fibrosis","volume":"293","author":"Broughton-Head","year":"2007","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1124\/pharmrev.122.000684_bib93","doi-asserted-by":"crossref","first-page":"748","DOI":"10.3390\/ijms18040748","article-title":"Chemokine CXCL7 heterodimers: structural insights, CXCR2 receptor function, and glycosaminoglycan interactions","volume":"18","author":"Brown","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1124\/pharmrev.122.000684_bib94","doi-asserted-by":"crossref","first-page":"508","DOI":"10.3390\/ijms18030508","article-title":"Structural basis of native CXCL7 monomer binding to CXCR2 receptor N-domain and glycosaminoglycan heparin","volume":"18","author":"Brown","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1124\/pharmrev.122.000684_bib95","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/glycob\/cwaa054","article-title":"Host glycan utilization within the bacteroidetes Sus-like paradigm","volume":"31","author":"Brown","year":"2021","journal-title":"Glycobiology"},{"key":"10.1124\/pharmrev.122.000684_bib96","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/sj.bjp.0705291","article-title":"Effects of heparin and related molecules upon neutrophil aggregation and elastase release in vitro","volume":"139","author":"Brown","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pharmrev.122.000684_bib97","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1182\/blood.V71.2.335.335","article-title":"The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action","volume":"71","author":"Broze","year":"1988","journal-title":"Blood"},{"key":"10.1124\/pharmrev.122.000684_bib98","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00018-014-1743-8","article-title":"Of von Willebrand factor and platelets","volume":"72","author":"Bryckaert","year":"2015","journal-title":"Cell Mol Life Sci"},{"key":"10.1124\/pharmrev.122.000684_bib99","doi-asserted-by":"crossref","first-page":"15768","DOI":"10.1038\/s41598-019-52201-w","article-title":"Heparin and heparan sulfate proteoglycans promote HIV-1 p17 matrix protein oligomerization: computational, biochemical and biological implications","volume":"9","author":"Bugatti","year":"2019","journal-title":"Sci Rep"},{"key":"10.1124\/pharmrev.122.000684_bib100","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.3390\/ijms19041054","article-title":"The role of single-molecule force spectroscopy in unraveling typical and autoimmune heparin-induced thrombocytopenia","volume":"19","author":"Bui","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1124\/pharmrev.122.000684_bib101","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.2116\/analsci.20P214","article-title":"Quality control of heparin injections: comparison of four established methods","volume":"36","author":"Burmistrova","year":"2020","journal-title":"Anal Sci"},{"key":"10.1124\/pharmrev.122.000684_bib102","doi-asserted-by":"crossref","first-page":"113811","DOI":"10.1016\/j.jpba.2020.113811","article-title":"Is infrared spectroscopy combined with multivariate analysis a promising tool for heparin authentication?","volume":"194","author":"Burmistrova","year":"2021","journal-title":"J Pharm Biomed Anal"},{"key":"10.1124\/pharmrev.122.000684_bib103","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2174\/1389450116666150825110840","article-title":"HIV-1 matrix protein p17 and its receptors","volume":"17","author":"Caccuri","year":"2016","journal-title":"Curr Drug Targets"},{"key":"10.1124\/pharmrev.122.000684_bib104","doi-asserted-by":"crossref","first-page":"596","DOI":"10.3390\/v11070596","article-title":"Heparan sulfate proteoglycans and viral attachment: true receptors or adaptation bias?","volume":"11","author":"Cagno","year":"2019","journal-title":"Viruses"},{"key":"10.1124\/pharmrev.122.000684_bib105","doi-asserted-by":"crossref","first-page":"115146","DOI":"10.1016\/j.carbpol.2019.115146","article-title":"Precise structures and anti-intrinsic tenase complex activity of three fucosylated glycosaminoglycans and their fragments","volume":"224","author":"Cai","year":"2019","journal-title":"Carbohydr Polym"},{"key":"10.1124\/pharmrev.122.000684_bib106","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.carres.2018.05.007","article-title":"An anticoagulant fucan sulfate with hexasaccharide repeating units from the sea cucumber Holothuria albiventer","volume":"464","author":"Cai","year":"2018","journal-title":"Carbohydr Res"},{"key":"10.1124\/pharmrev.122.000684_bib107","doi-asserted-by":"crossref","first-page":"8277","DOI":"10.1038\/ncomms9277","article-title":"Atomic description of the immune complex involved in heparin-induced thrombocytopenia","volume":"6","author":"Cai","year":"2015","journal-title":"Nat Commun"},{"key":"10.1124\/pharmrev.122.000684_bib108","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12931-017-0572-3","article-title":"Role of heparin in pulmonary cell populations in an in-vitro model of acute lung injury","volume":"18","author":"Camprub\u00ed-Rimblas","year":"2017","journal-title":"Respir Res"},{"key":"10.1124\/pharmrev.122.000684_bib109","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/jth.14685","article-title":"Effects of nebulized antithrombin and heparin on inflammatory and coagulation alterations in an acute lung injury model in rats","volume":"18","author":"Camprub\u00ed-Rimblas","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1124\/pharmrev.122.000684_bib110","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/1521-3773(20020201)41:3<390::AID-ANIE390>3.0.CO;2-B","article-title":"Heparin-protein interactions","volume":"41","author":"Capila","year":"2002","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1124\/pharmrev.122.000684_bib111","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/0049-3848(77)90107-4","article-title":"Decreased binding of heparin to antithrombin following the interaction between antithrombin and thrombin","volume":"11","author":"Carlstr\u00f6m","year":"1977","journal-title":"Thromb Res"},{"key":"10.1124\/pharmrev.122.000684_bib112","doi-asserted-by":"crossref","first-page":"7037","DOI":"10.1073\/pnas.1704367114","article-title":"How members of the human gut microbiota overcome the sulfation problem posed by glycosaminoglycans","volume":"114","author":"Cartmell","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Suppl 1","key":"10.1124\/pharmrev.122.000684_bib113","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/S0167-5273(16)12004-2","article-title":"Old and new applications of non-anticoagulant heparin","volume":"212","author":"Cassinelli","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1124\/pharmrev.122.000684_bib114","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/978-3-030-34521-1_20","article-title":"Non-anticoagulant heparins as heparanase inhibitors","volume":"1221","author":"Cassinelli","year":"2020","journal-title":"Adv Exp Med Biol"},{"key":"10.1124\/pharmrev.122.000684_bib115","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/CRD.0000000000000347","article-title":"Thrombotic complications of COVID-19 infection: a review","volume":"29","author":"Castro","year":"2021","journal-title":"Cardiol Rev"},{"key":"10.1124\/pharmrev.122.000684_bib116","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1002\/eji.202048558","article-title":"Glycosaminoglycans bind human IL-27 and regulate its activity","volume":"50","author":"Cav\u00e9","year":"2020","journal-title":"Eur J Immunol"},{"key":"10.1124\/pharmrev.122.000684_bib117","doi-asserted-by":"crossref","first-page":"31585","DOI":"10.1021\/acsami.9b08653","article-title":"Protamine-induced supramolecular self-assembly of red-emissive alkynylplatinum(II) 2,6-bis(benzimidazol-2\u2032-yl)pyridine complex for selective label-free sensing of heparin and real-time monitoring of trypsin activity","volume":"11","author":"Chan","year":"2019","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1124\/pharmrev.122.000684_bib118","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1093\/eurheartj\/ehab706","article-title":"Ciraparantag as a potential universal anticoagulant reversal agent","volume":"43","author":"Chan","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1124\/pharmrev.122.000684_bib119","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1093\/cvr\/cvp097","article-title":"Antithrombin reduces shedding of the endothelial glycocalyx following ischaemia\/reperfusion","volume":"83","author":"Chappell","year":"2009","journal-title":"Cardiovasc Res"},{"key":"10.1124\/pharmrev.122.000684_bib120","doi-asserted-by":"crossref","DOI":"10.1177\/1076029619840701","article-title":"Comparison of low-molecular-weight heparins prepared from ovine heparins with enoxaparin","volume":"25","author":"Chen","year":"2019","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1124\/pharmrev.122.000684_bib121","doi-asserted-by":"crossref","first-page":"159024","DOI":"10.1016\/j.bbalip.2021.159024","article-title":"Mast cell and heparin promote adipogenesis in superficial fascia of rats","volume":"1866","author":"Chen","year":"2021","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipid"},{"key":"10.1124\/pharmrev.122.000684_bib122","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1160\/TH12-12-0935","article-title":"Perturbation of the heparin\/heparin-sulfate interactome of human breast cancer cells modulates pro-tumourigenic effects associated with PI3K\/Akt and MAPK\/ERK signalling","volume":"109","author":"Chen","year":"2013","journal-title":"Thromb Haemost"},{"key":"10.1124\/pharmrev.122.000684_bib123","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.vetmic.2019.03.029","article-title":"N-terminus of classical swine fever virus strain TD96 glycoprotein Erns contains a potential heparin-binding domain","volume":"232","author":"Cheng","year":"2019","journal-title":"Vet Microbiol"},{"key":"10.1124\/pharmrev.122.000684_bib124","doi-asserted-by":"crossref","first-page":"4113","DOI":"10.1021\/acs.biomac.7b01174","article-title":"Heparin binding to an engineered virus-like nanoparticle antagonist","volume":"18","author":"Cheong","year":"2017","journal-title":"Biomacromolecules"},{"key":"10.1124\/pharmrev.122.000684_bib125","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/978-3-642-23056-1_6","article-title":"Case study: contamination of heparin with oversulfated chondroitin sulfate","volume":"207","author":"Chess","year":"2012","journal-title":"Handb Exp Pharmacol"},{"key":"10.1124\/pharmrev.122.000684_bib126","doi-asserted-by":"crossref","first-page":"6342","DOI":"10.3390\/molecules20046342","article-title":"Heparin\/heparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical use","volume":"20","author":"Chiodelli","year":"2015","journal-title":"Molecules"},{"key":"10.1124\/pharmrev.122.000684_bib127","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/0049-3848(80)90356-4","article-title":"Anti-Xa active heparin oligosaccharides","volume":"18","author":"Choay","year":"1980","journal-title":"Thromb Res"},{"key":"10.1124\/pharmrev.122.000684_bib128","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/0006-291X(83)90550-8","article-title":"Structure-activity relationship in heparin: a synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity","volume":"116","author":"Choay","year":"1983","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/pharmrev.122.000684_bib129","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1021\/acs.molpharmaceut.8b00135","article-title":"Polyvalent hybrid virus-like nanoparticles with displayed heparin antagonist peptides","volume":"15","author":"Choi","year":"2018","journal-title":"Mol Pharm"},{"key":"10.1124\/pharmrev.122.000684_bib130","doi-asserted-by":"crossref","first-page":"14461","DOI":"10.1038\/s41598-017-14573-9","article-title":"Heparin at physiological concentration can enhance PEG-free in vitro infection with human hepatitis B virus","volume":"7","author":"Choijilsuren","year":"2017","journal-title":"Sci Rep"},{"key":"10.1124\/pharmrev.122.000684_bib131","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1445-5994.1986.tb00023.x","article-title":"Platelet proaggregating effect of heparin: possible mechanism for non-immune heparin-associated thrombocytopenia","volume":"16","author":"Chong","year":"1986","journal-title":"Aust N Z J Med"},{"key":"10.1124\/pharmrev.122.000684_bib132","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2012935118","article-title":"The 3-O-sulfation of heparan sulfate modulates protein binding and lyase degradation","volume":"118","author":"Chopra","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pharmrev.122.000684_bib133","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/s41467-020-20457-w","article-title":"Host and viral determinants for efficient SARS-CoV-2 infection of the human lung","volume":"12","author":"Chu","year":"2021","journal-title":"Nat Commun"},{"key":"10.1124\/pharmrev.122.000684_bib134","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM198703053161004","article-title":"Immune endothelial-cell injury in heparin-associated thrombocytopenia","volume":"316","author":"Cines","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1124\/pharmrev.122.000684_bib135","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.4049\/jimmunol.1201751","article-title":"Tissue-specific host recognition by complement factor H is mediated by differential activities of its glycosaminoglycan-binding regions","volume":"190","author":"Clark","year":"2013","journal-title":"J Immunol"},{"key":"10.1124\/pharmrev.122.000684_bib136","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.cell.2020.09.033","article-title":"SARS-CoV-2 infection depends on cellular heparan sulfate and ACE2","volume":"183","author":"Clausen","year":"2020","journal-title":"Cell"},{"key":"10.1124\/pharmrev.122.000684_bib137","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.thromres.2013.09.040","article-title":"Managing pulmonary embolism from presentation to extended treatment","volume":"133","author":"Cohen","year":"2014","journal-title":"Thromb Res"},{"key":"10.1124\/pharmrev.122.000684_bib138","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1177\/1358863X20932640","article-title":"COVID-19-associated coagulopathy: an exploration of mechanisms","volume":"25","author":"Colling","year":"2020","journal-title":"Vasc Med"},{"key":"10.1124\/pharmrev.122.000684_bib139","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0167-4838(99)00051-5","article-title":"Amino acid residues of heparin cofactor II required for stimulation of thrombin inhibition by sulphated polyanions","volume":"1431","author":"Colwell","year":"1999","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/pharmrev.122.000684_bib140","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1172\/JCI110584","article-title":"Activation of protein C in vivo","volume":"70","author":"Comp","year":"1982","journal-title":"J Clin Invest"},{"key":"10.1124\/pharmrev.122.000684_bib141","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00216-010-4362-8","article-title":"A quantitative PCR method to quantify ruminant DNA in porcine crude heparin","volume":"399","author":"Concannon","year":"2011","journal-title":"Anal Bioanal Chem"},{"key":"10.1124\/pharmrev.122.000684_bib142","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1182\/blood.2020006000","article-title":"COVID-19 and its implications for thrombosis and anticoagulation","volume":"135","author":"Connors","year":"2020","journal-title":"Blood"},{"key":"10.1124\/pharmrev.122.000684_bib143","doi-asserted-by":"crossref","first-page":"e218","DOI":"10.7861\/clinmed.2020-0351","article-title":"Inhaled and systemic heparin as a repurposed direct antiviral drug for prevention and treatment of COVID-19","volume":"20","author":"Conzelmann","year":"2020","journal-title":"Clin Med (Lond)"},{"key":"10.1124\/pharmrev.122.000684_bib144","doi-asserted-by":"crossref","first-page":"R32","DOI":"10.1186\/cc6810","article-title":"Venous thromboembolism and bleeding in critically ill patients with severe renal insufficiency receiving dalteparin thromboprophylaxis: prevalence, incidence and risk factors","volume":"12","author":"Cook","year":"2008","journal-title":"Crit Care"},{"key":"10.1124\/pharmrev.122.000684_bib145","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1039\/C3MB70370C","article-title":"On the catalytic mechanism of polysaccharide lyases: evidence of His and Tyr involvement in heparin lysis by heparinase I and the role of Ca2+","volume":"10","author":"C\u00f3rdula","year":"2014","journal-title":"Mol Biosyst"},{"key":"10.1124\/pharmrev.122.000684_bib146","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0243604","article-title":"Coagulation profile of COVID-19 patients admitted to the ICU: An exploratory study","volume":"15","author":"Corr\u00eaa","year":"2020","journal-title":"PLoS One"},{"key":"10.1124\/pharmrev.122.000684_bib147","doi-asserted-by":"crossref","first-page":"11973","DOI":"10.1002\/anie.201806770","article-title":"Dynamic covalent identification of an efficient heparin ligand","volume":"57","author":"Corredor","year":"2018","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1124\/pharmrev.122.000684_bib148","doi-asserted-by":"crossref","first-page":"7106","DOI":"10.1021\/acs.analchem.0c00496","article-title":"Highly sensitive and selective detection of heparin in serum based on a long-wavelength tetraphenylethylene-cyanopyridine aggregation-induced emission luminogen","volume":"92","author":"Cui","year":"2020","journal-title":"Anal Chem"},{"key":"10.1124\/pharmrev.122.000684_bib149","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1182\/bloodadvances.2020003763","article-title":"American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19","volume":"5","author":"Cuker","year":"2021","journal-title":"Blood Adv"},{"key":"10.1124\/pharmrev.122.000684_bib150","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1182\/bloodadvances.2021005493","article-title":"American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: May 2021 update on the use of intermediate-intensity anticoagulation in critically ill patients","volume":"5","author":"Cuker","year":"2021","journal-title":"Blood Adv"},{"key":"10.1124\/pharmrev.122.000684_bib151","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1107\/S1399004714027114","article-title":"Interaction of the amyloid precursor protein-like protein 1 (APLP1) E2 domain with heparan sulfate involves two distinct binding modes","volume":"71","author":"Dahms","year":"2015","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1124\/pharmrev.122.000684_bib152","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.thromres.2021.01.015","article-title":"Sulfated non-anticoagulant low molecular weight heparin in the prevention of cancer and non-cancer associated thrombosis without compromising hemostasis","volume":"200","author":"Darwish","year":"2021","journal-title":"Thromb Res"},{"key":"10.1124\/pharmrev.122.000684_bib153","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1074\/jbc.M110.160184","article-title":"Structural basis of oligosaccharide receptor recognition by human papillomavirus","volume":"286","author":"Dasgupta","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1124\/pharmrev.122.000684_bib154","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.thromres.2020.10.004","article-title":"COVID-19 associated coagulopathy: thrombosis, hemorrhage and mortality rates with an escalated-dose thromboprophylaxis strategy","volume":"196","author":"Daughety","year":"2020","journal-title":"Thromb Res"},{"key":"10.1124\/pharmrev.122.000684_bib155","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1160\/TH10-01-0073","article-title":"C1 inhibitor, a multi-functional serine protease inhibitor","volume":"104","author":"Davis","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.1124\/pharmrev.122.000684_bib156","first-page":"45","article-title":"Effect of extension of the heparin binding pocket on the structure, stability, and cell proliferation activity of the human acidic fibroblast growth factor","volume":"13","author":"Davis","year":"2018","journal-title":"Biochem Biophys Rep"},{"key":"10.1124\/pharmrev.122.000684_bib157","doi-asserted-by":"crossref","first-page":"13767","DOI":"10.1128\/JVI.01364-12","article-title":"Heparan sulfate facilitates Rift Valley fever virus entry into the cell","volume":"86","author":"de Boer","year":"2012","journal-title":"J Virol"},{"key":"10.1124\/pharmrev.122.000684_bib158","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1160\/TH16-04-0258","article-title":"Biophysical tools to assess the interaction of PF4 with polyanions","volume":"116","author":"Delcea","year":"2016","journal-title":"Thromb Haemost"},{"key":"10.1124\/pharmrev.122.000684_bib159","doi-asserted-by":"crossref","first-page":"13736","DOI":"10.1038\/s41598-018-31854-z","article-title":"Replacement of the L-iduronic acid unit of the anticoagulant pentasaccharide idraparinux by a 6-deoxy-L-talopyranose\u2014synthesis and conformational analysis","volume":"8","author":"Demeter","year":"2018","journal-title":"Sci Rep"},{"key":"10.1124\/pharmrev.122.000684_bib160","doi-asserted-by":"crossref","first-page":"129799","DOI":"10.1016\/j.bbagen.2020.129799","article-title":"BMP6 binding to heparin and heparan sulfate is mediated by N-terminal and C-terminal clustered basic residues","volume":"1865","author":"Denardo","year":"2021","journal-title":"Biochim Biophys Acta, Gen Subj"},{"key":"10.1124\/pharmrev.122.000684_bib161","doi-asserted-by":"crossref","first-page":"13033","DOI":"10.1021\/bi981426h","article-title":"Mechanism of heparin activation of antithrombin: evidence for an induced-fit model of allosteric activation involving two interaction subsites","volume":"37","author":"Desai","year":"1998","journal-title":"Biochemistry"},{"key":"10.1124\/pharmrev.122.000684_bib162","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1021\/acschembio.9b00325","article-title":"Major differences between the self-assembly and seeding behavior of heparin-induced and in vitro phosphorylated tau and their modulation by potential inhibitors","volume":"14","author":"Despres","year":"2019","journal-title":"ACS Chem Biol"},{"key":"10.1124\/pharmrev.122.000684_bib163","doi-asserted-by":"crossref","first-page":"636","DOI":"10.3390\/medicina55100636","article-title":"Tools for the quality control of pharmaceutical heparin","volume":"55","author":"Devlin","year":"2019","journal-title":"Medicina (Kaunas)"},{"issue":"Suppl 1","key":"10.1124\/pharmrev.122.000684_bib164","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/ijlh.13547","article-title":"COVID-19-related laboratory coagulation findings","volume":"43","author":"Devreese","year":"2021","journal-title":"Int J Lab Hematol"},{"key":"10.1124\/pharmrev.122.000684_bib165","doi-asserted-by":"crossref","first-page":"4638","DOI":"10.1021\/acs.orglett.0c01386","article-title":"Programmable one-pot synthesis of heparin pentasaccharide fondaparinux","volume":"22","author":"Dey","year":"2020","journal-title":"Org Lett"},{"key":"10.1124\/pharmrev.122.000684_bib166","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02222-18","article-title":"Porcine circovirus 2 uses a multitude of weak binding sites to interact with heparan sulfate, and the interactions do not follow the symmetry of the capsid","volume":"93","author":"Dhindwal","year":"2019","journal-title":"J Virol"},{"key":"10.1124\/pharmrev.122.000684_bib167","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1016\/j.bmcl.2017.04.013","article-title":"Efficient and practical synthesis of Fondaparinux","volume":"27","author":"Ding","year":"2017","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/pharmrev.122.000684_bib168","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1016\/j.thromres.2010.08.022","article-title":"Pre-operative heparin reduces pulmonary microvascular fibrin deposition following cardiac surgery","volume":"127","author":"Dixon","year":"2011","journal-title":"Thromb Res"},{"key":"10.1124\/pharmrev.122.000684_bib169","doi-asserted-by":"crossref","first-page":"R180","DOI":"10.1186\/cc9286","article-title":"Nebulized heparin is associated with fewer days of mechanical ventilation in critically ill patients: a randomized controlled trial","volume":"14","author":"Dixon","year":"2010","journal-title":"Crit Care"},{"key":"10.1124\/pharmrev.122.000684_bib170","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1177\/0310057X1604400106","article-title":"A trial of nebulised heparin to limit lung injury following cardiac surgery","volume":"44","author":"Dixon","year":"2016","journal-title":"Anaesth Intensive Care"},{"key":"10.1124\/pharmrev.122.000684_bib171","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S2213-2600(20)30470-7","article-title":"Nebulised heparin for patients with or at risk of acute respiratory distress syndrome: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial","volume":"9","author":"Dixon","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1124\/pharmrev.122.000684_bib172","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s10719-017-9761-z","article-title":"Chondroitin sulfates and their binding molecules in the central nervous system","volume":"34","author":"Djerbal","year":"2017","journal-title":"Glycoconj J"},{"key":"10.1124\/pharmrev.122.000684_bib173","doi-asserted-by":"crossref","first-page":"107405","DOI":"10.1016\/j.pharmthera.2019.107405","article-title":"Antidotes for reversal of direct oral anticoagulants","volume":"204","author":"Dobesh","year":"2019","journal-title":"Pharmacol Ther"},{"key":"10.1124\/pharmrev.122.000684_bib174","doi-asserted-by":"crossref","first-page":"102663","DOI":"10.1016\/j.jaut.2021.102663","article-title":"Perspectives on vaccine induced thrombotic thrombocytopenia","volume":"121","author":"Dotan","year":"2021","journal-title":"J Autoimmun"},{"key":"10.1124\/pharmrev.122.000684_bib175","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/bs.pmbts.2019.02.005","article-title":"Heparinoids danaparoid and sulodexide as clinically used drugs","volume":"163","author":"Dou","year":"2019","journal-title":"Prog Mol Biol Transl Sci"},{"key":"10.1124\/pharmrev.122.000684_bib176","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/ccd.1810260404","article-title":"Activated clotting times and activated partial thromboplastin times in patients undergoing coronary angioplasty who receive bolus doses of heparin","volume":"26","author":"Dougherty","year":"1992","journal-title":"Cathet Cardiovasc Diagn"},{"key":"10.1124\/pharmrev.122.000684_bib177","article-title":"Estraition directe de l'antithrombine du foie. Influence de la congelation","volume":"70","author":"Doyon","year":"1911","journal-title":"C R Soc Biol Paris"},{"key":"10.1124\/pharmrev.122.000684_bib178","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1021\/acs.biochem.0c00342","article-title":"Hydration and dynamics of full-length tau amyloid fibrils investigated by solid-state nuclear magnetic resonance","volume":"59","author":"Dregni","year":"2020","journal-title":"Biochemistry"},{"key":"10.1124\/pharmrev.122.000684_bib179","doi-asserted-by":"crossref","first-page":"7839","DOI":"10.1021\/jacs.1c03314","article-title":"Inclusion of the C-terminal domain in the \u03b2-sheet core of heparin-fibrillized three-repeat tau protein revealed by solid-state nuclear magnetic resonance spectroscopy","volume":"143","author":"Dregni","year":"2021","journal-title":"J Am Chem Soc"},{"key":"10.1124\/pharmrev.122.000684_bib180","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s10517-019-04509-w","article-title":"Analysis of the action of quaternized chitosans with different molecular weight on anticoagulant activity of heparins in vitro","volume":"167","author":"Drozd","year":"2019","journal-title":"Bull Exp Biol Med"},{"key":"10.1124\/pharmrev.122.000684_bib181","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s10517-017-3640-2","article-title":"Effect of sulfation and molecular weight on anticoagulant activity of dextran","volume":"162","author":"Drozd","year":"2017","journal-title":"Bull Exp Biol Med"},{"key":"10.1124\/pharmrev.122.000684_bib182","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jchromb.2016.12.033","article-title":"Purification of foot-and-mouth disease virus by heparin as ligand for certain strains","volume":"1049-1050","author":"Du","year":"2017","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1124\/pharmrev.122.000684_bib183","doi-asserted-by":"crossref","first-page":"23671","DOI":"10.18632\/oncotarget.4409","article-title":"Chemically modified, non-anticoagulant heparin derivatives are potent galectin-3 binding inhibitors and inhibit circulating galectin-3-promoted metastasis","volume":"6","author":"Duckworth","year":"2015","journal-title":"Oncotarget"},{"key":"10.1124\/pharmrev.122.000684_bib184","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1093\/annonc\/mdx716","article-title":"Randomized phase III trial of low-molecular-weight heparin enoxaparin in addition to standard treatment in small-cell lung cancer: the RASTEN trial","volume":"29","author":"Ek","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1124\/pharmrev.122.000684_bib185","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s12016-019-08769-2","article-title":"Mast cell biology at molecular level: a comprehensive review","volume":"58","author":"Elieh Ali Komi","year":"2020","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1124\/pharmrev.122.000684_bib186","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1055\/s-0034-1395153","article-title":"Tissue factor pathway inhibitor: then and now","volume":"40","author":"Ellery","year":"2014","journal-title":"Semin Thromb Hemost"},{"key":"10.1124\/pharmrev.122.000684_bib187","doi-asserted-by":"crossref","first-page":"11814","DOI":"10.1002\/chem.202001346","article-title":"Degeneracy of the antithrombin binding sequence in heparin: 2-O-sulfated iduronic acid can replace the critical glucuronic acid","volume":"26","author":"Elli","year":"2020","journal-title":"Chemistry"},{"key":"10.1124\/pharmrev.122.000684_bib188","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3390\/biomedicines10010049","article-title":"Enoxaparin and pentosan polysulfate bind to the Sars-Cov-2 spike protein and human ACE2 receptor, inhibiting vero cell infection","volume":"10","author":"Ennemoser","year":"2021","journal-title":"Biomedicines"},{"key":"10.1124\/pharmrev.122.000684_bib189","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1053\/j.jvca.2020.11.052","article-title":"Andexanet alfa-induced heparin resistance: when anticoagulation really remains reversed","volume":"35","author":"Erdoes","year":"2021","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1124\/pharmrev.122.000684_bib190","series-title":"European Pharmacopeia","first-page":"4187","article-title":"Assay of heparin","year":"2015"},{"key":"10.1124\/pharmrev.122.000684_bib191","article-title":"Effect of taurolidine citrate and unfractionated heparin on inflammatory state and dialysis adequacy in hemodialysis patients","author":"Ezzat","year":"2021","journal-title":"J Vasc Access"},{"key":"10.1124\/pharmrev.122.000684_bib192","doi-asserted-by":"crossref","first-page":"7809","DOI":"10.1039\/D0AN01562H","article-title":"Chemical sensors for selective and quantitative heparin sensing","volume":"145","author":"Fan","year":"2021","journal-title":"Analyst (Lond)"},{"key":"10.1124\/pharmrev.122.000684_bib193","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1055\/s-0028-1086092","article-title":"Biological profile of the hyper\/oversulfated chondroitin sulfate contaminant isolated from recalled heparin","volume":"34","author":"Fareed","year":"2008","journal-title":"Semin Thromb Hemost"},{"key":"10.1124\/pharmrev.122.000684_bib194","doi-asserted-by":"crossref","first-page":"11458","DOI":"10.1074\/jbc.RA119.008647","article-title":"Hyaluronidase-4 is produced by mast cells and can cleave serglycin chondroitin sulfate chains into lower molecular weight forms","volume":"294","author":"Farrugia","year":"2019","journal-title":"J Biol Chem"},{"key":"10.1124\/pharmrev.122.000684_bib195","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.1039\/C8CC01355A","article-title":"Heparin-induced tau filaments are structurally heterogeneous and differ from Alzheimer\u2019s disease filaments","volume":"54","author":"Fichou","year":"2018","journal-title":"Chem Commun (Camb)"},{"issue":"Suppl 2","key":"10.1124\/pharmrev.122.000684_bib196","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13052-018-0553-2","article-title":"Biochemical and molecular analysis in mucopolysaccharidoses: what a paediatrician must know","volume":"44","author":"Filocamo","year":"2018","journal-title":"Ital J Pediatr"},{"key":"10.1124\/pharmrev.122.000684_bib197","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/joim.12604","article-title":"Heparin-binding protein: a key player in the pathophysiology of organ dysfunction in sepsis","volume":"281","author":"Fisher","year":"2017","journal-title":"J Intern Med"},{"key":"10.1124\/pharmrev.122.000684_bib198","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/0002-9378(65)90518-1","article-title":"Placental transport of heparin","volume":"93","author":"Flessa","year":"1965","journal-title":"Am J Obstet Gynecol"},{"key":"10.1124\/pharmrev.122.000684_bib199","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/978-1-4899-2444-5_34","article-title":"Control of angiogenesis by heparin and other sulfated polysaccharides","volume":"313","author":"Folkman","year":"1992","journal-title":"Adv Exp Med Biol"},{"key":"10.1124\/pharmrev.122.000684_bib200","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1160\/TH16-09-0694","article-title":"Improved anticoagulant effect of fucosylated chondroitin sulfate orally administered as gastro-resistant tablets","volume":"117","author":"Fonseca","year":"2017","journal-title":"Thromb Haemost"},{"key":"10.1124\/pharmrev.122.000684_bib201","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0049-3848(84)90260-3","article-title":"Low molecular weight heparin (PK 10169) does not cross the placenta during the second trimester of pregnancy study by direct fetal blood sampling under ultrasound","volume":"34","author":"Forestier","year":"1984","journal-title":"Thromb Res"},{"key":"10.1124\/pharmrev.122.000684_bib202","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1055\/s-0038-1651102","article-title":"Low molecular weight heparin (CY 216) does not cross the placenta during the third trimester of pregnancy","volume":"57","author":"Forestier","year":"1987","journal-title":"Thromb Haemost"},{"key":"10.1124\/pharmrev.122.000684_bib203","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1002\/jps.23501","article-title":"Structural characterization of pharmaceutical heparins prepared from different animal tissues","volume":"102","author":"Fu","year":"2013","journal-title":"J Pharm Sci"},{"key":"10.1124\/pharmrev.122.000684_bib204","doi-asserted-by":"crossref","first-page":"8673","DOI":"10.1021\/acs.jmedchem.7b01269","article-title":"Enzymatic generation of highly anticoagulant bovine intestinal heparin","volume":"60","author":"Fu","year":"2017","journal-title":"J Med Chem"},{"key":"10.1124\/pharmrev.122.000684_bib205","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.str.2017.05.019","article-title":"Glycan activation of a sheddase: electrostatic recognition between heparin and proMMP-7","volume":"25","author":"Fulcher","year":"2017","journal-title":"Structure"},{"key":"10.1124\/pharmrev.122.000684_bib206","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.chroma.2016.03.078","article-title":"Oligosaccharide mapping of heparinase I-treated heparins by hydrophilic interaction liquid chromatography separation and online fluorescence detection and electrospray ionization-mass spectrometry characterization","volume":"1445","author":"Galeotti","year":"2016","journal-title":"J Chromatogr A"},{"key":"10.1124\/pharmrev.122.000684_bib207","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.biomaterials.2017.06.023","article-title":"Linker-free covalent immobilization of heparin, SDF-1\u03b1, and CD47 on PTFE surface for antithrombogenicity, endothelialization and anti-inflammation","volume":"140","author":"Gao","year":"2017","journal-title":"Biomaterials"},{"key":"10.1124\/pharmrev.122.000684_bib208","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.3390\/ijms18061293","article-title":"Interactions between a heparin trisaccharide library and FGF-1 analyzed by NMR methods","volume":"18","author":"Garc\u00eda-Jim\u00e9nez","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1124\/pharmrev.122.000684_bib209","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3389\/fcimb.2016.00173","article-title":"Different use of cell surface glycosaminoglycans as adherence receptors to corneal cells by gram positive and gram-negative pathogens","volume":"6","author":"Garc\u00eda","year":"2016","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1124\/pharmrev.122.000684_bib210","doi-asserted-by":"crossref","first-page":"e24S","DOI":"10.1378\/chest.11-2291","article-title":"Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Garcia","year":"2012","journal-title":"Chest"},{"key":"10.1124\/pharmrev.122.000684_bib211","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.3390\/molecules22071116","article-title":"Characterization of danaparoid complex extractive drug by an orthogonal analytical approach","volume":"22","author":"Gardini","year":"2017","journal-title":"Molecules"},{"key":"10.1124\/pharmrev.122.000684_bib212","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cyto.2018.04.014","article-title":"The localisation of the heparin binding sites of human and murine interleukin-12 within the carboxyterminal domain of the P40 subunit","volume":"110","author":"Garnier","year":"2018","journal-title":"Cytokine"},{"key":"10.1124\/pharmrev.122.000684_bib213","doi-asserted-by":"crossref","first-page":"20441","DOI":"10.1074\/jbc.R800064200","article-title":"Exosite determinants of serpin specificity","volume":"284","author":"Gettins","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1124\/pharmrev.122.000684_bib214","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.antiviral.2016.12.023","article-title":"Heparin prevents Zika virus induced-cytopathic effects in human neural progenitor cells","volume":"140","author":"Ghezzi","year":"2017","journal-title":"Antiviral Res"},{"key":"10.1124\/pharmrev.122.000684_bib215","first-page":"80","article-title":"Heparin binding proteins as therapeutic target: an historical account and current trends","volume":"6","author":"Ghiselli","year":"2019","journal-title":"Medicines (Basel)"},{"key":"10.1124\/pharmrev.122.000684_bib216","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/s12967-018-1621-5","article-title":"Sulfated non-anticoagulant heparin blocks Th2-induced asthma by modulating the IL-4\/signal transducer and activator of transcription 6\/Janus kinase 1 pathway","volume":"16","author":"Ghonim","year":"2018","journal-title":"J Transl Med"},{"key":"10.1124\/pharmrev.122.000684_bib217","doi-asserted-by":"crossref","first-page":"15180","DOI":"10.1021\/acs.langmuir.9b02414","article-title":"Fabrication of orange-emitting organic nanoparticle-protamine conjugate: fluorimetric sensor of heparin","volume":"35","author":"Ghosh","year":"2019","journal-title":"Langmuir"},{"key":"10.1124\/pharmrev.122.000684_bib218","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1021\/acssensors.0c00193","article-title":"Mechanisms of heparin-induced tau aggregation revealed by a single nanopore","volume":"5","author":"Giamblanco","year":"2020","journal-title":"ACS Sens"},{"key":"10.1124\/pharmrev.122.000684_bib219","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3389\/fmed.2018.00341","article-title":"Recombinant heparin\u2014new opportunities","volume":"5","author":"Glass","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"10.1124\/pharmrev.122.000684_bib220","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/B978-0-12-800096-0.00007-X","article-title":"Marine sulfated glycans with serpin-unrelated anticoagulant properties","volume":"62","author":"Glauser","year":"2013","journal-title":"Adv Clin Chem"},{"key":"10.1124\/pharmrev.122.000684_bib221","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1111\/jth.14221","article-title":"Chemical and pharmacological aspects of neutralization of heparins from different animal sources by protamine","volume":"16","author":"Glauser","year":"2018","journal-title":"J Thromb Haemost"},{"key":"10.1124\/pharmrev.122.000684_bib222","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003648","article-title":"Thrombotic thrombocytopenia associated with COVID-19 infection or vaccination: possible paths to platelet factor 4 autoimmunity","volume":"18","author":"Goldman","year":"2021","journal-title":"PLoS Med"},{"key":"10.1124\/pharmrev.122.000684_bib223","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1093\/glycob\/cwu119","article-title":"Antitumor properties of a new non-anticoagulant heparin analog from the mollusk Nodipecten nodosus: effect on P-selectin, heparanase, metastasis and cellular recruitment","volume":"25","author":"Gomes","year":"2015","journal-title":"Glycobiology"},{"key":"10.1124\/pharmrev.122.000684_bib224","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1369\/0022155420988661","article-title":"A systems view of the heparan sulfate interactome","volume":"69","author":"G\u00f3mez Toledo","year":"2021","journal-title":"J Histochem Cytochem"},{"key":"10.1124\/pharmrev.122.000684_bib225","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.saa.2016.07.026","article-title":"A pyrene-based fluorescent sensor for ratiometric detection of heparin and its complex with heparin for reversed ratiometric detection of protamine in aqueous solution","volume":"170","author":"Gong","year":"2017","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"key":"10.1124\/pharmrev.122.000684_bib226","doi-asserted-by":"crossref","first-page":"197771","DOI":"10.1016\/j.virusres.2019.197771","article-title":"Biodistribution of adeno-associated virus type 2 with mutations in the capsid that contribute to heparan sulfate proteoglycan binding","volume":"274","author":"Gorbatyuk","year":"2019","journal-title":"Virus Res"},{"key":"10.1124\/pharmrev.122.000684_bib227","doi-asserted-by":"crossref","first-page":"338208","DOI":"10.1016\/j.aca.2021.338208","article-title":"Quantitative determination of dextran sulfate and pentosan polysulfate and their binding with protamine using chronopotentiometry with polyion-selective electrodes","volume":"1149","author":"Gordon","year":"2021","journal-title":"Anal Chim Acta"},{"key":"10.1124\/pharmrev.122.000684_bib228","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.cbpa.2020.09.008","article-title":"Current state on the enzymatic synthesis of glycosaminoglycans","volume":"61","author":"Gottschalk","year":"2021","journal-title":"Curr Opin Chem Biol"},{"key":"10.1124\/pharmrev.122.000684_bib229","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/SHK.0000000000000680","article-title":"Extracellular histones increase tissue factor activity and enhance thrombin generation by human blood monocytes","volume":"46","author":"Gould","year":"2016","journal-title":"Shock"},{"key":"10.1124\/pharmrev.122.000684_bib230","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1515\/BC.2006.139","article-title":"Heparin modulation of human plasma kallikrein on different substrates and inhibitors","volume":"387","author":"Gozzo","year":"2006","journal-title":"Biol Chem"},{"key":"10.1124\/pharmrev.122.000684_bib231","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1590\/S0100-879X2003000800011","article-title":"Glycosaminoglycans affect the interaction of human plasma kallikrein with plasminogen, factor XII and inhibitors","volume":"36","author":"Gozzo","year":"2003","journal-title":"Braz J Med Biol Res"},{"key":"10.1124\/pharmrev.122.000684_bib232","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.3389\/fphar.2020.01307","article-title":"The potential role of heparin in patients with covid-19: beyond the anticoagulant effect. A review","volume":"11","author":"Gozzo","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1124\/pharmrev.122.000684_bib233","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1021\/acs.jcim.7b00413","article-title":"Locating large, flexible ligands on proteins","volume":"58","author":"Grad","year":"2018","journal-title":"J Chem Inf Model"},{"key":"10.1124\/pharmrev.122.000684_bib234","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.it.2019.03.009","article-title":"Leukocyte adhesion: reconceptualizing chemokine presentation by glycosaminoglycans","volume":"40","author":"Graham","year":"2019","journal-title":"Trends Immunol"},{"key":"10.1124\/pharmrev.122.000684_bib235","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/978-3-642-23056-1_4","article-title":"Standardisation of unfractionated and low-molecular-weight heparin","volume":"207","author":"Gray","year":"2012","journal-title":"Handb Exp Pharmacol"},{"key":"10.1124\/pharmrev.122.000684_bib236","first-page":"203","article-title":"Low affinity heparin is an antithrombotic agent","volume":"71","author":"Gray","year":"1994","journal-title":"Thromb Haemost"},{"key":"10.1124\/pharmrev.122.000684_bib237","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/978-3-642-23056-1_3","article-title":"The anticoagulant and antithrombotic mechanisms of heparin","volume":"207","author":"Gray","year":"2012","journal-title":"Handb Exp Pharmacol"},{"key":"10.1124\/pharmrev.122.000684_bib238","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1160\/TH08-01-0032","article-title":"Heparin and low-molecular-weight heparin","volume":"99","author":"Gray","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1124\/pharmrev.122.000684_bib239","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1182\/blood-2005-02-0626","article-title":"Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy","volume":"106","author":"Greer","year":"2005","journal-title":"Blood"},{"key":"10.1124\/pharmrev.122.000684_bib240","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1111\/j.1538-7836.2007.02617.x","article-title":"Heparin-induced thrombocytopenia: a prospective study on the incidence, platelet-activating capacity and clinical significance of antiplatelet factor 4\/heparin antibodies of the IgG, IgM, and IgA classes","volume":"5","author":"Greinacher","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1124\/pharmrev.122.000684_bib241","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1182\/blood.2021013231","article-title":"Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia","volume":"138","author":"Greinacher","year":"2021","journal-title":"Blood"},{"key":"10.1124\/pharmrev.122.000684_bib242","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1111\/jth.13813","article-title":"Autoimmune heparin-induced thrombocytopenia","volume":"15","author":"Greinacher","year":"2017","journal-title":"J Thromb Haemost"},{"key":"10.1124\/pharmrev.122.000684_bib243","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1165\/rcmb.2013-0338RC","article-title":"2-O, 3-O-desulfated heparin inhibits neutrophil elastase-induced HMGB-1 secretion and airway inflammation","volume":"50","author":"Griffin","year":"2014","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1124\/pharmrev.122.000684_bib244","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.str.2016.12.001","article-title":"Cryoelectron microscopy maps of human papillomavirus 16 reveal l2 densities and heparin binding site","volume":"25","author":"Guan","year":"2017","journal-title":"Structure"},{"key":"10.1124\/pharmrev.122.000684_bib245","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/j.xphs.2016.03.037","article-title":"Comparison of low-molecular-weight heparins prepared from bovine lung heparin and porcine intestine heparin","volume":"105","author":"Guan","year":"2016","journal-title":"J Pharm Sci"},{"key":"10.1124\/pharmrev.122.000684_bib246","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1021\/acscentsci.1c01293","article-title":"Synthetic heparan sulfate mimetic pixatimod (PG545) potently inhibits SARS-CoV-2 by disrupting the spike\u2013ACE2 interaction","volume":"27","author":"Guimond","year":"2022","journal-title":"ACS Cent Sci"},{"key":"10.1124\/pharmrev.122.000684_bib247","doi-asserted-by":"crossref","first-page":"108052","DOI":"10.1016\/j.carres.2020.108052","article-title":"The conformation of the idopyranose ring revisited: how subtle O-substituent induced changes can be deduced from vicinal 1H-NMR coupling constants","volume":"496","author":"Haasnoot","year":"2020","journal-title":"Carbohydr Res"},{"key":"10.1124\/pharmrev.122.000684_bib248","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1002\/ajh.25982","article-title":"Thrombosis in COVID-19","volume":"95","author":"Hanff","year":"2020","journal-title":"Am J Hematol"},{"key":"10.1124\/pharmrev.122.000684_bib249","doi-asserted-by":"crossref","first-page":"100623","DOI":"10.1016\/j.biteb.2020.100623","article-title":"Antiviral activity of sulfated polysaccharides from marine algae and its application in combating COVID-19: mini review","volume":"13","author":"Hans","year":"2021","journal-title":"Bioresour Technol Rep"},{"key":"10.1124\/pharmrev.122.000684_bib250","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/bs.pmbts.2019.02.003","article-title":"Low molecular weight heparins and their clinical applications","volume":"163","author":"Hao","year":"2019","journal-title":"Prog Mol Biol Transl Sci"},{"key":"10.1124\/pharmrev.122.000684_bib251","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.3389\/fimmu.2020.01728","article-title":"Characterization of binding properties of individual functional sites of human complement factor H","volume":"11","author":"Haque","year":"2020","journal-title":"Front Immunol"},{"key":"10.1124\/pharmrev.122.000684_bib252","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12959-020-00230-1","article-title":"Management of the thrombotic risk associated with COVID-19: guidance for the hemostasis laboratory","volume":"18","author":"Hardy","year":"2020","journal-title":"Thromb J"},{"key":"10.1124\/pharmrev.122.000684_bib253","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3390\/biom9070273","article-title":"Ligand binding and signaling of HARE\/stabilin-2","volume":"9","author":"Harris","year":"2019","journal-title":"Biomolecules"},{"key":"10.1124\/pharmrev.122.000684_bib254","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1007\/s11239-020-02235-z","article-title":"Venous thromboembolism in critically ill COVID-19 patients receiving prophylactic or therapeutic anticoagulation: a systematic review and meta-analysis","volume":"50","author":"Hasan","year":"2020","journal-title":"J Thromb Thrombolysis"},{"key":"10.1124\/pharmrev.122.000684_bib255","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jconrel.2014.05.056","article-title":"Low molecular weight protamine (LMWP): a nontoxic protamine substitute and an effective cell-penetrating peptide","volume":"193","author":"He","year":"2014","journal-title":"J Control Release"},{"key":"10.1124\/pharmrev.122.000684_bib256","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1172\/JCI0213432","article-title":"Heparin cofactor II inhibits arterial thrombosis after endothelial injury","volume":"109","author":"He","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1124\/pharmrev.122.000684_bib257","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ijbiomac.2020.07.080","article-title":"Structure and anticoagulant activity of a sulfated fucan from the sea cucumber Acaudina leucoprocta","volume":"164","author":"He","year":"2020","journal-title":"Int J Biol Macromol"},{"key":"10.1124\/pharmrev.122.000684_bib258","doi-asserted-by":"crossref","first-page":"105918","DOI":"10.1016\/j.pep.2021.105918","article-title":"Optimized expression and purification of a soluble BMP2 variant based on in-silico design","volume":"186","author":"Heinks","year":"2021","journal-title":"Protein Expr Purif"},{"key":"10.1124\/pharmrev.122.000684_bib259","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1111\/jth.13555","article-title":"A century of heparin: past, present and future","volume":"14","author":"Hemker","year":"2016","journal-title":"J Thromb Haemost"},{"key":"10.1124\/pharmrev.122.000684_bib260","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.bbrc.2019.09.126","article-title":"Chondroitin sulfate E blocks enzymatic action of heparanase and heparanase-induced cellular responses","volume":"520","author":"Higashi","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"issue":"3, Suppl","key":"10.1124\/pharmrev.122.000684_bib261","doi-asserted-by":"crossref","first-page":"188S","DOI":"10.1378\/chest.126.3_suppl.188S","article-title":"Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy","volume":"126","author":"Hirsh","year":"2004","journal-title":"Chest"},{"issue":"Suppl 1","key":"10.1124\/pharmrev.122.000684_bib262","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0268-960X(03)90000-2","article-title":"A cell-based model of coagulation and the role of factor VIIa","volume":"17","author":"Hoffman","year":"2003","journal-title":"Blood Rev"},{"key":"10.1124\/pharmrev.122.000684_bib263","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1055\/s-0037-1615947","article-title":"A cell-based model of hemostasis","volume":"85","author":"Hoffman","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1124\/pharmrev.122.000684_bib264","doi-asserted-by":"crossref","DOI":"10.3390\/ph10030059","article-title":"Precipitation and neutralization of heparin from different sources by protamine sulfate","volume":"10","author":"Hogwood","year":"2017","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1124\/pharmrev.122.000684_bib265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193482","article-title":"The effect of increasing the sulfation level of chondroitin sulfate on anticoagulant specific activity and activation of the kinin system","volume":"13","author":"Hogwood","year":"2018","journal-title":"PLoS One"},{"key":"10.1124\/pharmrev.122.000684_bib266","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0233644","article-title":"Heparin and non-anticoagulant heparin attenuate histone-induced inflammatory responses in whole blood","volume":"15","author":"Hogwood","year":"2020","journal-title":"PLoS One"},{"key":"10.1124\/pharmrev.122.000684_bib267","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s42004-021-00506-1","article-title":"High sensitivity analysis of nanogram quantities of glycosaminoglycans using ToF-SIMS","volume":"4","author":"Hook","year":"2021","journal-title":"Commun Chem"},{"key":"10.1124\/pharmrev.122.000684_bib268","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.molimm.2020.06.018","article-title":"Mapping the binding site of C1-inhibitor for polyanion cofactors","volume":"126","author":"Hor","year":"2020","journal-title":"Mol Immunol"},{"key":"10.1124\/pharmrev.122.000684_bib269","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1177\/1076029608320831","article-title":"Quantitative PCR and disaccharide profiling to characterize the animal origin of low-molecular-weight heparins","volume":"15","author":"Houiste","year":"2009","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1124\/pharmrev.122.000684_bib270","doi-asserted-by":"crossref","first-page":"5670","DOI":"10.1016\/S0021-9258(18)91066-5","article-title":"Involvement of heparin chain length in the heparin-catalyzed inhibition of thrombin by antithrombin III","volume":"259","author":"Hoylaerts","year":"1984","journal-title":"J Biol Chem"},{"key":"10.1124\/pharmrev.122.000684_bib271","doi-asserted-by":"crossref","first-page":"28425","DOI":"10.1038\/srep28425","article-title":"Systematic protein interactome analysis of glycosaminoglycans revealed YcbS as a novel bacterial virulence factor","volume":"6","author":"Hsiao","year":"2016","journal-title":"Sci Rep"},{"key":"10.1124\/pharmrev.122.000684_bib272","doi-asserted-by":"crossref","first-page":"103485","DOI":"10.1016\/j.jprot.2019.103485","article-title":"Protein interactome analysis of iduronic acid-containing glycosaminoglycans reveals a novel flagellar invasion factor MbhA","volume":"208","author":"Hsiao","year":"2019","journal-title":"J Proteomics"},{"key":"10.1124\/pharmrev.122.000684_bib273","doi-asserted-by":"crossref","first-page":"8374","DOI":"10.1128\/JVI.72.10.8374-8379.1998","article-title":"Cell surface proteoglycans are necessary for A27L protein-mediated cell fusion: identification of the N-terminal region of A27L protein as the glycosaminoglycan-binding domain","volume":"72","author":"Hsiao","year":"1998","journal-title":"J Virol"},{"key":"10.1124\/pharmrev.122.000684_bib274","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.3389\/fimmu.2018.01670","article-title":"Mitogen-activated protein kinase signaling regulates proteoglycan composition of mast cell secretory granules","volume":"9","author":"Hu Frisk","year":"2018","journal-title":"Front Immunol"},{"key":"10.1124\/pharmrev.122.000684_bib275","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.coviro.2014.05.007","article-title":"Parvovirus glycan interactions","volume":"7","author":"Huang","year":"2014","journal-title":"Curr Opin Virol"},{"key":"10.1124\/pharmrev.122.000684_bib276","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1007\/s00216-011-5590-2","article-title":"Species-specific identification of ruminant components contaminating industrial crude porcine heparin using real-time fluorescent qualitative and quantitative PCR","volume":"402","author":"Huang","year":"2012","journal-title":"Anal Bioanal Chem"},{"key":"10.1124\/pharmrev.122.000684_bib277","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s13361-017-1815-8","article-title":"Probing conformational dynamics of tau protein by hydrogen\/deuterium exchange mass spectrometry","volume":"29","author":"Huang","year":"2018","journal-title":"J Am Soc Mass Spectrom"},{"key":"10.1124\/pharmrev.122.000684_bib278","doi-asserted-by":"crossref","first-page":"4192","DOI":"10.1002\/anie.201612518","article-title":"Structure of the complex between a heparan sulfate octasaccharide and mycobacterial heparin-binding hemagglutinin","volume":"56","author":"Huang","year":"2017","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1124\/pharmrev.122.000684_bib279","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/pds.4982","article-title":"Assessment of risk of variant creutzfeldt-Jakob disease (vCJD) from use of bovine heparin","volume":"29","author":"Huang","year":"2020","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1124\/pharmrev.122.000684_bib280","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.drudis.2021.10.004","article-title":"Receptors and ligands for herpes simplex viruses: Novel insights for drug targeting","volume":"27","author":"Huang","year":"2022","journal-title":"Drug Discov Today"},{"key":"10.1124\/pharmrev.122.000684_bib281","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.carres.2016.12.002","article-title":"Investigating the relationship between temperature, conformation and calcium binding in heparin model oligosaccharides","volume":"438","author":"Hughes","year":"2017","journal-title":"Carbohydr Res"},{"key":"10.1124\/pharmrev.122.000684_bib282","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1046\/j.1538-7836.2003.00305.x","article-title":"Mechanisms of glycosaminoglycan activation of the serpins in hemostasis","volume":"1","author":"Huntington","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1124\/pharmrev.122.000684_bib283","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.tibs.2006.06.005","article-title":"Shape-shifting serpins--advantages of a mobile mechanism","volume":"31","author":"Huntington","year":"2006","journal-title":"Trends Biochem Sci"},{"issue":"Suppl 1","key":"10.1124\/pharmrev.122.000684_bib284","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1538-7836.2011.04360.x","article-title":"Serpin structure, function and dysfunction","volume":"9","author":"Huntington","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1124\/pharmrev.122.000684_bib285","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3389\/fncel.2020.00208","article-title":"Role of chondroitin sulfation following spinal cord injury","volume":"14","author":"Hussein","year":"2020","journal-title":"Front Cell Neurosci"},{"key":"10.1124\/pharmrev.122.000684_bib286","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jconrel.2019.12.035","article-title":"Single injection of IL-12 coacervate as an effective therapy against B16-F10 melanoma in mice","volume":"318","author":"Hwang","year":"2020","journal-title":"J Control Release"},{"key":"10.1124\/pharmrev.122.000684_bib287","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00011-020-01401-6","article-title":"The coagulopathy, endotheliopathy, and vasculitis of COVID-19","volume":"69","author":"Iba","year":"2020","journal-title":"Inflamm Res"},{"key":"10.1124\/pharmrev.122.000684_bib288","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/jth.13911","article-title":"Inflammation and thrombosis: roles of neutrophils, platelets and endothelial cells and their interactions in thrombus formation during sepsis","volume":"16","author":"Iba","year":"2018","journal-title":"J Thromb Haemost"},{"key":"10.1124\/pharmrev.122.000684_bib289","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/s13054-020-03077-0","article-title":"The unique characteristics of COVID-19 coagulopathy","volume":"24","author":"Iba","year":"2020","journal-title":"Crit Care"},{"key":"10.1124\/pharmrev.122.000684_bib290","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.2165\/00003495-200262150-00016","article-title":"Danaparoid: a review of its use in thromboembolic and coagulation disorders","volume":"62","author":"Ibbotson","year":"2002","journal-title":"Drugs"},{"key":"10.1124\/pharmrev.122.000684_bib291","first-page":"L387","article-title":"Heparin inhibits histamine release from canine mast cells","volume":"264","author":"Inase","year":"1993","journal-title":"Am J Physiol"},{"key":"10.1124\/pharmrev.122.000684_bib292","doi-asserted-by":"crossref","first-page":"4630","DOI":"10.3390\/molecules24244630","article-title":"Heparinoid complex-based heparin-binding cytokines and cell delivery carriers","volume":"24","author":"Ishihara","year":"2019","journal-title":"Molecules"},{"key":"10.1124\/pharmrev.122.000684_bib293","doi-asserted-by":"crossref","first-page":"34049","DOI":"10.1074\/jbc.M114.611707","article-title":"Conformational activation of antithrombin by heparin involves an altered exosite interaction with protease","volume":"289","author":"Izaguirre","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1124\/pharmrev.122.000684_bib294","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1021\/acs.biochem.1c00128","article-title":"Paramount importance of core conformational changes for heparin allosteric activation of antithrombin","volume":"60","author":"Izaguirre","year":"2021","journal-title":"Biochemistry"},{"key":"10.1124\/pharmrev.122.000684_bib295","doi-asserted-by":"crossref","first-page":"13263","DOI":"10.1039\/C7CP06300H","article-title":"A \u201cturn-off\u201d red-emitting fluorophore for nanomolar detection of heparin","volume":"20","author":"Jana","year":"2018","journal-title":"Phys Chem Chem Phys"},{"key":"10.1124\/pharmrev.122.000684_bib296","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0031-6997(25)06829-2","article-title":"Heparins\u2014anionic polyelectrolyte drugs","volume":"31","author":"Jaques","year":"1979","journal-title":"Pharmacol Rev"},{"key":"10.1124\/pharmrev.122.000684_bib297","doi-asserted-by":"crossref","first-page":"5360","DOI":"10.1038\/s41598-017-05382-1","article-title":"Modulation of Interleukin-12 activity in the presence of heparin","volume":"7","author":"Jayanthi","year":"2017","journal-title":"Sci Rep"},{"key":"10.1124\/pharmrev.122.000684_bib298","doi-asserted-by":"crossref","first-page":"13846","DOI":"10.1039\/C5CC05222J","article-title":"Synthetic heparan sulfate dodecasaccharides reveal single sulfation site interconverts CXCL8 and CXCL12 chemokine biology","volume":"51","author":"Jayson","year":"2015","journal-title":"Chem Commun (Camb)"},{"key":"10.1124\/pharmrev.122.000684_bib299","doi-asserted-by":"crossref","first-page":"150s","DOI":"10.1177\/1076029618798956","article-title":"Comparative pharmacokinetic profile of 3 batches of ovine low-molecular-weight heparin and 1 batch of branded enoxaparin","volume":"24","author":"Jeske","year":"2018","journal-title":"Clin Applied Throm Hemostat"},{"key":"10.1124\/pharmrev.122.000684_bib300","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3389\/fmed.2018.00360","article-title":"Bovine mucosal heparins are comparable to porcine mucosal heparin at USP potency adjusted levels","volume":"5","author":"Jeske","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"10.1124\/pharmrev.122.000684_bib301","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.ijbiomac.2019.11.150","article-title":"Fluorescence detection of protamine, heparin and heparinase II based on a novel AIE molecule with four carboxyl","volume":"156","author":"Jiang","year":"2020","journal-title":"Int J Biol Macromol"},{"key":"10.1124\/pharmrev.122.000684_bib302","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/2162-3619-2-21","article-title":"Tinzaparin and other low-molecular-weight heparins: what is the evidence for differential dependence on renal clearance?","volume":"2","author":"Johansen","year":"2013","journal-title":"Exp Hematol Oncol"},{"key":"10.1124\/pharmrev.122.000684_bib303","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1073\/pnas.0910144107","article-title":"Molecular basis of factor IXa recognition by heparin-activated antithrombin revealed by a 1.7-A structure of the ternary complex","volume":"107","author":"Johnson","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pharmrev.122.000684_bib304","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1055\/s-0038-1648001","article-title":"Four heparin preparations: anti-Xa potentiating effect of heparin after subcutaneous injection","volume":"35","author":"Johnson","year":"1976","journal-title":"Thromb Haemost"},{"key":"10.1124\/pharmrev.122.000684_bib305","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1182\/blood.2018881607","article-title":"Recognition of PF4-VWF complexes by heparin-induced thrombocytopenia antibodies contributes to thrombus propagation","volume":"135","author":"Johnston","year":"2020","journal-title":"Blood"},{"key":"10.1124\/pharmrev.122.000684_bib306","doi-asserted-by":"crossref","first-page":"12289","DOI":"10.1038\/s41598-018-30697-y","article-title":"Lysines and arginines play non-redundant roles in mediating chemokine-glycosaminoglycan interactions","volume":"8","author":"Joseph","year":"2018","journal-title":"Sci Rep"},{"key":"10.1124\/pharmrev.122.000684_bib307","doi-asserted-by":"crossref","first-page":"170168","DOI":"10.1098\/rsob.170168","article-title":"Heparin-bound chemokine CXCL8 monomer and dimer are impaired for CXCR1 and CXCR2 activation: implications for gradients and neutrophil trafficking","volume":"7","author":"Joseph","year":"2017","journal-title":"Open Biol"},{"key":"10.1124\/pharmrev.122.000684_bib308","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1124\/jpet.119.262931","article-title":"Heparin-binding copolymer as a complete antidote for low-molecular-weight heparins in rats","volume":"373","author":"Kalaska","year":"2020","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pharmrev.122.000684_bib309","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1021\/acs.biomac.7b00994","article-title":"A polymer therapeutic having universal heparin reversal activity: molecular design and functional mechanism","volume":"18","author":"Kalathottukaren","year":"2017","journal-title":"Biomacromolecules"},{"key":"10.1124\/pharmrev.122.000684_bib310","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.carbpol.2019.01.017","article-title":"Long-term local PDGF delivery using porous microspheres modified with heparin for tendon healing of rotator cuff tendinitis in a rabbit model","volume":"209","author":"Kang","year":"2019","journal-title":"Carbohydr Polym"},{"key":"10.1124\/pharmrev.122.000684_bib311","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s10719-016-9728-5","article-title":"Biological function of unique sulfated glycosaminoglycans in primitive chordates","volume":"34","author":"Karamanou","year":"2017","journal-title":"Glycoconj J"},{"key":"10.1124\/pharmrev.122.000684_bib312","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1042\/BCJ20161050","article-title":"Analysis and identification of the Grem2 heparin\/heparan sulfate-binding motif","volume":"474","author":"Kattamuri","year":"2017","journal-title":"Biochem J"},{"key":"10.1124\/pharmrev.122.000684_bib313","doi-asserted-by":"crossref","first-page":"10674","DOI":"10.1038\/s41598-018-28886-w","article-title":"Probiotics in human gut microbiota can degrade host glycosaminoglycans","volume":"8","author":"Kawai","year":"2018","journal-title":"Sci Rep"},{"key":"10.1124\/pharmrev.122.000684_bib314","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1182\/blood.V72.3.925.bloodjournal723925","article-title":"Heparin-induced thrombocytopenia: laboratory studies","volume":"72","author":"Kelton","year":"1988","journal-title":"Blood"},{"key":"10.1124\/pharmrev.122.000684_bib315","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1200\/JCO.19.01461","article-title":"Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO clinical practice guideline update","volume":"38","author":"Key","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1124\/pharmrev.122.000684_bib316","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1160\/TH16-01-0074","article-title":"Immune pathogenesis of heparin-induced thrombocytopenia","volume":"116","author":"Khandelwal","year":"2016","journal-title":"Thromb Haemost"},{"key":"10.1124\/pharmrev.122.000684_bib317","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1182\/blood-2018-03-834598","article-title":"Polyreactive IgM initiates complement activation by PF4\/heparin complexes through the classical pathway","volume":"132","author":"Khandelwal","year":"2018","journal-title":"Blood"},{"key":"10.1124\/pharmrev.122.000684_bib318","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1099\/jgv.0.000921","article-title":"Heparan sulfate as a receptor for poxvirus infections and as a target for antiviral agents","volume":"98","author":"Khanna","year":"2017","journal-title":"J Gen Virol"},{"key":"10.1124\/pharmrev.122.000684_bib319","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.3390\/jcm10194294","article-title":"A review of current and future antithrombotic strategies in surgical patients-leaving the graduated compression stockings behind?","volume":"10","author":"Khatri","year":"2021","journal-title":"J Clin Med"},{"key":"10.1124\/pharmrev.122.000684_bib320","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1160\/TH06-10-0606","article-title":"The management of thrombosis in pregnancy: role of low-molecular-weight heparin","volume":"97","author":"Kher","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1124\/pharmrev.122.000684_bib321","doi-asserted-by":"crossref","first-page":"806","DOI":"10.3390\/molecules22050806","article-title":"Structure-activity relationships of bioengineered heparin\/heparan sulfates produced in different bioreactors","volume":"22","author":"Kim","year":"2017","journal-title":"Molecules"},{"key":"10.1124\/pharmrev.122.000684_bib322","doi-asserted-by":"crossref","first-page":"104873","DOI":"10.1016\/j.antiviral.2020.104873","article-title":"Characterization of heparin and severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) spike glycoprotein binding interactions","volume":"181","author":"Kim","year":"2020","journal-title":"Antiviral Res"},{"key":"10.1124\/pharmrev.122.000684_bib323","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1021\/acs.biochem.8b01267","article-title":"Glycosaminoglycan compositional analysis of relevant tissues in Zika virus pathogenesis and in vitro evaluation of heparin as an antiviral against Zika virus infection","volume":"58","author":"Kim","year":"2019","journal-title":"Biochemistry"},{"key":"10.1124\/pharmrev.122.000684_bib324","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3390\/ph10020044","article-title":"Pathogenesis and inhibition of flaviviruses from a carbohydrate perspective","volume":"10","author":"Kim","year":"2017","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1124\/pharmrev.122.000684_bib325","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1056\/NEJMoa0803200","article-title":"Contaminated heparin associated with adverse clinical events and activation of the contact system","volume":"358","author":"Kishimoto","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1124\/pharmrev.122.000684_bib326","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000350551","article-title":"Heparin treatment for allergic conjunctivitis in the experimental BALB\/c model","volume":"50","author":"Kocat\u00fcrk","year":"2013","journal-title":"Ophthalmic Res"},{"key":"10.1124\/pharmrev.122.000684_bib327","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1039\/D1MD00264C","article-title":"Synthesis of low-molecular weight fucoidan derivatives and their binding abilities to SARS-CoV-2 spike proteins","volume":"12","author":"Koike","year":"2021","journal-title":"RSC Med Chem"},{"key":"10.1124\/pharmrev.122.000684_bib328","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1111\/jth.15258","article-title":"Size- and charge-dependent modulation of the lytic susceptibility and mechanical stability of fibrin-histone clots by heparin and polyphosphate variants","volume":"19","author":"Komorowicz","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1124\/pharmrev.122.000684_bib329","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074043","article-title":"Ongoing contact activation in patients with hereditary angioedema","volume":"8","author":"Konings","year":"2013","journal-title":"PLoS One"},{"key":"10.1124\/pharmrev.122.000684_bib330","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1152\/japplphysiol.01086.2009","article-title":"Circulating platelet-neutrophil complexes are important for subsequent neutrophil activation and migration","volume":"109","author":"Kornerup","year":"2010","journal-title":"J Appl Physiol"},{"key":"10.1124\/pharmrev.122.000684_bib331","doi-asserted-by":"crossref","first-page":"15408","DOI":"10.1038\/ncomms15408","article-title":"Rules of engagement between \u03b1v\u03b26 integrin and foot-and-mouth disease virus","volume":"8","author":"Kotecha","year":"2017","journal-title":"Nat Commun"},{"key":"10.1124\/pharmrev.122.000684_bib332","doi-asserted-by":"crossref","DOI":"10.1177\/1076029620951851","article-title":"Studies on tissue factor pathway inhibitor antigen release by bovine, ovine and porcine heparins following intravenous administration to non-human primates","volume":"26","author":"Kouta","year":"2020","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1124\/pharmrev.122.000684_bib333","doi-asserted-by":"crossref","DOI":"10.1177\/10760296211005544","article-title":"Protamine sulfate neutralization profile of various dosages of bovine, ovine and porcine UFHs and their depolymerized derivatives in non-human primates","volume":"27","author":"Kouta","year":"2021","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1124\/pharmrev.122.000684_bib334","doi-asserted-by":"crossref","DOI":"10.1177\/1076029619889406","article-title":"Comparative pharmacological profiles of various bovine, ovine, and porcine heparins","volume":"25","author":"Kouta","year":"2019","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1124\/pharmrev.122.000684_bib335","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nprot.2016.169","article-title":"The ClusPro web server for protein-protein docking","volume":"12","author":"Kozakov","year":"2017","journal-title":"Nat Protoc"},{"key":"10.1124\/pharmrev.122.000684_bib336","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.jcrs.2013.11.043","article-title":"Intraindividual aqueous flare comparison after implantation of hydrophobic intraocular lenses with or without a heparin-coated surface","volume":"40","author":"Krall","year":"2014","journal-title":"J Cataract Refract Surg"},{"key":"10.1124\/pharmrev.122.000684_bib337","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/0022-4804(88)90014-5","article-title":"Anticoagulant effects of protamine sulfate in a canine model","volume":"45","author":"Kresowik","year":"1988","journal-title":"J Surg Res"},{"key":"10.1124\/pharmrev.122.000684_bib338","doi-asserted-by":"crossref","first-page":"620","DOI":"10.3389\/fimmu.2015.00620","article-title":"Mast cell: a multi-functional master cell","volume":"6","author":"Krystel-Whittemore","year":"2016","journal-title":"Front Immunol"},{"key":"10.1124\/pharmrev.122.000684_bib339","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1517\/13543784.17.11.1769","article-title":"PI-88: a novel inhibitor of angiogenesis","volume":"17","author":"Kudchadkar","year":"2008","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1124\/pharmrev.122.000684_bib340","doi-asserted-by":"crossref","first-page":"12480","DOI":"10.1074\/jbc.RA118.002644","article-title":"Molecular principles for heparin oligosaccharide-based inhibition of neutrophil elastase in cystic fibrosis","volume":"293","author":"Kummarapurugu","year":"2018","journal-title":"J Biol Chem"},{"key":"10.1124\/pharmrev.122.000684_bib341","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s11239-021-02569-2","article-title":"Prophylactic versus therapeutic anticoagulation for survival of patients with COVID-19 on steroid","volume":"53","author":"Kuno","year":"2022","journal-title":"J Thromb Thrombolysis"},{"key":"10.1124\/pharmrev.122.000684_bib342","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1515\/hsz-2021-0119","article-title":"Investigation of the structure of regulatory proteins interacting with glycosaminoglycans by combining NMR spectroscopy and molecular modeling\u2014the beginning of a wonderful friendship","volume":"402","author":"K\u00fcnze","year":"2021","journal-title":"Biol Chem"},{"key":"10.1124\/pharmrev.122.000684_bib343","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1074\/jbc.M115.681759","article-title":"Identification of the glycosaminoglycan binding site of interleukin-10 by NMR spectroscopy","volume":"291","author":"K\u00fcnze","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1124\/pharmrev.122.000684_bib344","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1183\/09031936.93.04081004","article-title":"Prevention of leucocyte elastase-induced emphysema in mice by heparin fragments","volume":"4","author":"Lafuma","year":"1991","journal-title":"Eur Respir J"},{"key":"10.1124\/pharmrev.122.000684_bib345","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.carbpol.2018.02.035","article-title":"Size-dependent pharmacological activities of differently degraded fucoidan fractions from Fucus vesiculosus","volume":"189","author":"Lahrsen","year":"2018","journal-title":"Carbohydr Polym"},{"key":"10.1124\/pharmrev.122.000684_bib346","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1021\/acsbiomaterials.8b01113","article-title":"Degradation of eight sulfated polysaccharides extracted from red and brown algae and its impact on structure and pharmacological activities","volume":"5","author":"Lahrsen","year":"2019","journal-title":"ACS Biomater Sci Eng"},{"issue":"Suppl 1","key":"10.1124\/pharmrev.122.000684_bib347","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S0886-3350(96)80170-2","article-title":"Effect of heparin-surface-modified poly(methyl methacrylate) intraocular lenses on the postoperative inflammation in an Asian population","volume":"22","author":"Lai","year":"1996","journal-title":"J Cataract Refract Surg"},{"key":"10.1124\/pharmrev.122.000684_bib348","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1093\/glycob\/cws085","article-title":"Sulfamate proton solvent exchange in heparin oligosaccharides: evidence for a persistent hydrogen bond in the antithrombin-binding pentasaccharide Arixtra","volume":"22","author":"Langeslay","year":"2012","journal-title":"Glycobiology"},{"key":"10.1124\/pharmrev.122.000684_bib349","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v26.i6.20","article-title":"Enhancement of transdermal delivery of heparin by various physical and chemical enhancement techniques","volume":"26","author":"Lanke","year":"2009","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"10.1124\/pharmrev.122.000684_bib350","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.3390\/molecules23112915","article-title":"Heparan sulfate mimetics in cancer therapy: the challenge to define structural determinants and the relevance of targets for optimal activity","volume":"23","author":"Lanzi","year":"2018","journal-title":"Molecules"},{"key":"10.1124\/pharmrev.122.000684_bib351","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/bs.ctm.2018.08.005","article-title":"The pulmonary endothelial glycocalyx in ARDS: a critical role for heparan sulfate","volume":"82","author":"LaRivi\u00e8re","year":"2018","journal-title":"Curr Top Membr"},{"key":"10.1124\/pharmrev.122.000684_bib352","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1001\/archinte.158.8.873","article-title":"The incidence of symptomatic venous thromboembolism during and after prophylaxis with enoxaparin: a multi-institutional cohort study of patients who underwent hip or knee arthroplasty","volume":"158","author":"Leclerc","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1124\/pharmrev.122.000684_bib353","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1183\/09031936.01.17100360","article-title":"Nebulized heparin in Burkholderia cepacia colonized adult cystic fibrosis patients","volume":"17","author":"Ledson","year":"2001","journal-title":"Eur Respir J"},{"key":"10.1124\/pharmrev.122.000684_bib354","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.thromres.2020.09.026","article-title":"Therapeutic versus prophylactic anticoagulation for severe COVID-19: a randomized phase II clinical trial (HESACOVID)","volume":"196","author":"Lemos","year":"2020","journal-title":"Thromb Res"},{"key":"10.1124\/pharmrev.122.000684_bib355","first-page":"1134","article-title":"Venous thromboembolism during pregnancy: a retrospective study of enoxaparin safety in 624 pregnancies","volume":"108","author":"Lepercq","year":"2001","journal-title":"BJOG"},{"key":"10.1124\/pharmrev.122.000684_bib356","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s40620-019-00592-4","article-title":"Anticoagulation in CKD and ESRD","volume":"32","author":"Leung","year":"2019","journal-title":"J Nephrol"},{"key":"10.1124\/pharmrev.122.000684_bib357","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/sj.bjp.0703099","article-title":"The effects of heparin and related molecules upon the adhesion of human polymorphonuclear leucocytes to vascular endothelium in vitro","volume":"129","author":"Lever","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pharmrev.122.000684_bib358","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/sj.bjp.0707298","article-title":"Size-fractionated heparins have differential effects on human neutrophil function in vitro","volume":"151","author":"Lever","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pharmrev.122.000684_bib359","doi-asserted-by":"crossref","first-page":"C1184","DOI":"10.1152\/ajpcell.00269.2013","article-title":"Heparanase induces inflammatory cell recruitment in vivo by promoting adhesion to vascular endothelium","volume":"306","author":"Lever","year":"2014","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1124\/pharmrev.122.000684_bib360","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.pupt.2016.11.002","article-title":"Biochemical and functional characterization of glycosaminoglycans released from degranulating rat peritoneal mast cells: insights into the physiological role of endogenous heparin","volume":"41","author":"Lever","year":"2016","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1124\/pharmrev.122.000684_bib361","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1053\/j.jvca.2020.09.091","article-title":"Andexanet alfa use in cardiac surgical patients: a Xa inhibitor and heparin reversal agent","volume":"35","author":"Levy","year":"2021","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1124\/pharmrev.122.000684_bib362","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.thromres.2018.02.144","article-title":"Direct oral anticoagulant (DOAC) versus low-molecular-weight heparin (LMWH) for treatment of cancer associated thrombosis (CAT): a systematic review and meta-analysis","volume":"173","author":"Li","year":"2019","journal-title":"Thromb Res"},{"key":"10.1124\/pharmrev.122.000684_bib363","doi-asserted-by":"crossref","first-page":"117034","DOI":"10.1016\/j.carbpol.2020.117034","article-title":"Low-molecular-weight fucosylated glycosaminoglycan and its oligosaccharides from sea cucumber as novel anticoagulants: a review","volume":"251","author":"Li","year":"2021","journal-title":"Carbohydr Polym"},{"key":"10.1124\/pharmrev.122.000684_bib364","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.carbpol.2019.04.047","article-title":"Concise chemoenzymatic synthesis of heparan sulfate analogues as potent BACE-1 inhibitors","volume":"217","author":"Li","year":"2019","journal-title":"Carbohydr Polym"},{"key":"10.1124\/pharmrev.122.000684_bib365","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3389\/fvets.2018.00291","article-title":"A comparative review of neutrophil extracellular traps in sepsis","volume":"5","author":"Li","year":"2018","journal-title":"Front Vet Sci"},{"key":"10.1124\/pharmrev.122.000684_bib366","doi-asserted-by":"crossref","first-page":"36039","DOI":"10.1074\/jbc.M805974200","article-title":"The heparin binding site of protein C inhibitor is protease-dependent","volume":"283","author":"Li","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1124\/pharmrev.122.000684_bib367","doi-asserted-by":"crossref","first-page":"117513","DOI":"10.1016\/j.carbpol.2020.117513","article-title":"A regular fucan sulfate from Stichopus herrmanni and its peroxide depolymerization: structure and anticoagulant activity","volume":"256","author":"Li","year":"2021","journal-title":"Carbohydr Polym"},{"key":"10.1124\/pharmrev.122.000684_bib368","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/bjh.14885","article-title":"The role of heparin in sepsis: much more than just an anticoagulant","volume":"179","author":"Li","year":"2017","journal-title":"Br J Haematol"},{"key":"10.1124\/pharmrev.122.000684_bib369","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1007\/s10529-021-03156-4","article-title":"The construction of a dual-functional strain that produces both polysaccharides and sulfotransferases","volume":"43","author":"Li","year":"2021","journal-title":"Biotechnol Lett"},{"key":"10.1124\/pharmrev.122.000684_bib370","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00774-021-01268-5","article-title":"Impaired bone healing by enoxaparin via inhibiting the differentiation of bone marrow mesenchymal stem cells towards osteoblasts","volume":"40","author":"Li","year":"2022","journal-title":"J Bone Miner Metab"},{"key":"10.1124\/pharmrev.122.000684_bib371","doi-asserted-by":"crossref","first-page":"150275","DOI":"10.1098\/rsob.150275","article-title":"Heparin binding preference and structures in the fibroblast growth factor family parallel their evolutionary diversification","volume":"6","author":"Li","year":"2016","journal-title":"Open Biol"},{"key":"10.1124\/pharmrev.122.000684_bib372","doi-asserted-by":"crossref","first-page":"5000","DOI":"10.1073\/pnas.1523981113","article-title":"Structural basis for oligomerization and glycosaminoglycan binding of CCL5 and CCL3","volume":"113","author":"Liang","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pharmrev.122.000684_bib373","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1007\/s13277-015-4085-8","article-title":"PI-88 inhibits postoperative recurrence of hepatocellular carcinoma via disrupting the surge of heparanase after liver resection","volume":"37","author":"Liao","year":"2016","journal-title":"Tumour Biol"},{"key":"10.1124\/pharmrev.122.000684_bib374","doi-asserted-by":"crossref","first-page":"106","DOI":"10.7150\/thno.16911","article-title":"Heparin improves BMSC cell therapy: anticoagulant treatment by heparin improves the safety and therapeutic effect of bone marrow-derived mesenchymal stem cell cytotherapy","volume":"7","author":"Liao","year":"2017","journal-title":"Theranostics"},{"key":"10.1124\/pharmrev.122.000684_bib375","doi-asserted-by":"crossref","DOI":"10.1002\/jmr.2854","article-title":"Quantification of heparin\u2019s antimetastatic effect by single-cell force spectroscopy","volume":"34","author":"Liebsch","year":"2021","journal-title":"J Mol Recognit"},{"key":"10.1124\/pharmrev.122.000684_bib376","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1039\/D0AN02061C","article-title":"A rolling circle amplification based platform for ultrasensitive detection of heparin","volume":"146","author":"Lin","year":"2021","journal-title":"Analyst (Lond)"},{"key":"10.1124\/pharmrev.122.000684_bib377","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1039\/C9AN01006H","article-title":"Bottom-up and top-down profiling of pentosan polysulfate","volume":"144","author":"Lin","year":"2019","journal-title":"Analyst (Lond)"},{"key":"10.1124\/pharmrev.122.000684_bib378","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0304-4165(01)00117-9","article-title":"Antithrombin binding of low molecular weight heparins and inhibition of factor Xa","volume":"1526","author":"Lin","year":"2001","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/pharmrev.122.000684_bib379","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1099\/mic.0.000571","article-title":"Borrelia burgdorferi glycosaminoglycan-binding proteins: a potential target for new therapeutics against Lyme disease","volume":"163","author":"Lin","year":"2017","journal-title":"Microbiology (Reading)"},{"key":"10.1124\/pharmrev.122.000684_bib380","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1073\/pnas.76.7.3198","article-title":"Structure of the antithrombin-binding site in heparin","volume":"76","author":"Lindahl","year":"1979","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pharmrev.122.000684_bib381","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/978-3-030-34521-1_2","article-title":"Heparanase\u2014discovery and targets","volume":"1221","author":"Lindahl","year":"2020","journal-title":"Adv Exp Med Biol"},{"key":"10.1124\/pharmrev.122.000684_bib382","doi-asserted-by":"crossref","first-page":"12368","DOI":"10.1016\/S0021-9258(18)90755-6","article-title":"Extension and structural variability of the antithrombin-binding sequence in heparin","volume":"259","author":"Lindahl","year":"1984","journal-title":"J Biol Chem"},{"key":"10.1124\/pharmrev.122.000684_bib383","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.survophthal.2021.05.005","article-title":"Pentosan polysulfate maculopathy","volume":"67","author":"Lindeke-Myers","year":"2022","journal-title":"Surv Ophthalmol"},{"key":"10.1124\/pharmrev.122.000684_bib384","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41582-020-0311-0","article-title":"Multi-target approaches to CNS repair: olfactory mucosa-derived cells and heparan sulfates","volume":"16","author":"Lindsay","year":"2020","journal-title":"Nat Rev Neurol"},{"key":"10.1124\/pharmrev.122.000684_bib385","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.mvr.2017.03.007","article-title":"Inhibition of inflammation induced shedding of the endothelial glycocalyx with low molecular weight heparin","volume":"112","author":"Lipowsky","year":"2017","journal-title":"Microvasc Res"},{"key":"10.1124\/pharmrev.122.000684_bib386","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/rth2.12353","article-title":"Using heparin molecules to manage COVID-2019","volume":"4","author":"Liu","year":"2020","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1124\/pharmrev.122.000684_bib387","doi-asserted-by":"crossref","first-page":"790","DOI":"10.3349\/ymj.2016.57.3.790","article-title":"Simple purification of adeno-associated virus-DJ for liver-specific gene expression","volume":"57","author":"Liu","year":"2016","journal-title":"Yonsei Med J"},{"key":"10.1124\/pharmrev.122.000684_bib388","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1021\/acscentsci.1c00010","article-title":"Heparan sulfate proteoglycans as attachment factor for SARS-CoV-2","volume":"7","author":"Liu","year":"2021","journal-title":"ACS Cent Sci"},{"key":"10.1124\/pharmrev.122.000684_bib389","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1177\/1076029616686422","article-title":"Comparison of low-molecular-weight heparins prepared from bovine heparins with enoxaparin","volume":"23","author":"Liu","year":"2017","journal-title":"Clin Appl Thromb Hemostat"},{"key":"10.1124\/pharmrev.122.000684_bib390","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.chroma.2016.12.021","article-title":"Top-down and bottom-up analysis of commercial enoxaparins","volume":"1480","author":"Liu","year":"2017","journal-title":"J Chromatogr A"},{"key":"10.1124\/pharmrev.122.000684_bib391","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.aca.2017.01.042","article-title":"Parent heparin and daughter LMW heparin correlation analysis using LC-MS and NMR","volume":"961","author":"Liu","year":"2017","journal-title":"Anal Chim Acta"},{"key":"10.1124\/pharmrev.122.000684_bib392","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jss.2019.01.020","article-title":"Unfractionated heparin alleviates sepsis-induced acute lung injury by protecting tight junctions","volume":"238","author":"Liu","year":"2019","journal-title":"J Surg Res"},{"key":"10.1124\/pharmrev.122.000684_bib393","doi-asserted-by":"crossref","first-page":"3895","DOI":"10.3892\/mmr.2015.3807","article-title":"Heparin inhibits lipopolysaccharide-induced inflammation via inducing caveolin-1 and activating the p38\/mitogen-activated protein kinase pathway in murine peritoneal macrophages","volume":"12","author":"Liu","year":"2015","journal-title":"Mol Med Rep"},{"key":"10.1124\/pharmrev.122.000684_bib394","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1160\/th15-03-0214","article-title":"Neutralisation of the anti-coagulant effects of heparin by histones in blood plasma and purified systems","volume":"115","author":"Longstaff","year":"2016","journal-title":"Thromb Haemost"},{"key":"10.1124\/pharmrev.122.000684_bib395","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1016\/S0140-6736(21)01203-4","article-title":"Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial","volume":"397","author":"Lopes","year":"2021","journal-title":"Lancet"},{"key":"10.1124\/pharmrev.122.000684_bib396","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ymben.2016.07.006","article-title":"Bioengineered human heparin with anticoagulant activity","volume":"38","author":"Lord","year":"2016","journal-title":"Metab Eng"},{"key":"10.1124\/pharmrev.122.000684_bib397","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1080\/21655979.2017.1301328","article-title":"Optimization of bioengineered heparin\/heparan sulfate production for therapeutic applications","volume":"8","author":"Lord","year":"2017","journal-title":"Bioengineered"},{"key":"10.1124\/pharmrev.122.000684_bib398","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3390\/ijms19010207","article-title":"Synthesized heparan sulfate competitors attenuate pseudomonas aeruginosa lung infection","volume":"19","author":"Lor\u00e8","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1124\/pharmrev.122.000684_bib399","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.msec.2017.03.295","article-title":"Pancreatic islet surface bioengineering with a heparin-incorporated starPEG nanofilm","volume":"78","author":"Lou","year":"2017","journal-title":"Mater Sci Eng C"},{"key":"10.1124\/pharmrev.122.000684_bib400","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/OGX.0000000000000505","article-title":"The safety of low-molecular-weight heparin during and after pregnancy","volume":"72","author":"Lu","year":"2017","journal-title":"Obstet Gynecol Surv"},{"key":"10.1124\/pharmrev.122.000684_bib401","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nm.3102","article-title":"A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa","volume":"19","author":"Lu","year":"2013","journal-title":"Nat Med"},{"key":"10.1124\/pharmrev.122.000684_bib402","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ijid.2020.08.023","article-title":"A meta-analysis of the incidence of venous thromboembolic events and impact of anticoagulation on mortality in patients with COVID-19","volume":"100","author":"Lu","year":"2020","journal-title":"Int J Infect Dis"},{"key":"10.1124\/pharmrev.122.000684_bib403","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s00705-015-2733-3","article-title":"Conserved arginine residues in the carboxyl terminus of the equine arteritis virus E protein may play a role in heparin binding but may not affect viral infectivity in equine endothelial cells","volume":"161","author":"Lu","year":"2016","journal-title":"Arch Virol"},{"key":"10.1124\/pharmrev.122.000684_bib404","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1159\/000489375","article-title":"Unfractionated heparin alleviates human lung endothelial barrier dysfunction induced by high mobility group box 1 through regulation of P38-GSK3beta-snail signaling pathway","volume":"46","author":"Luan","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"10.1124\/pharmrev.122.000684_bib405","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1007\/s10753-014-9812-6","article-title":"Treatment of low molecular weight heparin inhibits systemic inflammation and prevents endotoxin-induced acute lung injury in rats","volume":"37","author":"Luan","year":"2014","journal-title":"Inflammation"},{"key":"10.1124\/pharmrev.122.000684_bib406","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1042\/BCJ20200586","article-title":"Lysosomal sulfatases: a growing family","volume":"477","author":"L\u00fcbke","year":"2020","journal-title":"Biochem J"},{"key":"10.1124\/pharmrev.122.000684_bib407","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.cyto.2019.04.004","article-title":"Amino acid residues involved in the heparin-binding activity of murine IL-12 in the context of an antibody-cytokine fusion protein","volume":"120","author":"Luria-P\u00e9rez","year":"2019","journal-title":"Cytokine"},{"key":"10.1124\/pharmrev.122.000684_bib408","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.thromres.2012.01.017","article-title":"Pregnancy-related venous thromboembolism: risk and the effect of thromboprophylaxis","volume":"129","author":"Lussana","year":"2012","journal-title":"Thromb Res"},{"key":"10.1124\/pharmrev.122.000684_bib409","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1182\/bloodadvances.2020003442","article-title":"American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer","volume":"5","author":"Lyman","year":"2021","journal-title":"Blood Adv"},{"key":"10.1124\/pharmrev.122.000684_bib410","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.thromres.2006.05.007","article-title":"Molecular weight dependent tissue factor pathway inhibitor release by heparin and heparin oligosaccharides","volume":"119","author":"Ma","year":"2007","journal-title":"Thromb Res"},{"key":"10.1124\/pharmrev.122.000684_bib411","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1080\/19336918.2020.1767489","article-title":"The anti-cancer properties of heparin and its derivatives: a review and prospect","volume":"14","author":"Ma","year":"2020","journal-title":"Cell Adhes Migr"},{"key":"10.1124\/pharmrev.122.000684_bib412","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1200\/JCO.2015.64.0268","article-title":"Randomized phase III trial of standard therapy plus low molecular weight heparin in patients with lung cancer: FRAGMATIC trial","volume":"34","author":"Macbeth","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1124\/pharmrev.122.000684_bib413","doi-asserted-by":"crossref","first-page":"617578","DOI":"10.3389\/fcimb.2020.617578","article-title":"Herpes simplex virus cell entry mechanisms: an update","volume":"10","author":"Madavaraju","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1124\/pharmrev.122.000684_bib414","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/j.jcrs.2013.05.040","article-title":"Effect of heparin coating of a foldable intraocular lens on inflammation and capsular bag performance after cataract surgery","volume":"39","author":"Maedel","year":"2013","journal-title":"J Cataract Refract Surg"},{"key":"10.1124\/pharmrev.122.000684_bib415","article-title":"Rationale for the role of heparin and related GAG antithrombotics in COVID-19 infection","volume":"27","author":"Magnani","year":"2021","journal-title":"Clin Appl Thromb Hemostat"},{"key":"10.1124\/pharmrev.122.000684_bib416","doi-asserted-by":"crossref","first-page":"671458","DOI":"10.3389\/fmolb.2021.671458","article-title":"The sulfation code of tauopathies: heparan sulfate proteoglycans in the prion like spread of tau pathology","volume":"8","author":"Mah","year":"2021","journal-title":"Front Mol Biosci"},{"key":"10.1124\/pharmrev.122.000684_bib417","doi-asserted-by":"crossref","first-page":"18263","DOI":"10.1016\/S0021-9258(17)44747-8","article-title":"Structure of a dermatan sulfate hexasaccharide that binds to heparin cofactor II with high affinity","volume":"265","author":"Maimone","year":"1990","journal-title":"J Biol Chem"},{"key":"10.1124\/pharmrev.122.000684_bib418","doi-asserted-by":"crossref","first-page":"13156","DOI":"10.1002\/chem.201602240","article-title":"Fluorescent peptide beacons for the selective ratiometric detection of heparin","volume":"22","author":"Maity","year":"2016","journal-title":"Chemistry"},{"key":"10.1124\/pharmrev.122.000684_bib419","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ceb.2014.05.010","article-title":"New paradigms in the establishment and maintenance of gradients during directed cell migration","volume":"30","author":"Majumdar","year":"2014","journal-title":"Curr Opin Cell Biol"},{"key":"10.1124\/pharmrev.122.000684_bib420","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12529","article-title":"Vaccine-induced immune thrombocytopenia and thrombosis (VITT)","volume":"5","author":"Makris","year":"2021","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1124\/pharmrev.122.000684_bib421","doi-asserted-by":"crossref","first-page":"4746","DOI":"10.1182\/blood-2005-11-4674","article-title":"Cellular localization and trafficking of tissue factor","volume":"107","author":"Mandal","year":"2006","journal-title":"Blood"},{"key":"10.1124\/pharmrev.122.000684_bib422","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1177\/1060028020943160","article-title":"Andexanet alfa, the possible alternative to protamine for reversal of unfractionated heparin","volume":"55","author":"Maneno","year":"2021","journal-title":"Ann Pharmacother"},{"key":"10.1124\/pharmrev.122.000684_bib423","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1089\/jamp.2009.0780","article-title":"Safety and tolerability of inhaled heparin in idiopathic pulmonary fibrosis","volume":"23","author":"Markart","year":"2010","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"10.1124\/pharmrev.122.000684_bib424","first-page":"253","article-title":"Activated partial thromboplastin time monitoring of unfractionated heparin therapy: issues and recommendations","volume":"43","author":"Marlar","year":"2017","journal-title":"Semin Thromb Hemost"},{"key":"10.1124\/pharmrev.122.000684_bib425","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3390\/biom9080385","article-title":"Unchain my blood: lessons learned from self-assembled dendrimers as nanoscale heparin binders","volume":"9","author":"Marson","year":"2019","journal-title":"Biomolecules"},{"key":"10.1124\/pharmrev.122.000684_bib426","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1182\/blood-2005-04-1546","article-title":"Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis","volume":"106","author":"Martel","year":"2005","journal-title":"Blood"},{"key":"10.1124\/pharmrev.122.000684_bib427","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3920\/BM2018.0128","article-title":"Widespread use of Lactobacillus OppA, a surface located protein, as an adhesin that recognises epithelial cell surface glycosaminoglycans","volume":"10","author":"Mart\u00edn","year":"2019","journal-title":"Benef Microbes"},{"key":"10.1124\/pharmrev.122.000684_bib428","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.thromres.2010.11.008","article-title":"Heparin affinity of factor VIIa: implications on the physiological inhibition by antithrombin and clearance of recombinant factor VIIa","volume":"127","author":"Mart\u00ednez-Mart\u00ednez","year":"2011","journal-title":"Thromb Res"},{"key":"10.1124\/pharmrev.122.000684_bib429","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1161\/ATVBAHA.115.305996","article-title":"Tissue factor pathway inhibitor: multiple anticoagulant activities for a single protein","volume":"36","author":"Mast","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1124\/pharmrev.122.000684_bib430","doi-asserted-by":"crossref","first-page":"fcaa091","DOI":"10.1093\/braincomms\/fcaa091","article-title":"Dextran sulphate-induced tau assemblies cause endogenous tau aggregation and propagation in wild-type mice","volume":"2","author":"Masuda-Suzukake","year":"2020","journal-title":"Brain Comm"},{"key":"10.1124\/pharmrev.122.000684_bib431","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jpba.2016.12.031","article-title":"Qualification of HSQC methods for quantitative composition of heparin and low molecular weight heparins","volume":"136","author":"Mauri","year":"2017","journal-title":"J Pharm Biomed Anal"},{"key":"10.1124\/pharmrev.122.000684_bib432","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.3390\/molecules22071146","article-title":"Combining NMR spectroscopy and chemometrics to monitor structural features of crude heparin","volume":"22","author":"Mauri","year":"2017","journal-title":"Molecules"},{"key":"10.1124\/pharmrev.122.000684_bib433","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.actbio.2005.04.004","article-title":"Discovery of a sulfated tetrapeptide that binds to vascular endothelial growth factor","volume":"1","author":"Maynard","year":"2005","journal-title":"Acta Biomater"},{"key":"10.1124\/pharmrev.122.000684_bib434","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01500-20","article-title":"Chikungunya virus strains from each genetic clade bind sulfated glycosaminoglycans as attachment factors","volume":"94","author":"McAllister","year":"2020","journal-title":"J Virol"},{"key":"10.1124\/pharmrev.122.000684_bib435","article-title":"The use of myelinating cultures as a screen of glycomolecules for cns repair","volume":"8","author":"McCanney","year":"2019","journal-title":"Biology (Basel)"},{"key":"10.1124\/pharmrev.122.000684_bib436","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/glia.23562","article-title":"Low sulfated heparins target multiple proteins for central nervous system repair","volume":"67","author":"McCanney","year":"2019","journal-title":"Glia"},{"key":"10.1124\/pharmrev.122.000684_bib437","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0140-6736(19)33135-6","article-title":"Running thin: implications of a heparin shortage","volume":"395","author":"McCarthy","year":"2020","journal-title":"Lancet"},{"key":"10.1124\/pharmrev.122.000684_bib438","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114242","article-title":"Removal of carbapenem-resistant enterobacteriaceae (CRE) from blood by heparin-functional hemoperfusion media","volume":"9","author":"McCrea","year":"2014","journal-title":"PLoS One"},{"key":"10.1124\/pharmrev.122.000684_bib439","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/BCR.0000000000000439","article-title":"Outcomes following the use of nebulized heparin for inhalation injury (HIHI study)","volume":"38","author":"McIntire","year":"2017","journal-title":"J Burn Care Res"},{"key":"10.1124\/pharmrev.122.000684_bib440","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1152\/ajplegacy.1916.41.2.250","article-title":"The thromboplastic action of cephalin","volume":"41","author":"McLean","year":"1916","journal-title":"Am J Physiol"},{"key":"10.1124\/pharmrev.122.000684_bib441","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.ccc.2011.07.001","article-title":"Venous thromboembolism prophylaxis in critically ill patients","volume":"27","author":"McLeod","year":"2011","journal-title":"Crit Care Clin"},{"key":"10.1124\/pharmrev.122.000684_bib442","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1369\/0022155420959147","article-title":"The role of chondroitin sulfate proteoglycans in nervous system development","volume":"69","author":"Mencio","year":"2021","journal-title":"J Histochem Cytochem"},{"key":"10.1124\/pharmrev.122.000684_bib443","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.3390\/molecules24162988","article-title":"Crude heparin preparations unveil the presence of structurally diverse oversulfated contaminants","volume":"24","author":"Mendes","year":"2019","journal-title":"Molecules"},{"key":"10.1124\/pharmrev.122.000684_bib444","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1055\/s-0038-1661070","article-title":"High and low affinity heparin compared with unfractionated heparin as antithrombotic drugs","volume":"51","author":"Merton","year":"1984","journal-title":"Thromb Haemost"},{"key":"10.1124\/pharmrev.122.000684_bib445","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01220-2018","article-title":"Anti-tumour effect of low molecular weight heparin in localised lung cancer: a phase III clinical trial","volume":"52","author":"Meyer","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1124\/pharmrev.122.000684_bib446","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1002\/1873-3468.12426","article-title":"Heparin promotes fibril formation by the N-terminal fragment of amyloidogenic apolipoprotein A-I","volume":"590","author":"Mikawa","year":"2016","journal-title":"FEBS Lett"},{"key":"10.1124\/pharmrev.122.000684_bib447","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1007\/s13361-017-1596-0","article-title":"Electrostatic forces as dominant interactions between proteins and polyanions: an ESI ms study of fibroblast growth factor binding to heparin oligomers","volume":"28","author":"Minsky","year":"2017","journal-title":"J Am Soc Mass Spectrom"},{"key":"10.1124\/pharmrev.122.000684_bib448","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3390\/ph10040078","article-title":"Heparin mimetics: their therapeutic potential","volume":"10","author":"Mohamed","year":"2017","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1124\/pharmrev.122.000684_bib449","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/rth2.12359","article-title":"Direct oral anticoagulants compared to low-molecular-weight heparin for the treatment of cancer-associated thrombosis: Updated systematic review and meta-analysis of randomized controlled trials","volume":"4","author":"Moik","year":"2020","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1124\/pharmrev.122.000684_bib450","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jpba.2019.05.024","article-title":"Retrospective multivariate analysis of pharmaceutical preparations using 1H nuclear magnetic resonance (NMR) spectroscopy: example of 990 heparin samples","volume":"173","author":"Monakhova","year":"2019","journal-title":"J Pharm Biomed Anal"},{"key":"10.1124\/pharmrev.122.000684_bib451","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jpba.2017.11.016","article-title":"Novel method for the determination of average molecular weight of natural polymers based on 2D DOSY NMR and chemometrics: example of heparin","volume":"149","author":"Monakhova","year":"2018","journal-title":"J Pharm Biomed Anal"},{"key":"10.1124\/pharmrev.122.000684_bib452","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jpba.2019.06.036","article-title":"Anticoagulant activity of porcine heparin: Structural-property relationship and semi-quantitative estimation by nuclear magnetic resonance (NMR) spectrometry","volume":"174","author":"Monakhova","year":"2019","journal-title":"J Pharm Biomed Anal"},{"key":"10.1124\/pharmrev.122.000684_bib453","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.jpba.2017.05.034","article-title":"Current role and future perspectives of multivariate (chemometric) methods in NMR spectroscopic analysis of pharmaceutical products","volume":"147","author":"Monakhova","year":"2018","journal-title":"J Pharm Biomed Anal"},{"key":"10.1124\/pharmrev.122.000684_bib454","doi-asserted-by":"crossref","first-page":"170133","DOI":"10.1098\/rsob.170133","article-title":"Solution structure of CXCL13 and heparan sulfate binding show that GAG binding site and cellular signalling rely on distinct domains","volume":"7","author":"Monneau","year":"2017","journal-title":"Open Biol"},{"key":"10.1124\/pharmrev.122.000684_bib455","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1055\/s-0040-1709712","article-title":"The efficacy and safety of low molecular weight heparin administration to improve survival of cancer patients: a systematic review and meta-analysis","volume":"120","author":"Montroy","year":"2020","journal-title":"Thromb Haemost"},{"key":"10.1124\/pharmrev.122.000684_bib456","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.1021\/acs.jmedchem.9b00379","article-title":"On the process of discovering leads that target the heparin-binding site of neutrophil elastase in the sputum of cystic fibrosis patients","volume":"62","author":"Morla","year":"2019","journal-title":"J Med Chem"},{"key":"10.1124\/pharmrev.122.000684_bib457","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0049-3848(00)00334-0","article-title":"Anti-thrombotic efficacies of enoxaparin, dalteparin, and unfractionated heparin in venous thrombo-embolism","volume":"100","author":"Morris","year":"2000","journal-title":"Thromb Res"},{"key":"10.1124\/pharmrev.122.000684_bib458","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0048632","article-title":"On the specificity of heparin\/heparan sulfate binding to proteins. Anion-binding sites on antithrombin and thrombin are fundamentally different","volume":"7","author":"Mosier","year":"2012","journal-title":"PLoS One"},{"key":"10.1124\/pharmrev.122.000684_bib459","doi-asserted-by":"crossref","first-page":"5553","DOI":"10.3390\/molecules25235553","article-title":"Specific non-reducing ends in heparins from different animal origins: building blocks analysis using reductive amination tagging by sulfanilic acid","volume":"25","author":"Mourier","year":"2020","journal-title":"Molecules"},{"key":"10.1124\/pharmrev.122.000684_bib460","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.jpba.2016.07.033","article-title":"Analytical comparison of a US generic enoxaparin with the originator product: The focus on comparative assessment of antithrombin-binding components","volume":"129","author":"Mourier","year":"2016","journal-title":"J Pharm Biomed Anal"},{"key":"10.1124\/pharmrev.122.000684_bib461","first-page":"507151","article-title":"Anti-inflammatory effects of heparin and its derivatives: a systematic review","volume":"2015","author":"Mousavi","year":"2015","journal-title":"Adv Pharmacol Sci"},{"key":"10.1124\/pharmrev.122.000684_bib462","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/978-3-642-23056-1_5","article-title":"Structure and physicochemical characterisation of heparin","volume":"207","author":"Mulloy","year":"2012","journal-title":"Handb Exp Pharmacol"},{"key":"10.1124\/pharmrev.122.000684_bib463","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.coph.2019.03.009","article-title":"The non-anticoagulant promise of heparin and its mimetics","volume":"46","author":"Mulloy","year":"2019","journal-title":"Curr Opin Pharmacol"},{"key":"10.1124\/pharmrev.122.000684_bib464","doi-asserted-by":"crossref","first-page":"4815","DOI":"10.1007\/s00216-014-7940-3","article-title":"USP compendial methods for analysis of heparin: chromatographic determination of molecular weight distributions for heparin sodium","volume":"406","author":"Mulloy","year":"2014","journal-title":"Anal Bioanal Chem"},{"key":"10.1124\/pharmrev.122.000684_bib465","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1124\/pr.115.011247","article-title":"Pharmacology of heparin and related drugs","volume":"68","author":"Mulloy","year":"2016","journal-title":"Pharmacol Rev"},{"key":"10.1124\/pharmrev.122.000684_bib466","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s10719-016-9749-0","article-title":"Mast cell glycosaminoglycans","volume":"34","author":"Mulloy","year":"2017","journal-title":"Glycoconj J"},{"key":"10.1124\/pharmrev.122.000684_bib467","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.thromres.2017.05.012","article-title":"Reversal of anticoagulant activity of heparin and low molecular weight heparins by poly-l-lysine: A comparative \u201cin vitro\u201d study versus protamine sulfate","volume":"155","author":"Muralidharan-Chari","year":"2017","journal-title":"Thromb Res"},{"key":"10.1124\/pharmrev.122.000684_bib468","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3390\/md19040203","article-title":"Glycosaminoglycans from Litopenaeus vannamei Inhibit the Alzheimer\u2019s disease \u03b2 secretase, BACE1","volume":"19","author":"Mycroft-West","year":"2021","journal-title":"Mar Drugs"},{"key":"10.1124\/pharmrev.122.000684_bib469","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.4103\/1673-5374.274341","article-title":"Inhibition of BACE1, the \u03b2-secretase implicated in Alzheimer\u2019s disease, by a chondroitin sulfate extract from Sardina pilchardus","volume":"15","author":"Mycroft-West","year":"2020","journal-title":"Neural Regen Res"},{"key":"10.1124\/pharmrev.122.000684_bib470","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1055\/s-0040-1721319","article-title":"Heparin inhibits cellular invasion by Sars-Cov-2: structural dependence of the interaction of the spike S1 receptor-binding domain with heparin","volume":"120","author":"Mycroft-West","year":"2020","journal-title":"Thromb Haemost"},{"key":"10.1124\/pharmrev.122.000684_bib471","doi-asserted-by":"crossref","first-page":"6113","DOI":"10.1021\/acscatal.0c01231","article-title":"Engineer P. multocida heparosan synthase 2 (PmHS2) for size-controlled synthesis of longer heparosan oligosaccharides","volume":"10","author":"Na","year":"2020","journal-title":"ACS Catal"},{"key":"10.1124\/pharmrev.122.000684_bib472","doi-asserted-by":"crossref","first-page":"951","DOI":"10.2174\/1381612043452758","article-title":"Heparins and heparinoids: occurrence, structure and mechanism of antithrombotic and hemorrhagic activities","volume":"10","author":"Nader","year":"2004","journal-title":"Curr Pharm Des"},{"key":"10.1124\/pharmrev.122.000684_bib473","doi-asserted-by":"crossref","first-page":"102356","DOI":"10.1016\/j.sbi.2022.102356","article-title":"Molecular dynamics simulations to understand glycosaminoglycan interactions in the free- and protein-bound states","volume":"74","author":"Nagarajan","year":"2022","journal-title":"Curr Opin Struct Biol"},{"key":"10.1124\/pharmrev.122.000684_bib474","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1097\/TA.0000000000001215","article-title":"Unfractionated heparin after TBI reduces in vivo cerebrovascular inflammation, brain edema and accelerates cognitive recovery","volume":"81","author":"Nagata","year":"2016","journal-title":"J Trauma Acute Care Surg"},{"key":"10.1124\/pharmrev.122.000684_bib475","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/TA.0000000000001819","article-title":"Early low-anticoagulant desulfated heparin after traumatic brain injury: reduced brain edema and leukocyte mobilization is associated with improved watermaze learning ability weeks after injury","volume":"84","author":"Nagata","year":"2018","journal-title":"J Trauma Acute Care Surg"},{"key":"10.1124\/pharmrev.122.000684_bib476","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1111\/jth.13066","article-title":"Distinguishing between anti-platelet factor 4\/heparin antibodies that can and cannot cause heparin-induced thrombocytopenia","volume":"13","author":"Nazi","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1124\/pharmrev.122.000684_bib477","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1007\/s12010-021-03541-9","article-title":"Application of dual promoter expression system for the enhanced heparosan production in bacillus megaterium","volume":"193","author":"Nehru","year":"2021","journal-title":"Appl Biochem Biotechnol"},{"key":"10.1124\/pharmrev.122.000684_bib478","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1039\/C6CC09770G","article-title":"Heparin acts as a structural component of \u03b2-endorphin amyloid fibrils rather than a simple aggregation promoter","volume":"53","author":"Nespovitaya","year":"2017","journal-title":"Chem Commun (Camb)"},{"key":"10.1124\/pharmrev.122.000684_bib479","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1182\/bloodadvances.2019000840","article-title":"DOACs vs LMWHs in hospitalized medical patients: a systematic review and meta-analysis that informed 2018 ASH guidelines","volume":"4","author":"Neumann","year":"2020","journal-title":"Blood Adv"},{"key":"10.1124\/pharmrev.122.000684_bib480","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/978-1-62703-339-8_21","article-title":"Protamine titration","volume":"992","author":"Newall","year":"2013","journal-title":"Methods Mol Biol"},{"key":"10.1124\/pharmrev.122.000684_bib481","doi-asserted-by":"crossref","first-page":"119540","DOI":"10.1016\/j.biomaterials.2019.119540","article-title":"Macroporous heparin-based microcarriers allow long-term 3D culture and differentiation of neural precursor cells","volume":"230","author":"Newland","year":"2020","journal-title":"Biomaterials"},{"key":"10.1124\/pharmrev.122.000684_bib482","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/jth.14657","article-title":"Characterization of the interaction between platelet factor 4 and homogeneous synthetic low molecular weight heparins","volume":"18","author":"Nguyen","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1124\/pharmrev.122.000684_bib483","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/ajh.26194","article-title":"Comparative effectiveness and safety of anticoagulants for the treatment of heparin-induced thrombocytopenia","volume":"96","author":"Nilius","year":"2021","journal-title":"Am J Hematol"},{"key":"10.1124\/pharmrev.122.000684_bib484","doi-asserted-by":"crossref","DOI":"10.1177\/1744806921999924","article-title":"Genome-wide association study identifies candidate loci associated with chronic pain and postherpetic neuralgia","volume":"17","author":"Nishizawa","year":"2021","journal-title":"Mol Pain"},{"key":"10.1124\/pharmrev.122.000684_bib485","doi-asserted-by":"crossref","first-page":"116550","DOI":"10.1016\/j.ijms.2021.116550","article-title":"Towards better understanding of the heparin role in NETosis: feasibility of using native mass spectrometry to monitor interactions of neutrophil elastase with heparin oligomers","volume":"463","author":"Niu","year":"2021","journal-title":"Int J Mass Spectrom"},{"key":"10.1124\/pharmrev.122.000684_bib486","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1160\/TH14-09-0724","article-title":"Vascular repair utilising immobilised heparin conjugate for protection against early activation of inflammation and coagulation","volume":"113","author":"Nordling","year":"2015","journal-title":"Thromb Haemost"},{"key":"10.1124\/pharmrev.122.000684_bib487","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.pan.2013.08.004","article-title":"The heparin-binding protein interactome in pancreatic diseases","volume":"13","author":"Nunes","year":"2013","journal-title":"Pancreatology"},{"key":"10.1124\/pharmrev.122.000684_bib488","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.virol.2008.11.037","article-title":"Adeno-associated virus-2 and its primary cellular receptor\u2014cryo-EM structure of a heparin complex","volume":"385","author":"O\u2019Donnell","year":"2009","journal-title":"Virology"},{"key":"10.1124\/pharmrev.122.000684_bib489","doi-asserted-by":"crossref","first-page":"9075","DOI":"10.1128\/JVI.00732-08","article-title":"Heparan sulfate-binding foot-and-mouth disease virus enters cells via caveola-mediated endocytosis","volume":"82","author":"O\u2019Donnell","year":"2008","journal-title":"J Virol"},{"key":"10.1124\/pharmrev.122.000684_bib490","doi-asserted-by":"crossref","first-page":"50267","DOI":"10.1074\/jbc.M408774200","article-title":"The heparin binding properties of heparin cofactor II suggest an antithrombin-like activation mechanism","volume":"279","author":"O\u2019Keeffe","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1124\/pharmrev.122.000684_bib491","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ejca.2020.03.005","article-title":"Randomised phase II trial of gemcitabine and nab-paclitaxel with necuparanib or placebo in untreated metastatic pancreas ductal adenocarcinoma","volume":"132","author":"O\u2019Reilly","year":"2020","journal-title":"Eur J Cancer"},{"key":"10.1124\/pharmrev.122.000684_bib492","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3390\/ph9030038","article-title":"Heparin: past, present, and future","volume":"9","author":"Oduah","year":"2016","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1124\/pharmrev.122.000684_bib493","doi-asserted-by":"crossref","DOI":"10.1177\/17448069211052171","article-title":"Heparan sulfate 3-O-sulfotransferase 4 is genetically associated with herpes zoster and enhances varicella-zoster virus-mediated fusogenic activity","volume":"17","author":"Ohka","year":"2021","journal-title":"Mol Pain"},{"key":"10.1124\/pharmrev.122.000684_bib494","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/s41598-017-00917-y","article-title":"A bacterial ABC transporter enables import of mammalian host glycosaminoglycans","volume":"7","author":"Oiki","year":"2017","journal-title":"Sci Rep"},{"key":"10.1124\/pharmrev.122.000684_bib495","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jaci.2018.01.034","article-title":"Mast cells signal their importance in health and disease","volume":"142","author":"Olivera","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1124\/pharmrev.122.000684_bib496","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.biochi.2010.05.011","article-title":"Molecular mechanisms of antithrombin-heparin regulation of blood clotting proteinases. A paradigm for understanding proteinase regulation by serpin family protein proteinase inhibitors","volume":"92","author":"Olson","year":"2010","journal-title":"Biochimie"},{"key":"10.1124\/pharmrev.122.000684_bib497","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1160\/TH04-06-0384","article-title":"Accelerating ability of synthetic oligosaccharides on antithrombin inhibition of proteinases of the clotting and fibrinolytic systems. Comparison with heparin and low-molecular-weight heparin","volume":"92","author":"Olson","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1124\/pharmrev.122.000684_bib498","doi-asserted-by":"crossref","first-page":"19892","DOI":"10.1074\/jbc.M111.228114","article-title":"A systems biology approach for the investigation of the heparin\/heparan sulfate interactome","volume":"286","author":"Ori","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1124\/pharmrev.122.000684_bib499","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1182\/bloodadvances.2020001830","article-title":"American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism","volume":"4","author":"Ortel","year":"2020","journal-title":"Blood Adv"},{"key":"10.1124\/pharmrev.122.000684_bib500","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1021\/acsmedchemlett.9b00090","article-title":"Dendrigraft of poly-l-lysine as a promising candidate to reverse heparin-based anticoagulants in clinical settings","volume":"10","author":"Ourri","year":"2019","journal-title":"ACS Med Chem Lett"},{"key":"10.1124\/pharmrev.122.000684_bib501","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jpba.2018.10.052","article-title":"Chemometric analysis of porcine, bovine and ovine heparins","volume":"164","author":"Ouyang","year":"2019","journal-title":"J Pharm Biomed Anal"},{"key":"10.1124\/pharmrev.122.000684_bib502","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2147\/OPTH.S5127","article-title":"Effect of heparin in the intraocular irrigating solution on postoperative inflammation in the pediatric cataract surgery","volume":"3","author":"Ozkurt","year":"2009","journal-title":"Clin Ophthalmol"},{"key":"10.1124\/pharmrev.122.000684_bib503","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/0140-6736(91)90289-2","article-title":"One explanation of the asthma paradox: inhibition of natural anti-inflammatory mechanism by beta 2-agonists","volume":"337","author":"Page","year":"1991","journal-title":"Lancet"},{"key":"10.1124\/pharmrev.122.000684_bib504","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/978-3-642-23056-1_11","article-title":"Neutralization of heparin activity","volume":"207","author":"Pai","year":"2012","journal-title":"Handb Exp Pharmacol"},{"key":"10.1124\/pharmrev.122.000684_bib505","doi-asserted-by":"crossref","first-page":"739","DOI":"10.3390\/biom11050739","article-title":"A Bittersweet Computational journey among glycosaminoglycans","volume":"11","author":"Paiardi","year":"2021","journal-title":"Biomolecules"},{"key":"10.1124\/pharmrev.122.000684_bib506","doi-asserted-by":"crossref","first-page":"101507","DOI":"10.1016\/j.jbc.2021.101507","article-title":"The binding of heparin to spike glycoprotein inhibits SARS-CoV-2 infection by three mechanisms","volume":"298","author":"Paiardi","year":"2022","journal-title":"J Biol Chem"},{"key":"10.1124\/pharmrev.122.000684_bib507","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ijpharm.2011.10.048","article-title":"Chitosan nanoconstructs for improved oral delivery of low molecular weight heparin: In vitro and in vivo evaluation","volume":"422","author":"Paliwal","year":"2012","journal-title":"Int J Pharm"},{"key":"10.1124\/pharmrev.122.000684_bib508","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1021\/acs.biomac.6b01147","article-title":"Heparin-mimicking polymers: synthesis and biological applications","volume":"17","author":"Paluck","year":"2016","journal-title":"Biomacromolecules"},{"key":"10.1124\/pharmrev.122.000684_bib509","doi-asserted-by":"crossref","first-page":"115312","DOI":"10.1016\/j.carbpol.2019.115312","article-title":"Identification of a heparosan heptasaccharide as an effective anti-inflammatory agent by partial desulfation of low molecular weight heparin","volume":"227","author":"Pan","year":"2020","journal-title":"Carbohydr Polym"},{"key":"10.1124\/pharmrev.122.000684_bib510","doi-asserted-by":"crossref","first-page":"28284","DOI":"10.1074\/jbc.M114.572297","article-title":"Fucosylated chondroitin sulfates from the body wall of the sea cucumber Holothuria forskali: conformation, selectin binding, and biological activity","volume":"289","author":"Panagos","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1124\/pharmrev.122.000684_bib511","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.ijbiomac.2021.02.134","article-title":"A colorimetric and fluorometric based dual readout approach for effective heparin sensing","volume":"178","author":"Pandey","year":"2021","journal-title":"Int J Biol Macromol"},{"key":"10.1124\/pharmrev.122.000684_bib512","first-page":"1209","article-title":"The structural investigation of glycosaminoglycan binding to CXCL12 displays distinct interaction sites","volume":"26","author":"Panitz","year":"2016","journal-title":"Glycobiology"},{"key":"10.1124\/pharmrev.122.000684_bib513","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1007\/s00018-016-2418-4","article-title":"Complement factor H in host defense and immune evasion","volume":"74","author":"Parente","year":"2017","journal-title":"Cell Mol Life Sci"},{"key":"10.1124\/pharmrev.122.000684_bib514","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1055\/s-0041-1726034","article-title":"Different anticoagulant regimens, mortality, and bleeding in hospitalized patients with COVID-19: a systematic review and an updated meta-analysis","volume":"47","author":"Parisi","year":"2021","journal-title":"Semin Thromb Hemost"},{"key":"10.1124\/pharmrev.122.000684_bib515","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1021\/mp900319k","article-title":"Anticoagulant efficacy of solid oral formulations containing a new heparin derivative","volume":"7","author":"Park","year":"2010","journal-title":"Mol Pharm"},{"key":"10.1124\/pharmrev.122.000684_bib516","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/00004311-200404230-00011","article-title":"Protamine and protamine reactions","volume":"42","author":"Park","year":"2004","journal-title":"Int Anesthesiol Clin"},{"key":"10.1124\/pharmrev.122.000684_bib517","doi-asserted-by":"crossref","first-page":"180018","DOI":"10.1183\/16000617.0018-2018","article-title":"How bacteria hack the matrix and dodge the bullets of immunity","volume":"27","author":"Paulsson","year":"2018","journal-title":"Eur Respir Rev"},{"key":"10.1124\/pharmrev.122.000684_bib518","doi-asserted-by":"crossref","first-page":"20774","DOI":"10.1074\/jbc.M111.320069","article-title":"Probing structural selectivity of synthetic heparin binding to Stabilin protein receptors","volume":"287","author":"Pempe","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1124\/pharmrev.122.000684_bib519","first-page":"3109","article-title":"Construction of heparin-based hydrogel incorporated with Cu5.4O ultrasmall nanozymes for wound healing and inflammation inhibition","volume":"6","author":"Peng","year":"2021","journal-title":"Bioact Mater"},{"key":"10.1124\/pharmrev.122.000684_bib520","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/glycob\/cwz047","article-title":"NMR and molecular modeling reveal specificity of the interactions between CXCL14 and glycosaminoglycans","volume":"29","author":"Penk","year":"2019","journal-title":"Glycobiology"},{"key":"10.1124\/pharmrev.122.000684_bib521","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1160\/th15-04-0354","article-title":"Role of exosite binding modulators in the inhibition of Fxa by TFPI","volume":"115","author":"Peraramelli","year":"2016","journal-title":"Thromb Haemost"},{"key":"10.1124\/pharmrev.122.000684_bib522","doi-asserted-by":"crossref","first-page":"461378","DOI":"10.1016\/j.chroma.2020.461378","article-title":"Capture and purification of human immunodeficiency virus-1 virus-like particles: convective media vs porous beads","volume":"1627","author":"Pereira Aguilar","year":"2020","journal-title":"J Chromatogr A"},{"key":"10.1124\/pharmrev.122.000684_bib523","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1111\/jth.15450","article-title":"Standard prophylactic versus intermediate dose enoxaparin in adults with severe COVID-19: a multi-center, open-label, randomized controlled trial","volume":"19","author":"Perepu","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1124\/pharmrev.122.000684_bib524","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1093\/cvr\/cvab308","article-title":"Low-molecular-weight heparin use in coronavirus disease 2019 is associated with curtailed viral persistence: a retrospective multicentre observational study","volume":"117","author":"Pereyra","year":"2021","journal-title":"Cardiovasc Res"},{"key":"10.1124\/pharmrev.122.000684_bib525","first-page":"319","article-title":"Mechanism action of platelets and crucial blood coagulation pathways in hemostasis","volume":"11","author":"Periayah","year":"2017","journal-title":"Int J Hematol Oncol Stem Cell Res"},{"key":"10.1124\/pharmrev.122.000684_bib526","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3389\/fimmu.2014.00126","article-title":"Molecular interactions between complement factor h and its heparin and heparan sulfate ligands","volume":"5","author":"Perkins","year":"2014","journal-title":"Front Immunol"},{"issue":"Suppl 2","key":"10.1124\/pharmrev.122.000684_bib527","first-page":"s3","article-title":"Role of von Willebrand factor in the haemostasis","volume":"9","author":"Peyvandi","year":"2011","journal-title":"Blood Transfus"},{"key":"10.1124\/pharmrev.122.000684_bib528","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1055\/s-0038-1650660","article-title":"Thrombin-activated human platelets release two NAP-2 variants that stimulate polymorphonuclear leukocytes","volume":"76","author":"Piccardoni","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1124\/pharmrev.122.000684_bib529","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1182\/blood-2003-05-1707","article-title":"Platelets are necessary for airway wall remodeling in a murine model of chronic allergic inflammation","volume":"103","author":"Pitchford","year":"2004","journal-title":"Blood"},{"key":"10.1124\/pharmrev.122.000684_bib530","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/0003-9861(87)90606-0","article-title":"Effect of negatively charged activating compounds on inactivation of factor XIIa by Cl inhibitor","volume":"256","author":"Pixley","year":"1987","journal-title":"Arch Biochem Biophys"},{"key":"10.1124\/pharmrev.122.000684_bib531","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/bip.21200","article-title":"Review: an overview about the structure-function relationship of marine sulfated homopolysaccharides with regular chemical structures","volume":"91","author":"Pomin","year":"2009","journal-title":"Biopolymers"},{"key":"10.1124\/pharmrev.122.000684_bib532","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.biochi.2016.05.017","article-title":"Paradigms in the structural biology of the mitogenic ternary complex FGF:FGFR:heparin","volume":"127","author":"Pomin","year":"2016","journal-title":"Biochimie"},{"key":"10.1124\/pharmrev.122.000684_bib533","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/cei.12777","article-title":"New insight into the effects of heparinoids on complement inhibition by C1-inhibitor","volume":"184","author":"Poppelaars","year":"2016","journal-title":"Clin Exp Immunol"},{"key":"10.1124\/pharmrev.122.000684_bib534","doi-asserted-by":"crossref","first-page":"119376","DOI":"10.1016\/j.lfs.2021.119376","article-title":"Heparin prevents in vitro glycocalyx shedding induced by plasma from COVID-19 patients","volume":"276","author":"Potje","year":"2021","journal-title":"Life Sci"},{"key":"10.1124\/pharmrev.122.000684_bib535","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1182\/blood.V97.10.3300","article-title":"Induction of monocyte tissue factor expression by antibodies to heparin-platelet factor 4 complexes developed in heparin-induced thrombocytopenia","volume":"97","author":"Pouplard","year":"2001","journal-title":"Blood"},{"key":"10.1124\/pharmrev.122.000684_bib536","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.thromres.2020.09.024","article-title":"The hazard of fondaparinux in non-critically ill patients with COVID-19: retrospective controlled study versus enoxaparin","volume":"196","author":"Prandoni","year":"2020","journal-title":"Thromb Res"},{"key":"10.1124\/pharmrev.122.000684_bib537","doi-asserted-by":"crossref","first-page":"8789","DOI":"10.1016\/S0021-9258(19)50348-9","article-title":"Heparin binding to protein C inhibitor","volume":"267","author":"Pratt","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1124\/pharmrev.122.000684_bib538","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1093\/glycob\/cwab012","article-title":"Deciphering the structural attributes of protein-heparan sulfate interactions using chemo-enzymatic approaches and NMR spectroscopy","volume":"31","author":"Pr\u00e9choux","year":"2021","journal-title":"Glycobiology"},{"key":"10.1124\/pharmrev.122.000684_bib539","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00216-019-02267-2","article-title":"Surface plasmon resonance imaging coupled to on-chip mass spectrometry: a new tool to probe protein-GAG interactions","volume":"412","author":"Przybylski","year":"2020","journal-title":"Anal Bioanal Chem"},{"key":"10.1124\/pharmrev.122.000684_bib540","doi-asserted-by":"crossref","first-page":"893","DOI":"10.17219\/acem\/121011","article-title":"Association between heparin-binding hemagglutinin and tuberculosis","volume":"29","author":"Pu","year":"2020","journal-title":"Adv Clin Exp Med"},{"key":"10.1124\/pharmrev.122.000684_bib541","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.3892\/mmr.2016.5719","article-title":"Heparin inhibits the inflammation and proliferation of human rheumatoid arthritis fibroblast-like synoviocytes through the NF-\u03baB pathway","volume":"14","author":"Qi","year":"2016","journal-title":"Mol Med Rep"},{"key":"10.1124\/pharmrev.122.000684_bib542","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.saa.2019.03.073","article-title":"A facile chemiluminescence sensing for ultrasensitive detection of heparin using charge effect of positively-charged AuNPs","volume":"216","author":"Qi","year":"2019","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"key":"10.1124\/pharmrev.122.000684_bib543","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3109\/15412555.2013.831062","article-title":"Efficacy of low molecular weight heparin in patients with acute exacerbation of chronic obstructive pulmonary disease receiving ventilatory support","volume":"11","author":"Qian","year":"2014","journal-title":"COPD"},{"key":"10.1124\/pharmrev.122.000684_bib544","doi-asserted-by":"crossref","first-page":"235501","DOI":"10.1088\/1361-6528\/abe905","article-title":"Lead halide perovskites with aggregation-induced emission feature coupled with gold nanoparticles for fluorescence detection of heparin","volume":"32","author":"Qu","year":"2021","journal-title":"Nanotechnology"},{"key":"10.1124\/pharmrev.122.000684_bib545","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3233\/JAD-171120","article-title":"Heparin modulates the kinetics of zinc-induced aggregation of amyloid-\u03b2 peptides","volume":"63","author":"Radko","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"10.1124\/pharmrev.122.000684_bib546","doi-asserted-by":"crossref","first-page":"660","DOI":"10.3389\/fimmu.2020.00660","article-title":"Structural insights into how proteoglycans determine chemokine-CXCR1\/CXCR2 interactions: progress and challenges","volume":"11","author":"Rajarathnam","year":"2020","journal-title":"Front Immunol"},{"key":"10.1124\/pharmrev.122.000684_bib547","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1186\/s12879-017-2418-5","article-title":"Glycosaminoglycans are involved in bacterial adherence to lung cells","volume":"17","author":"Rajas","year":"2017","journal-title":"BMC Infect Dis"},{"key":"10.1124\/pharmrev.122.000684_bib548","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/978-1-4939-6598-4_7","article-title":"Fourier transform infrared (FTIR) spectroscopy, ultraviolet resonance raman (UVRR) spectroscopy, and atomic force microscopy (AFM) for study of the kinetics of formation and structural characterization of tau fibrils","volume":"1523","author":"Ramachandran","year":"2017","journal-title":"Methods Mol Biol"},{"key":"10.1124\/pharmrev.122.000684_bib549","doi-asserted-by":"crossref","first-page":"C97","DOI":"10.1152\/ajpcell.00009.2010","article-title":"Low anticoagulant heparin targets multiple sites of inflammation, suppresses heparin-induced thrombocytopenia, and inhibits interaction of RAGE with its ligands","volume":"299","author":"Rao","year":"2010","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1124\/pharmrev.122.000684_bib550","doi-asserted-by":"crossref","first-page":"768","DOI":"10.3390\/molecules22050768","article-title":"A fluorescent probe for glycosaminoglycans applied to the detection of dermatan sulfate by a mix-and-read assay","volume":"22","author":"Rappold","year":"2017","journal-title":"Molecules"},{"key":"10.1124\/pharmrev.122.000684_bib551","doi-asserted-by":"crossref","first-page":"10443","DOI":"10.1096\/fj.201900627R","article-title":"Heparinoid sevuparin inhibits Streptococcus-induced vascular leak through neutralizing neutrophil-derived proteins","volume":"33","author":"Rasmuson","year":"2019","journal-title":"FASEB J"},{"key":"10.1124\/pharmrev.122.000684_bib552","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1182\/blood-2004-04-1544","article-title":"Ultralarge complexes of PF4 and heparin are central to the pathogenesis of heparin-induced thrombocytopenia","volume":"105","author":"Rauova","year":"2005","journal-title":"Blood"},{"key":"10.1124\/pharmrev.122.000684_bib553","doi-asserted-by":"crossref","first-page":"687","DOI":"10.4103\/1673-5374.206630","article-title":"Inhibition and enhancement of neural regeneration by chondroitin sulfate proteoglycans","volume":"12","author":"Rauvala","year":"2017","journal-title":"Neural Regen Res"},{"key":"10.1124\/pharmrev.122.000684_bib554","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jconrel.2008.03.013","article-title":"Inhalable large porous microspheres of low molecular weight heparin: in vitro and in vivo evaluation","volume":"128","author":"Rawat","year":"2008","journal-title":"J Control Release"},{"key":"10.1124\/pharmrev.122.000684_bib555","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/09537104.2021.1889310","article-title":"Platelets: bridging thrombosis and inflammation","volume":"32","author":"Rayes","year":"2021","journal-title":"Platelets"},{"key":"10.1124\/pharmrev.122.000684_bib556","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3109\/00365515409134865","article-title":"The titration of heparin with protamine","volume":"6","author":"Refn","year":"1954","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1124\/pharmrev.122.000684_bib557","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJMoa2103417","article-title":"Therapeutic anticoagulation with heparin in critically ill patients with COVID-19","volume":"385","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1124\/pharmrev.122.000684_bib558","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.bioelechem.2019.04.002","article-title":"A protamine-conjugated gold decorated graphene oxide composite as an electrochemical platform for heparin detection","volume":"128","author":"Rengaraj","year":"2019","journal-title":"Bioelectrochemistry"},{"key":"10.1124\/pharmrev.122.000684_bib559","doi-asserted-by":"crossref","first-page":"16824","DOI":"10.1074\/jbc.273.27.16824","article-title":"Calcium enhances heparin catalysis of the antithrombin-factor Xa reaction by a template mechanism. Evidence that calcium alleviates Gla domain antagonism of heparin binding to factor Xa","volume":"273","author":"Rezaie","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1124\/pharmrev.122.000684_bib560","doi-asserted-by":"crossref","first-page":"11426","DOI":"10.1128\/JVI.01721-13","article-title":"Multiple heparan sulfate binding site engagements are required for the infectious entry of human papillomavirus type 16","volume":"87","author":"Richards","year":"2013","journal-title":"J Virol"},{"key":"10.1124\/pharmrev.122.000684_bib561","doi-asserted-by":"crossref","first-page":"713","DOI":"10.3390\/molecules22050713","article-title":"Heparin, heparan sulphate and the TGF-\u03b2 cytokine superfamily","volume":"22","author":"Rider","year":"2017","journal-title":"Molecules"},{"key":"10.1124\/pharmrev.122.000684_bib562","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1165\/rcmb.2015-0172OC","article-title":"A non-anticoagulant fraction of heparin inhibits leukocyte diapedesis into the lung by an effect on platelets","volume":"55","author":"Riffo-Vasquez","year":"2016","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1124\/pharmrev.122.000684_bib563","doi-asserted-by":"crossref","first-page":"19421","DOI":"10.1074\/jbc.M308864200","article-title":"Mechanism of collagen activation in human platelets","volume":"279","author":"Roberts","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1124\/pharmrev.122.000684_bib564","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007123","article-title":"Reconstruction of the cell entry pathway of an extinct virus","volume":"14","author":"Robinson-McCarthy","year":"2018","journal-title":"PLoS Pathog"},{"key":"10.1124\/pharmrev.122.000684_bib565","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1111\/j.1471-0528.2002.01525.x","article-title":"Low molecular weight heparin for the treatment of venous thromboembolism in pregnancy: a case series","volume":"109","author":"Rodie","year":"2002","journal-title":"BJOG"},{"key":"10.1124\/pharmrev.122.000684_bib566","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/0741-5214(92)90456-I","article-title":"High-dose heparin suppresses platelet alpha granule secretion","volume":"15","author":"Rohrer","year":"1992","journal-title":"J Vasc Surg"},{"key":"10.1124\/pharmrev.122.000684_bib567","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1073\/pnas.76.3.1218","article-title":"Correlation between structure and function of heparin","volume":"76","author":"Rosenberg","year":"1979","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pharmrev.122.000684_bib568","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1634\/theoncologist.2019-0910","article-title":"When pigs fly: a multidisciplinary approach to navigating a critical heparin shortage","volume":"25","author":"Rosovsky","year":"2020","journal-title":"Oncologist"},{"key":"10.1124\/pharmrev.122.000684_bib569","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.3390\/jcm9082666","article-title":"The antitumor effect of heparin is not mediated by direct NK cell activation","volume":"9","author":"Rossi","year":"2020","journal-title":"J Clin Med"},{"key":"10.1124\/pharmrev.122.000684_bib570","doi-asserted-by":"crossref","first-page":"129765","DOI":"10.1016\/j.bbagen.2020.129765","article-title":"Metabolic engineering of non-pathogenic Escherichia coli strains for the controlled production of low molecular weight heparosan and size-specific heparosan oligosaccharides","volume":"1865","author":"Roy","year":"2021","journal-title":"Biochim Biophys Acta, Gen Subj"},{"key":"10.1124\/pharmrev.122.000684_bib571","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1021\/jm4016069","article-title":"Synthesis and biological evaluation of a unique heparin mimetic hexasaccharide for structure-activity relationship studies","volume":"57","author":"Roy","year":"2014","journal-title":"J Med Chem"},{"key":"10.1124\/pharmrev.122.000684_bib572","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1039\/C9FD00009G","article-title":"Multivariate analysis applied to complex biological medicines","volume":"218","author":"Rudd","year":"2019","journal-title":"Faraday Discuss"},{"key":"10.1124\/pharmrev.122.000684_bib573","doi-asserted-by":"crossref","first-page":"4905","DOI":"10.1038\/s41598-019-41355-2","article-title":"Glycosaminoglycans influence enzyme activity of MMP2 and MMP2\/TIMP3 complex formation - Insights at cellular and molecular level","volume":"9","author":"Ruiz-G\u00f3mez","year":"2019","journal-title":"Sci Rep"},{"key":"10.1124\/pharmrev.122.000684_bib574","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1001\/jama.2021.4152","volume":"325","author":"Sadeghipour","year":"2021","journal-title":"JAMA"},{"key":"10.1124\/pharmrev.122.000684_bib575","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20191077","article-title":"Conformational changes in Chikungunya virus E2 protein upon heparan sulfate receptor binding explain mechanism of E2-E1 dissociation during viral entry","volume":"39","author":"Sahoo","year":"2019","journal-title":"Biosci Rep"},{"key":"10.1124\/pharmrev.122.000684_bib576","doi-asserted-by":"crossref","first-page":"19019","DOI":"10.1038\/s41598-020-76034-0","article-title":"Antifibrotic therapy by sustained release of low molecular weight heparin from poly(lactic-co-glycolic acid) microparticles on bleomycin-induced pulmonary fibrosis in mice","volume":"10","author":"Saito","year":"2020","journal-title":"Sci Rep"},{"key":"10.1124\/pharmrev.122.000684_bib577","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1074\/jbc.RA119.011639","article-title":"Proteomics-based screening of the endothelial heparan sulfate interactome reveals that C-type lectin 14a (CLEC14A) is a heparin-binding protein","volume":"295","author":"Sandoval","year":"2020","journal-title":"J Biol Chem"},{"key":"10.1124\/pharmrev.122.000684_bib578","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/0049-3848(88)90340-4","article-title":"Heparin induces release of extrinsic coagulation pathway inhibitor (EPI)","volume":"50","author":"Sandset","year":"1988","journal-title":"Thromb Res"},{"key":"10.1124\/pharmrev.122.000684_bib579","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1093\/infdis\/jiy081","article-title":"The role of heparan sulfate proteoglycans as an attachment factor for rabies virus entry and infection","volume":"217","author":"Sasaki","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1124\/pharmrev.122.000684_bib580","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.celrep.2016.06.028","article-title":"Identification of Zika virus and dengue virus dependency factors using functional genomics","volume":"16","author":"Savidis","year":"2016","journal-title":"Cell Rep"},{"key":"10.1124\/pharmrev.122.000684_bib581","doi-asserted-by":"crossref","first-page":"640","DOI":"10.2174\/1389201015666140915151649","article-title":"Current developments for the oral delivery of heparin","volume":"15","author":"Schl\u00fcter","year":"2014","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1124\/pharmrev.122.000684_bib582","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/nm.2843","article-title":"The pulmonary endothelial glycocalyx regulates neutrophil adhesion and lung injury during experimental sepsis","volume":"18","author":"Schmidt","year":"2012","journal-title":"Nat Med"},{"key":"10.1124\/pharmrev.122.000684_bib583","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0165493","article-title":"Regulation of complement and contact system activation via C1 inhibitor potentiation and factor XIIa activity modulation by sulfated glycans\u2014structure-activity relationships","volume":"11","author":"Schoenfeld","year":"2016","journal-title":"PLoS One"},{"key":"10.1124\/pharmrev.122.000684_bib584","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00216-010-4220-8","article-title":"Protamine neutralisation of low molecular weight heparins and their oligosaccharide components","volume":"399","author":"Schroeder","year":"2011","journal-title":"Anal Bioanal Chem"},{"key":"10.1124\/pharmrev.122.000684_bib585","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Schultz","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1124\/pharmrev.122.000684_bib586","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1016\/j.csbj.2021.05.002","article-title":"Evidence of a putative glycosaminoglycan binding site on the glycosylated SARS-CoV-2 spike protein N-terminal domain","volume":"19","author":"Schuurs","year":"2021","journal-title":"Comput Struct Biotechnol J"},{"key":"10.1124\/pharmrev.122.000684_bib587","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000508647","article-title":"Heparin 2.0: a new approach to the infection crisis","volume":"50","author":"Seffer","year":"2021","journal-title":"Blood Purif"},{"key":"10.1124\/pharmrev.122.000684_bib588","doi-asserted-by":"crossref","first-page":"20539","DOI":"10.1074\/jbc.M116.745265","article-title":"Molecular basis of chemokine CXCL5-glycosaminoglycan interactions","volume":"291","author":"Sepuru","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1124\/pharmrev.122.000684_bib589","doi-asserted-by":"crossref","first-page":"17817","DOI":"10.1074\/jbc.RA118.004866","article-title":"Structural basis, stoichiometry, and thermodynamics of binding of the chemokines KC and MIP2 to the glycosaminoglycan heparin","volume":"293","author":"Sepuru","year":"2018","journal-title":"J Biol Chem"},{"key":"10.1124\/pharmrev.122.000684_bib590","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1042\/BCJ20200927","article-title":"Structural basis of a chemokine heterodimer binding to glycosaminoglycans","volume":"478","author":"Sepuru","year":"2021","journal-title":"Biochem J"},{"key":"10.1124\/pharmrev.122.000684_bib591","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1378\/chest.08-2830","article-title":"Heparin-induced thrombocytopenia. A contemporary clinical approach to diagnosis and management","volume":"135","author":"Shantsila","year":"2009","journal-title":"Chest"},{"key":"10.1124\/pharmrev.122.000684_bib592","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3109\/1547691X.2013.839587","article-title":"Partially-desulfated heparin improves survival in pseudomonas pneumonia by enhancing bacterial clearance and ameliorating lung injury","volume":"11","author":"Sharma","year":"2014","journal-title":"J Immunotoxicol"},{"key":"10.1124\/pharmrev.122.000684_bib593","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1111\/jth.15706","article-title":"Investigations of the effectiveness of heparin variants as inhibitors of histones","volume":"20","author":"Sharma","year":"2022","journal-title":"J Thromb Haemost"},{"key":"10.1124\/pharmrev.122.000684_bib594","article-title":"Porcine heparin shortages urge bovine heparin comeback: a literature review comparison of unfractionated heparin","author":"Sharma","year":"2020","journal-title":"Am J Ther"},{"key":"10.1124\/pharmrev.122.000684_bib595","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1517\/13543784.2014.866092","article-title":"Non-anticoagulant derivatives of heparin for the management of asthma: distant dream or close reality?","volume":"23","author":"Shastri","year":"2014","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1124\/pharmrev.122.000684_bib596","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s10557-020-07133-3","article-title":"The association of low molecular weight heparin use and in-hospital mortality among patients hospitalized with COVID-19","volume":"36","author":"Shen","year":"2022","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1124\/pharmrev.122.000684_bib597","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1007\/s00203-021-02255-0","article-title":"Protein A of staphylococcus aureus strain NCTC8325 interacted with heparin","volume":"203","author":"Shi","year":"2021","journal-title":"Arch Microbiol"},{"key":"10.1124\/pharmrev.122.000684_bib598","doi-asserted-by":"crossref","first-page":"5190","DOI":"10.1038\/s41598-021-84776-8","article-title":"Clot waveform of APTT has abnormal patterns in subjects with COVID-19","volume":"11","author":"Shimura","year":"2021","journal-title":"Sci Rep"},{"key":"10.1124\/pharmrev.122.000684_bib599","doi-asserted-by":"crossref","first-page":"n2400","DOI":"10.1136\/bmj.n2400","article-title":"Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with COVID-19 admitted to hospital: RAPID randomised clinical trial","volume":"375","author":"Sholzberg","year":"2021","journal-title":"BMJ"},{"key":"10.1124\/pharmrev.122.000684_bib600","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1080\/03639040701657552","article-title":"The spray drying of unfractionated heparin: optimization of the operating parameters","volume":"34","author":"Shur","year":"2008","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1124\/pharmrev.122.000684_bib601","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.pupt.2017.10.001","article-title":"Inhaled nebulised unfractionated heparin improves lung function in moderate to very severe COPD: a pilot study","volume":"48","author":"Shute","year":"2018","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1124\/pharmrev.122.000684_bib602","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.coph.2018.01.006","article-title":"Therapeutic use of heparin and derivatives beyond anticoagulation in patients with bronchial asthma or COPD","volume":"40","author":"Shute","year":"2018","journal-title":"Curr Opin Pharmacol"},{"key":"10.1124\/pharmrev.122.000684_bib603","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1877-1173(10)93008-1","article-title":"Anticoagulant heparan sulfate to not clot\u2014or not?","volume":"93","author":"Shworak","year":"2010","journal-title":"Prog Mol Biol Transl Sci"},{"key":"10.1124\/pharmrev.122.000684_bib604","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1182\/blood.2020008801","article-title":"Ciraparantag: the next anticoagulant airbag?","volume":"137","author":"Siegal","year":"2021","journal-title":"Blood"},{"key":"10.1124\/pharmrev.122.000684_bib605","doi-asserted-by":"crossref","first-page":"5275","DOI":"10.3390\/ijms20215275","article-title":"Anticoagulants and osteoporosis","volume":"20","author":"Signorelli","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1124\/pharmrev.122.000684_bib606","doi-asserted-by":"crossref","first-page":"5020","DOI":"10.1128\/JVI.02933-15","article-title":"The Vaccinia virus H3 envelope protein, a major target of neutralizing antibodies, exhibits a glycosyltransferase fold and binds UDP-glucose","volume":"90","author":"Singh","year":"2016","journal-title":"J Virol"},{"key":"10.1124\/pharmrev.122.000684_bib607","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1084\/jem.171.6.2025","article-title":"Tumor necrosis factor alpha\/cachectin stimulates eosinophil oxidant production and toxicity towards human endothelium","volume":"171","author":"Slungaard","year":"1990","journal-title":"J Exp Med"},{"key":"10.1124\/pharmrev.122.000684_bib608","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41573-020-00093-1","article-title":"The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans","volume":"20","author":"Smith","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/pharmrev.122.000684_bib609","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.biomaterials.2018.08.056","article-title":"Minimum structural requirements for BMP-2-binding of heparin oligosaccharides","volume":"184","author":"Smith","year":"2018","journal-title":"Biomaterials"},{"key":"10.1124\/pharmrev.122.000684_bib610","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1002\/pro.3149","article-title":"Heparin-induced amyloid fibrillation of \u03b2(2) -microglobulin explained by solubility and a supersaturation-dependent conformational phase diagram","volume":"26","author":"So","year":"2017","journal-title":"Protein Sci"},{"key":"10.1124\/pharmrev.122.000684_bib611","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1080\/17425255.2016.1194395","article-title":"The toxicology of heparin reversal with protamine: past, present and future","volume":"12","author":"Sokolowska","year":"2016","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1124\/pharmrev.122.000684_bib612","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jpba.2017.03.010","article-title":"Heparin and homogeneous model heparin oligosaccharides form distinct complexes with protamine: light scattering and zeta potential analysis","volume":"140","author":"Sommers","year":"2017","journal-title":"J Pharm Biomed Anal"},{"key":"10.1124\/pharmrev.122.000684_bib613","doi-asserted-by":"crossref","first-page":"685","DOI":"10.3390\/md19120685","article-title":"Anti-SARS-CoV-2 activity of rhamnan sulfate from Monostroma nitidum","volume":"19","author":"Song","year":"2021","journal-title":"Mar Drugs"},{"key":"10.1124\/pharmrev.122.000684_bib614","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3389\/fmed.2019.00078","article-title":"SAX-HPLC and HSQC NMR spectroscopy: orthogonal methods for characterizing heparin batches composition","volume":"6","author":"Spelta","year":"2019","journal-title":"Front Med (Lausanne)"},{"key":"10.1124\/pharmrev.122.000684_bib615","doi-asserted-by":"crossref","first-page":"5128","DOI":"10.1021\/acsbiomaterials.9b01139","article-title":"Modulation of human CXCL12 binding properties to glycosaminoglycans to enhance chemotactic gradients","volume":"5","author":"Spiller","year":"2019","journal-title":"ACS Biomater Sci Eng"},{"key":"10.1124\/pharmrev.122.000684_bib616","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/pro.3346","article-title":"A structural overview of mycobacterial adhesins: key biomarkers for diagnostics and therapeutics","volume":"27","author":"Squeglia","year":"2018","journal-title":"Protein Sci"},{"key":"10.1124\/pharmrev.122.000684_bib617","doi-asserted-by":"crossref","first-page":"e599","DOI":"10.1097\/MJT.0000000000001295","article-title":"Venous thromboembolism in hospitalized COVID-19 patients","volume":"27","author":"Sridharan","year":"2020","journal-title":"Am J Ther"},{"key":"10.1124\/pharmrev.122.000684_bib618","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1177\/1076029616643822","article-title":"Analysis of heparins derived from bovine tissues and comparison to porcine intestinal heparins","volume":"22","author":"St Ange","year":"2016","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1124\/pharmrev.122.000684_bib619","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/s41569-021-00552-1","article-title":"Interplay between inflammation and thrombosis in cardiovascular pathology","volume":"18","author":"Stark","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"10.1124\/pharmrev.122.000684_bib620","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1016\/j.jmb.2017.07.003","article-title":"Molecular origins of the compatibility between glycosaminoglycans and A\u03b240 amyloid fibrils","volume":"429","author":"Stewart","year":"2017","journal-title":"J Mol Biol"},{"key":"10.1124\/pharmrev.122.000684_bib621","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3390\/ijms18020342","article-title":"Mechanisms of regulation of the chemokine-receptor network","volume":"18","author":"Stone","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1124\/pharmrev.122.000684_bib622","doi-asserted-by":"crossref","first-page":"10826","DOI":"10.1074\/jbc.RA117.000378","article-title":"Specific glycosaminoglycan chain length and sulfation patterns are required for cell uptake of tau versus \u03b1-synuclein and \u03b2-amyloid aggregates","volume":"293","author":"Stopschinski","year":"2018","journal-title":"J Biol Chem"},{"key":"10.1124\/pharmrev.122.000684_bib623","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1074\/jbc.RA119.010353","article-title":"A synthetic heparinoid blocks Tau aggregate cell uptake and amplification","volume":"295","author":"Stopschinski","year":"2020","journal-title":"J Biol Chem"},{"key":"10.1124\/pharmrev.122.000684_bib624","doi-asserted-by":"crossref","first-page":"9043","DOI":"10.1074\/jbc.270.16.9043","article-title":"Mechanism of acceleration of antithrombin-proteinase reactions by low affinity heparin. Role of the antithrombin binding pentasaccharide in heparin rate enhancement","volume":"270","author":"Streusand","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1124\/pharmrev.122.000684_bib625","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1527-3458.2002.tb00213.x","article-title":"Neuroprotective profile of enoxaparin, a low molecular weight heparin, in in vivo models of cerebral ischemia or traumatic brain injury in rats: a review","volume":"8","author":"Stutzmann","year":"2002","journal-title":"CNS Drug Rev"},{"key":"10.1124\/pharmrev.122.000684_bib626","doi-asserted-by":"crossref","first-page":"E70","DOI":"10.1148\/radiol.2020203557","article-title":"Pulmonary embolism and deep vein thrombosis in COVID-19: a systematic review and meta-analysis","volume":"298","author":"Suh","year":"2021","journal-title":"Radiology"},{"key":"10.1124\/pharmrev.122.000684_bib627","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.ajo.2012.08.009","article-title":"Anti-inflammatory effect of low-molecular-weight heparin in pediatric cataract surgery","volume":"154","author":"Sukhija","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"10.1124\/pharmrev.122.000684_bib628","doi-asserted-by":"crossref","first-page":"791","DOI":"10.2147\/IJN.S152698","article-title":"Guided osteoporotic bone regeneration with composite scaffolds of mineralized ECM\/heparin membrane loaded with BMP2-related peptide","volume":"13","author":"Sun","year":"2018","journal-title":"Int J Nanomedicine"},{"key":"10.1124\/pharmrev.122.000684_bib629","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1021\/bi802138m","article-title":"Heparin enhances the inhibition of factor Xa by protein C inhibitor in the presence but not in the absence of Ca2+","volume":"48","author":"Sun","year":"2009","journal-title":"Biochemistry"},{"key":"10.1124\/pharmrev.122.000684_bib630","doi-asserted-by":"crossref","first-page":"118046","DOI":"10.1016\/j.saa.2020.118046","article-title":"Interaction between tau and water during the induced aggregation revealed by near-infrared spectroscopy","volume":"230","author":"Sun","year":"2020","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"key":"10.1124\/pharmrev.122.000684_bib631","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/rth2.12107","article-title":"Integrating platelet and coagulation activation in fibrin clot formation","volume":"2","author":"Swieringa","year":"2018","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1124\/pharmrev.122.000684_bib632","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/nbt.3606","article-title":"The US regulatory and pharmacopeia response to the global heparin contamination crisis","volume":"34","author":"Szajek","year":"2016","journal-title":"Nat Biotechnol"},{"key":"10.1124\/pharmrev.122.000684_bib633","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12985-018-1045-0","article-title":"Heparan sulfate is an important mediator of Ebola virus infection in polarized epithelial cells","volume":"15","author":"Tamhankar","year":"2018","journal-title":"Virol J"},{"key":"10.1124\/pharmrev.122.000684_bib634","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.virol.2016.11.009","article-title":"VP1 residues around the five-fold axis of enterovirus A71 mediate heparan sulfate interaction","volume":"501","author":"Tan","year":"2017","journal-title":"Virology"},{"key":"10.1124\/pharmrev.122.000684_bib635","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s00192-020-04517-9","article-title":"Current status of oral pentosan polysulphate in bladder pain syndrome\/interstitial cystitis","volume":"32","author":"Taneja","year":"2021","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"10.1124\/pharmrev.122.000684_bib636","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1111\/j.1538-7836.2009.03514.x","article-title":"Thrombin generation and heparin-induced thrombocytopenia","volume":"7","author":"Tardy-Poncet","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1124\/pharmrev.122.000684_bib637","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1042\/BJ20150228","article-title":"Mapping the heparin-binding site of the BMP antagonist gremlin by site-directed mutagenesis based on predictive modelling","volume":"470","author":"Tatsinkam","year":"2015","journal-title":"Biochem J"},{"key":"10.1124\/pharmrev.122.000684_bib638","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007863","article-title":"Electrostatic interactions at the five-fold axis alter heparin-binding phenotype and drive enterovirus A71 virulence in mice","volume":"15","author":"Tee","year":"2019","journal-title":"PLoS Pathog"},{"key":"10.1124\/pharmrev.122.000684_bib639","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/jlb.59.3.389","article-title":"Adhesion mechanisms involved in C5a-induced eosinophil homotypic aggregation","volume":"59","author":"Teixeira","year":"1996","journal-title":"J Leukoc Biol"},{"key":"10.1124\/pharmrev.122.000684_bib640","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3109\/03008208808992791","article-title":"The basis and applicability of the dimethylmethylene blue binding assay for sulfated glycosaminoglycans","volume":"17","author":"Templeton","year":"1988","journal-title":"Connect Tissue Res"},{"key":"10.1124\/pharmrev.122.000684_bib641","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1111\/jth.14933","article-title":"Clinical differentiation of anticoagulant and non-anticoagulant properties of heparin","volume":"18","author":"Thachil","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1124\/pharmrev.122.000684_bib642","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ymben.2022.01.002","article-title":"Multiplex genome editing of mammalian cells for producing recombinant heparin","volume":"70","author":"Thacker","year":"2022","journal-title":"Metab Eng"},{"key":"10.1124\/pharmrev.122.000684_bib643","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1080\/1744666X.2019.1596800","article-title":"Recent advances in our understanding of mast cell activation\u2013\u2014or should it be mast cell mediator disorders?","volume":"15","author":"Theoharides","year":"2019","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1124\/pharmrev.122.000684_bib644","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.pupt.2016.05.001","article-title":"Structural characterization and anti-inflammatory activity of two novel polysaccharides from the sea squirt, Ascidiella aspersa","volume":"40","author":"Thomson","year":"2016","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1124\/pharmrev.122.000684_bib645","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1172\/JCI110292","article-title":"Detection of a new heparin-dependent inhibitor of thrombin in human plasma","volume":"68","author":"Tollefsen","year":"1981","journal-title":"J Clin Invest"},{"key":"10.1124\/pharmrev.122.000684_bib646","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.bbadis.2005.02.008","article-title":"Dermatan sulfate is the predominant antithrombotic glycosaminoglycan in vessel walls: implications for a possible physiological function of heparin cofactor II","volume":"1740","author":"Tovar","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/pharmrev.122.000684_bib647","doi-asserted-by":"crossref","first-page":"35619","DOI":"10.1038\/srep35619","article-title":"Structural and haemostatic features of pharmaceutical heparins from different animal sources: challenges to define thresholds separating distinct drugs","volume":"6","author":"Tovar","year":"2016","journal-title":"Sci Rep"},{"key":"10.1124\/pharmrev.122.000684_bib648","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1055\/s-0039-1678663","article-title":"Converting the distinct heparins sourced from bovine or porcine mucosa into a single anticoagulant drug","volume":"119","author":"Tovar","year":"2019","journal-title":"Thromb Haemost"},{"key":"10.1124\/pharmrev.122.000684_bib649","doi-asserted-by":"crossref","first-page":"13822","DOI":"10.1021\/acs.analchem.0c02390","article-title":"Raman spectroscopy with 2D perturbation correlation moving windows for the characterization of heparin-amyloid interactions","volume":"92","author":"Townsend","year":"2020","journal-title":"Anal Chem"},{"key":"10.1124\/pharmrev.122.000684_bib650","doi-asserted-by":"crossref","first-page":"81","DOI":"10.5152\/tjg.2018.18583","article-title":"Low molecular weight heparin treatment of acute moderate and severe pancreatitis: a randomized, controlled,open-label study","volume":"30","author":"Tozlu","year":"2019","journal-title":"Turk J Gastroenterol"},{"key":"10.1124\/pharmrev.122.000684_bib651","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/bph.15304","article-title":"Unfractionated heparin inhibits live wild type SARS-CoV-2 cell infectivity at therapeutically relevant concentrations","volume":"178","author":"Tree","year":"2021","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pharmrev.122.000684_bib652","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.cbpa.2017.09.012","article-title":"Synthetic heparin and heparan sulfate: probes in defining biological functions","volume":"40","author":"Tsai","year":"2017","journal-title":"Curr Opin Chem Biol"},{"key":"10.1124\/pharmrev.122.000684_bib653","series-title":"United States Pharmacopeia and National Formulary","article-title":"USP 37 official monographs: heparin sodium","year":"2014"},{"key":"10.1124\/pharmrev.122.000684_bib654","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s00216-010-4193-7","article-title":"Quantification of chondroitin sulfate and dermatan sulfate in danaparoid sodium by (1)H NMR spectroscopy and PLS regression","volume":"399","author":"Ust\u00fcn","year":"2011","journal-title":"Anal Bioanal Chem"},{"key":"10.1124\/pharmrev.122.000684_bib655","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0049-3848(94)90066-3","article-title":"Characterization of the binding between tissue factor pathway inhibitor and glycosaminoglycans","volume":"75","author":"Valentin","year":"1994","journal-title":"Thromb Res"},{"key":"10.1124\/pharmrev.122.000684_bib656","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1021\/acs.biomac.6b00699","article-title":"Effect of PEG-PDMAEMA block copolymer architecture on polyelectrolyte complex formation with heparin","volume":"17","author":"V\u00e4lim\u00e4ki","year":"2016","journal-title":"Biomacromolecules"},{"key":"10.1124\/pharmrev.122.000684_bib657","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1369\/0022155420946403","article-title":"Glycosaminoglycan-protein interactions: the first draft of the glycosaminoglycan interactome","volume":"69","author":"Vallet","year":"2021","journal-title":"J Histochem Cytochem"},{"key":"10.1124\/pharmrev.122.000684_bib658","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22061025","article-title":"From farm to pharma: an overview of industrial heparin manufacturing methods","volume":"22","author":"van der Meer","year":"2017","journal-title":"Molecules"},{"key":"10.1124\/pharmrev.122.000684_bib659","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1186\/s13054-020-03148-2","article-title":"Nebulised heparin as a treatment for COVID-19: scientific rationale and a call for randomised evidence","volume":"24","author":"van Haren","year":"2020","journal-title":"Crit Care"},{"key":"10.1124\/pharmrev.122.000684_bib660","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1111\/bcp.15212","article-title":"Inhaled nebulised unfractionated heparin for the treatment of hospitalised patients with COVID-19: a multicentre case series of 98 patients","volume":"88","author":"van Haren","year":"2022","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/pharmrev.122.000684_bib661","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/jb\/mvq060","article-title":"Effect of covalent antithrombin-heparin on activated protein C inactivation by protein C inhibitor","volume":"148","author":"Van Walderveen","year":"2010","journal-title":"J Biochem"},{"key":"10.1124\/pharmrev.122.000684_bib662","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms5030051","article-title":"The sea as a rich source of structurally unique glycosaminoglycans and mimetics","volume":"5","author":"Vasconcelos","year":"2017","journal-title":"Microorganisms"},{"key":"10.1124\/pharmrev.122.000684_bib663","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jpba.2018.04.012","article-title":"Fine structural characterization of sulodexide","volume":"156","author":"Veraldi","year":"2018","journal-title":"J Pharm Biomed Anal"},{"key":"10.1124\/pharmrev.122.000684_bib664","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.carbpol.2014.09.079","article-title":"Heparin derivatives for the targeting of multiple activities in the inflammatory response","volume":"117","author":"Veraldi","year":"2015","journal-title":"Carbohydr Polym"},{"key":"10.1124\/pharmrev.122.000684_bib665","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1152\/physrev.00016.2011","article-title":"New fundamentals in hemostasis","volume":"93","author":"Versteeg","year":"2013","journal-title":"Physiol Rev"},{"key":"10.1124\/pharmrev.122.000684_bib666","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1007\/s11095-013-1043-2","article-title":"Oral delivery of low molecular weight heparin by polyaminomethacrylate coacervates","volume":"30","author":"Viehof","year":"2013","journal-title":"Pharm Res"},{"key":"10.1124\/pharmrev.122.000684_bib667","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1096\/fj.13-246777","article-title":"Heparin binding confers prion stability and impairs its aggregation","volume":"28","author":"Vieira","year":"2014","journal-title":"FASEB J"},{"key":"10.1124\/pharmrev.122.000684_bib668","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/jth.14372","article-title":"Imminent risk of a global shortage of heparin caused by the African swine fever afflicting the Chinese pig herd","volume":"17","author":"Vilanova","year":"2019","journal-title":"J Thromb Haemost"},{"key":"10.1124\/pharmrev.122.000684_bib669","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3389\/fmed.2019.00016","article-title":"Heparins sourced from bovine and porcine mucosa gain exclusive monographs in the Brazilian pharmacopeia","volume":"6","author":"Vilanova","year":"2019","journal-title":"Front Med (Lausanne)"},{"key":"10.1124\/pharmrev.122.000684_bib670","doi-asserted-by":"crossref","DOI":"10.1128\/JB.00547-20","article-title":"Seeing and touching the mycomembrane at the nanoscale","volume":"203","author":"Viljoen","year":"2021","journal-title":"J Bacteriol"},{"issue":"Suppl 2","key":"10.1124\/pharmrev.122.000684_bib671","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1016\/S0049-3848(07)70139-1","article-title":"Heparanase, heparin and the coagulation system in cancer progression","volume":"120","author":"Vlodavsky","year":"2007","journal-title":"Thromb Res"},{"key":"10.1124\/pharmrev.122.000684_bib672","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.3389\/fphar.2020.01011","article-title":"Glycosaminoglycans as multifunctional anti-elastase and anti-inflammatory drugs in cystic fibrosis lung disease","volume":"11","author":"Voynow","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1124\/pharmrev.122.000684_bib673","doi-asserted-by":"crossref","first-page":"607306","DOI":"10.3389\/fimmu.2021.607306","article-title":"Glycocalyx as possible limiting factor in COVID-19","volume":"12","author":"Wadowski","year":"2021","journal-title":"Front Immunol"},{"key":"10.1124\/pharmrev.122.000684_bib674","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/5584_2017_60","article-title":"Regulation of the extracellular SERPINA5 (protein C inhibitor) penetration through cellular membranes","volume":"966","author":"Wahlm\u00fcller","year":"2017","journal-title":"Adv Exp Med Biol"},{"key":"10.1124\/pharmrev.122.000684_bib675","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1186\/s13054-014-0563-4","article-title":"Heparin therapy reduces 28-day mortality in adult severe sepsis patients: a systematic review and meta-analysis","volume":"18","author":"Wang","year":"2014","journal-title":"Crit Care"},{"key":"10.1124\/pharmrev.122.000684_bib676","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","article-title":"Adeno-associated virus vector as a platform for gene therapy delivery","volume":"18","author":"Wang","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/pharmrev.122.000684_bib677","doi-asserted-by":"crossref","first-page":"110212","DOI":"10.1016\/j.msec.2019.110212","article-title":"Biologically responsive, long-term release nanocoating on an electrospun scaffold for vascular endothelialization and anticoagulation","volume":"107","author":"Wang","year":"2020","journal-title":"Mater Sci Eng C"},{"key":"10.1124\/pharmrev.122.000684_bib678","doi-asserted-by":"crossref","first-page":"32533","DOI":"10.1021\/acsami.9b10621","article-title":"Programmed release of multimodal, cross-linked vascular endothelial growth factor and heparin layers on electrospun polycaprolactone vascular grafts","volume":"11","author":"Wang","year":"2019","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1124\/pharmrev.122.000684_bib679","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.2741\/4370","article-title":"Heparin defends against the toxicity of circulating histones in sepsis","volume":"20","author":"Wang","year":"2015","journal-title":"Front Biosci"},{"key":"10.1124\/pharmrev.122.000684_bib680","doi-asserted-by":"crossref","first-page":"10120","DOI":"10.1039\/C8CC05072D","article-title":"Binding and neurotoxicity mitigation of toxic tau oligomers by synthetic heparin like oligosaccharides","volume":"54","author":"Wang","year":"2018","journal-title":"Chem Commun (Camb)"},{"key":"10.1124\/pharmrev.122.000684_bib681","doi-asserted-by":"crossref","first-page":"140301","DOI":"10.1016\/j.bbapap.2019.140301","article-title":"Chemoenzymatic synthesis of ultralow and low-molecular weight heparins","volume":"1868","author":"Wang","year":"2020","journal-title":"Biochim Biophys Acta Proteins Proteomics"},{"key":"10.1124\/pharmrev.122.000684_bib682","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.cca.2003.10.009","article-title":"Isolation and characterization of raw heparin from dromedary intestine: evaluation of a new source of pharmaceutical heparin","volume":"136","author":"Warda","year":"2003","journal-title":"Comp Biochem Physiol C Toxicol Pharmacol"},{"key":"10.1124\/pharmrev.122.000684_bib683","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cbpb.2005.09.015","article-title":"Dromedary glycosaminoglycans: molecular characterization of camel lung and liver heparan sulfate","volume":"143","author":"Warda","year":"2006","journal-title":"Comp Biochem Physiol B Biochem Mol Biol"},{"key":"10.1124\/pharmrev.122.000684_bib684","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S1096-4959(02)00250-6","article-title":"Turkey intestine as a commercial source of heparin? Comparative structural studies of intestinal avian and mammalian glycosaminoglycans","volume":"134","author":"Warda","year":"2003","journal-title":"Comp Biochem Physiol B Biochem Mol Biol"},{"key":"10.1124\/pharmrev.122.000684_bib685","doi-asserted-by":"crossref","first-page":"340S","DOI":"10.1378\/chest.08-0677","article-title":"Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)","volume":"133","author":"Warkentin","year":"2008","journal-title":"Chest"},{"key":"10.1124\/pharmrev.122.000684_bib686","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0002-9343(96)00258-6","article-title":"A 14-year study of heparin-induced thrombocytopenia","volume":"101","author":"Warkentin","year":"1996","journal-title":"Am J Med"},{"key":"10.1124\/pharmrev.122.000684_bib687","doi-asserted-by":"crossref","first-page":"8241","DOI":"10.1007\/s00216-016-9940-y","article-title":"A fluorescent probe assay (Heparin Red) for direct detection of heparins in human plasma","volume":"408","author":"Warttinger","year":"2016","journal-title":"Anal Bioanal Chem"},{"key":"10.1124\/pharmrev.122.000684_bib688","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.3390\/cells9112366","article-title":"Systemic glycosaminoglycan clearance by HARE\/stabilin-2 activates intracellular signaling","volume":"9","author":"Weigel","year":"2020","journal-title":"Cells"},{"key":"10.1124\/pharmrev.122.000684_bib689","doi-asserted-by":"crossref","first-page":"5656","DOI":"10.1039\/C7OB01058C","article-title":"Targeting heparin and heparan sulfate protein interactions","volume":"15","author":"Weiss","year":"2017","journal-title":"Org Biomol Chem"},{"key":"10.1124\/pharmrev.122.000684_bib690","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s11239-009-0411-6","article-title":"Update on heparin: what do we need to know?","volume":"29","author":"Weitz","year":"2010","journal-title":"J Thromb Thrombolysis"},{"key":"10.1124\/pharmrev.122.000684_bib691","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1001\/archinte.158.14.1525","article-title":"Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty","volume":"158","author":"White","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1124\/pharmrev.122.000684_bib692","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1160\/TH03-03-0152","article-title":"Incidence of symptomatic venous thromboembolism after different elective or urgent surgical procedures","volume":"90","author":"White","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1124\/pharmrev.122.000684_bib693","doi-asserted-by":"crossref","first-page":"35767","DOI":"10.1074\/jbc.M304803200","article-title":"Mechanism of catalysis of inhibition of factor IXa by antithrombin in the presence of heparin or pentasaccharide","volume":"278","author":"Wiebe","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1124\/pharmrev.122.000684_bib694","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1182\/blood-2013-07-514984","article-title":"Nonanticoagulant heparin prevents histone-mediated cytotoxicity in vitro and improves survival in sepsis","volume":"123","author":"Wildhagen","year":"2014","journal-title":"Blood"},{"key":"10.1124\/pharmrev.122.000684_bib695","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.3390\/molecules22081362","article-title":"Extended physicochemical characterization of the synthetic anticoagulant pentasaccharide fondaparinux sodium by quantitative NMR and single crystal X-ray analysis","volume":"22","author":"Wildt","year":"2017","journal-title":"Molecules"},{"key":"10.1124\/pharmrev.122.000684_bib696","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.bbagen.2018.12.014","article-title":"Molecular dynamics simulations of the chemokine CCL2 in complex with pull down-derived heparan sulfate hexasaccharides","volume":"1863","author":"Winkler","year":"2019","journal-title":"Biochim Biophys Acta, Gen Subj"},{"key":"10.1124\/pharmrev.122.000684_bib697","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1182\/bloodadvances.2018024893","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy","volume":"2","author":"Witt","year":"2018","journal-title":"Blood Adv"},{"key":"10.1124\/pharmrev.122.000684_bib698","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.3390\/jcm10081599","article-title":"Thrombocytopenia and intracranial venous sinus thrombosis after \u201cCOVID-19 vaccine AstraZeneca\u201d exposure","volume":"10","author":"Wolf","year":"2021","journal-title":"J Clin Med"},{"key":"10.1124\/pharmrev.122.000684_bib699","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3389\/fmed.2019.00315","article-title":"Quantitative analysis of impurities in unfractionated heparin of bovine origin","volume":"6","author":"Workman","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"10.1124\/pharmrev.122.000684_bib700","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12985-019-1246-1","article-title":"Heparin sulfate is the attachment factor of duck Tembus virus on both BHK21 and DEF cells","volume":"16","author":"Wu","year":"2019","journal-title":"Virol J"},{"key":"10.1124\/pharmrev.122.000684_bib701","doi-asserted-by":"crossref","first-page":"117490","DOI":"10.1016\/j.carbpol.2020.117490","article-title":"Tumor microenvironment-responsive PEGylated heparin-pyropheophorbide\u2014a nanoconjugates for photodynamic therapy","volume":"255","author":"Wu","year":"2021","journal-title":"Carbohydr Polym"},{"key":"10.1124\/pharmrev.122.000684_bib702","doi-asserted-by":"crossref","first-page":"116682","DOI":"10.1016\/j.carbpol.2020.116682","article-title":"A non-anticoagulant heparin-like snail glycosaminoglycan promotes healing of diabetic wound","volume":"247","author":"Wu","year":"2020","journal-title":"Carbohydr Polym"},{"key":"10.1124\/pharmrev.122.000684_bib703","doi-asserted-by":"crossref","DOI":"10.1002\/mabi.201900112","article-title":"Inhibition of Inflammation-associated thrombosis with ROS-responsive heparin-DOCA\/PVAX nanoparticles","volume":"19","author":"Xiang","year":"2019","journal-title":"Macromol Biosci"},{"key":"10.1124\/pharmrev.122.000684_bib704","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1182\/blood-2008-04-153288","article-title":"Immune complexes formed following the binding of anti-platelet factor 4 (CXCL4) antibodies to CXCL4 stimulate human neutrophil activation and cell adhesion","volume":"112","author":"Xiao","year":"2008","journal-title":"Blood"},{"key":"10.1124\/pharmrev.122.000684_bib705","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.2147\/JIR.S313374","article-title":"Systematic metabolic profiling of mice with dextran sulfate sodium-induced colitis","volume":"14","author":"Xie","year":"2021","journal-title":"J Inflamm Res"},{"key":"10.1124\/pharmrev.122.000684_bib706","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.omtm.2017.02.004","article-title":"The 2.8 \u00c5 electron microscopy structure of adeno-associated virus-DJ bound by a heparinoid pentasaccharide","volume":"5","author":"Xie","year":"2017","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1124\/pharmrev.122.000684_bib707","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jsb.2013.09.004","article-title":"Electron microscopy analysis of a disaccharide analog complex reveals receptor interactions of adeno-associated virus","volume":"184","author":"Xie","year":"2013","journal-title":"J Struct Biol"},{"key":"10.1124\/pharmrev.122.000684_bib708","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.carbpol.2018.05.070","article-title":"Preparation of low molecular weight heparins from bovine and ovine heparins using nitrous acid degradation","volume":"197","author":"Xie","year":"2018","journal-title":"Carbohydr Polym"},{"key":"10.1124\/pharmrev.122.000684_bib709","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0141-8130(02)00015-6","article-title":"Effect of heparin chain length on the interaction with tissue factor pathway inhibitor (TFPI)","volume":"30","author":"Xu","year":"2002","journal-title":"Int J Biol Macromol"},{"key":"10.1124\/pharmrev.122.000684_bib710","doi-asserted-by":"crossref","first-page":"eaan5954","DOI":"10.1126\/scitranslmed.aan5954","article-title":"Synthetic oligosaccharides can replace animal-sourced low-molecular weight heparins","volume":"9","author":"Xu","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1124\/pharmrev.122.000684_bib711","doi-asserted-by":"crossref","first-page":"10930","DOI":"10.1021\/acs.analchem.0c02449","article-title":"The utility of native MS for understanding the mechanism of action of repurposed therapeutics in COVID-19: heparin as a disruptor of the SARS-CoV-2 interaction with its host cell receptor","volume":"92","author":"Yang","year":"2020","journal-title":"Anal Chem"},{"key":"10.1124\/pharmrev.122.000684_bib712","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/7515346","article-title":"A promising candidate: heparin-binding protein steps onto the stage of sepsis prediction","volume":"2019","author":"Yang","year":"2019","journal-title":"J Immunol Res"},{"key":"10.1124\/pharmrev.122.000684_bib713","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0049-3848(98)00017-6","article-title":"Structural requirements of human tissue factor pathway inhibitor (TFPI) and heparin for TFPI-heparin interaction","volume":"89","author":"Ye","year":"1998","journal-title":"Thromb Res"},{"key":"10.1124\/pharmrev.122.000684_bib714","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1089\/jamp.2015.1273","article-title":"Inhaled heparin: therapeutic efficacy and recent formulations","volume":"30","author":"Yildiz-Pekoz","year":"2017","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"10.1124\/pharmrev.122.000684_bib715","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/glycob\/cww104","article-title":"Surprising absence of heparin in the intestinal mucosa of baby pigs","volume":"27","author":"Yu","year":"2017","journal-title":"Glycobiology"},{"key":"10.1124\/pharmrev.122.000684_bib716","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1080\/13880209.2016.1185444","article-title":"Prospects for the therapeutic application of sulfated polysaccharides of brown algae in diseases of the cardiovascular system: review","volume":"54","author":"Zaporozhets","year":"2016","journal-title":"Pharm Biol"},{"key":"10.1124\/pharmrev.122.000684_bib717","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1172\/JCI29499","article-title":"Complete reversal of acid-induced acute lung injury by blocking of platelet-neutrophil aggregation","volume":"116","author":"Zarbock","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1124\/pharmrev.122.000684_bib718","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/j.jcrs.2006.06.029","article-title":"Inhibition of intraocular fibrin formation after infusion of low-molecular-weight heparin during combined phacoemulsification-trabeculectomy surgery","volume":"32","author":"Zarei","year":"2006","journal-title":"J Cataract Refract Surg"},{"key":"10.1124\/pharmrev.122.000684_bib719","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3390\/md18110571","article-title":"Fucoidan characterization: determination of purity and physicochemical and chemical properties","volume":"18","author":"Zayed","year":"2020","journal-title":"Mar Drugs"},{"key":"10.1124\/pharmrev.122.000684_bib720","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3390\/ph15020258","article-title":"Potential anti-SARS-CoV-2 activity of pentosan polysulfate and mucopolysaccharide polysulfate","volume":"15","author":"Zhang","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1124\/pharmrev.122.000684_bib721","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10719-019-09900-3","article-title":"Interactions between sclerostin and glycosaminoglycans","volume":"37","author":"Zhang","year":"2020","journal-title":"Glycoconj J"},{"key":"10.1124\/pharmrev.122.000684_bib722","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.3390\/molecules24183360","article-title":"Comparison of the interactions of different growth factors and glycosaminoglycans","volume":"24","author":"Zhang","year":"2019","journal-title":"Molecules"},{"key":"10.1124\/pharmrev.122.000684_bib723","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.ejmech.2016.12.004","article-title":"an efficient anticoagulant candidate: characterization, synthesis and in vivo study of a fondaparinux analogue Rrt1.17","volume":"126","author":"Zhang","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1124\/pharmrev.122.000684_bib724","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1038\/s41467-021-21441-8","article-title":"Discovery of exolytic heparinases and their catalytic mechanism and potential application","volume":"12","author":"Zhang","year":"2021","journal-title":"Nat Commun"},{"key":"10.1124\/pharmrev.122.000684_bib725","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/s41421-020-00222-5","article-title":"Heparan sulfate assists SARS-CoV-2 in cell entry and can be targeted by approved drugs in vitro","volume":"6","author":"Zhang","year":"2020","journal-title":"Cell Discov"},{"key":"10.1124\/pharmrev.122.000684_bib726","article-title":"Heparin-coated albumin nanoparticles for drug combination in targeting inflamed intestine","volume":"9","author":"Zhang","year":"2020","journal-title":"Adv Healthc Mater"},{"key":"10.1124\/pharmrev.122.000684_bib727","article-title":"Heparin-induced tau filaments are polymorphic and differ from those in Alzheimer\u2019s and Pick\u2019s diseases","volume":"8","author":"Zhang","year":"2019","journal-title":"eLife"},{"key":"10.1124\/pharmrev.122.000684_bib728","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1177\/0885066621992320","article-title":"The role of histones and heparin in sepsis: a review","volume":"37","author":"Zhang","year":"2022","journal-title":"J Intensive Care Med"},{"key":"10.1124\/pharmrev.122.000684_bib729","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1021\/acs.accounts.9b00420","article-title":"Chemoenzymatic Synthesis of Glycosaminoglycans","volume":"53","author":"Zhang","year":"2020","journal-title":"Acc Chem Res"},{"key":"10.1124\/pharmrev.122.000684_bib730","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.carbpol.2016.05.050","article-title":"Low anticoagulant heparin oligosaccharides as inhibitors of BACE-1, the Alzheimer\u2019s \u03b2-secretase","volume":"151","author":"Zhang","year":"2016","journal-title":"Carbohydr Polym"},{"key":"10.1124\/pharmrev.122.000684_bib731","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.bpj.2017.01.024","article-title":"Glycan determinants of heparin-tau interaction","volume":"112","author":"Zhao","year":"2017","journal-title":"Biophys J"},{"key":"10.1124\/pharmrev.122.000684_bib732","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1039\/D0AN00097C","article-title":"Evaluation of top-down mass spectrometry and ion-mobility spectroscopy as a means of mapping protein-binding motifs within heparin chains","volume":"145","author":"Zhao","year":"2020","journal-title":"Analyst (Lond)"},{"key":"10.1124\/pharmrev.122.000684_bib733","doi-asserted-by":"crossref","first-page":"117888","DOI":"10.1016\/j.carbpol.2021.117888","article-title":"Synergistic effect between 2-N,6-O-sulfonated chitosan and bone morphogenetic protein-2","volume":"263","author":"Zheng","year":"2021","journal-title":"Carbohydr Polym"},{"key":"10.1124\/pharmrev.122.000684_bib734","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/TA.0000000000002387","article-title":"Unfractionated heparin attenuates histone-mediated cytotoxicity in vitro and prevents intestinal microcirculatory dysfunction in histone-infused rats","volume":"87","author":"Zhu","year":"2019","journal-title":"J Trauma Acute Care Surg"},{"key":"10.1124\/pharmrev.122.000684_bib735","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1111\/cmi.12627","article-title":"Syndecans promote mycobacterial internalization by lung epithelial cells","volume":"18","author":"Zimmermann","year":"2016","journal-title":"Cell Microbiol"},{"key":"10.1124\/pharmrev.122.000684_bib736","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3389\/fgene.2019.00102","article-title":"Structural biology of the FGF7 subfamily","volume":"10","author":"Zinkle","year":"2019","journal-title":"Front Genet"},{"key":"10.1124\/pharmrev.122.000684_bib737","doi-asserted-by":"crossref","first-page":"9534","DOI":"10.1021\/jacs.7b01399","article-title":"Heparan sulfate microarray reveals that heparan sulfate-protein binding exhibits different ligand requirements","volume":"139","author":"Zong","year":"2017","journal-title":"J Am Chem Soc"},{"key":"10.1124\/pharmrev.122.000684_bib738","doi-asserted-by":"crossref","first-page":"593310","DOI":"10.3389\/fmolb.2021.593310","article-title":"The Smad dependent TGF-\u03b2 and BMP signaling pathway in bone remodeling and therapies","volume":"8","author":"Zou","year":"2021","journal-title":"Front Mol Biosci"},{"key":"10.1124\/pharmrev.122.000684_bib739","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.sbi.2018.03.003","article-title":"Structural analysis of synthetic heparan sulfate oligosaccharides with fibroblast growth factors and heparin-binding hemagglutinin","volume":"50","author":"Zulueta","year":"2018","journal-title":"Curr Opin Struct Biol"}],"container-title":["Pharmacological Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699724007609?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699724007609?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/pharmrev.122.000684","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T12:45:39Z","timestamp":1740746739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031699724007609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":739,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0031699724007609"],"URL":"https:\/\/doi.org\/10.1124\/pharmrev.122.000684","relation":{},"ISSN":["0031-6997"],"issn-type":[{"value":"0031-6997","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacology of Heparin and Related Drugs: An Update","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/pharmrev.122.000684","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by The Author(s)","name":"copyright","label":"Copyright"}]}}